<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
January 12, 1997
Date of Report (Date of earliest event reported)
CELL GENESYS, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-19986 94-3061375
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification No.)
342 Lakeside Drive
Foster City, California 94404
(Address of principal executive offices, including zip code)
(415) 358-9600
(Registrant's telephone number, including area code)
Not applicable
(Former name or former address, if changed since last report)
<PAGE>
2
Item 5. Other Events.
On January 12, 1997, Cell Genesys, Inc. ("Cell Genesys") entered into
an agreement and plan of merger and reorganization (the "Merger Agreement") with
Somatix Therapy Corporation, a corporation organized under the laws of the State
of Delaware ("Somatix"), and S Merger Corp., a corporation organized under the
laws of the State of Delaware ("Merger Sub") and a direct wholly owned
subsidiary of Cell Genesys. Pursuant to the Merger Agreement, (i) Merger Sub
will be merged (the "Merger") with and into Somatix and Somatix will become a
wholly owned subsidiary of Cell Genesys, (ii) each issued and outstanding share
of capital stock of Somatix will be converted into the right to receive shares
of common stock, par value $.001 per share, of Cell Genesys ("CGI Common
Stock"), upon the terms set forth in the Merger Agreement, and (iii) each
unexpired and unexercised option or warrant to acquire shares of capital stock
of Somatix will be assumed by Cell Genesys and become an option or warrant to
acquire shares of CGI Common Stock.
A total of approximately 11,671,338 shares of CGI Common Stock will be
issued to former holders of capital stock of Somatix pursuant to the Merger, all
of which shares will be issued pursuant to a registration statement on Form S-4
under the Securities Act of 1933, as amended.
The Merger is subject to certain conditions, including the approval of
the stockholders of Cell Genesys and Somatix, and other customary closing
conditions.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits.
<TABLE>
<CAPTION>
Exhibit No. Description
----------- -----------
<S> <C>
2.1 Agreement and plan of merger and reorganization, dated as of January
12, 1997, among Cell Genesys, Inc., S Merger Corp. and Somatix
Therapy Corporation.
10.1 Stock option agreement, dated as of January 12, 1997, between Somatix
Therapy Corporation, as grantor, and Cell Genesys, Inc., as grantee.
10.2 Stock option agreement, dated as of January 12, 1997, between Cell
Genesys, Inc., as grantor, and Somatix Therapy Corporation, as grantee.
99.1 Press release issued January 13, 1997 announcing the proposed business
combination between Cell Genesys, Inc. and Somatix Therapy
Corporation.
</TABLE>
<PAGE>
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CELL GENESYS, INC.
Dated: January 27th, 1997 By: /s/ KATHLEEN SEREDA GLAUB
---------------------------
Kathleen Sereda Glaub
Senior Vice President and
Chief Financial Officer
<PAGE>
4
EXHIBIT INDEX
<TABLE>
<CAPTION>
Exhibit No. Description
----------- -----------
<S> <C>
2.1 Agreement and plan of merger and reorganization, dated as of January
12, 1997, among Cell Genesys, Inc., S Merger Corp. and Somatix
Therapy Corporation.
10.1 Stock option agreement, dated as of January 12, 1997, between Somatix
Therapy Corporation, as grantor, and Cell Genesys, Inc., as grantee.
10.2 Stock option agreement, dated as of January 12, 1997, between Cell
Genesys, Inc., as grantor, and Somatix Therapy Corporation, as grantee.
99.1 Press release issued January 13, 1997 announcing the proposed business
combination between Cell Genesys, Inc. and Somatix Therapy
Corporation.
</TABLE>
<PAGE>
EXHIBIT 2.1
CONFORMED COPY
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION
among
CELL GENESYS, INC.
S MERGER CORP.
and
SOMATIX THERAPY CORPORATION
Dated as of January 12, 1997
<PAGE>
TABLE OF CONTENTS
<TABLE>
<CAPTION>
Page
----
<C> <S> <C>
ARTICLE I
DEFINITIONS
SECTION 1.01. Certain Defined Terms......................................... 2
ARTICLE II
THE MERGER
SECTION 2.01. The Merger.................................................... 12
SECTION 2.02. Closing....................................................... 12
SECTION 2.03. Effective Time................................................ 13
SECTION 2.04. Effect of the Merger.......................................... 13
SECTION 2.05. Certificate of Incorporation; By-laws; Directors and
Officers of Surviving Corporation.......................... 13
ARTICLE III
CONVERSION OF SECURITIES; EXCHANGE OF CERTIFICATES
SECTION 3.01. Conversion of Securities...................................... 14
SECTION 3.02. Exchange of Shares Other than Treasury Shares................. 15
SECTION 3.03. Stock Transfer Books.......................................... 16
SECTION 3.04. No Fractional Share Certificates.............................. 16
SECTION 3.05. Options and Warrants to Purchase STC Common Stock............. 18
SECTION 3.06. Certain Adjustments........................................... 19
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF STC
SECTION 4.01. Organization and Qualification; Subsidiaries.................. 19
SECTION 4.02. Certificate of Incorporation and By-laws...................... 19
SECTION 4.03. Capitalization................................................ 20
</TABLE>
i
<PAGE>
<TABLE>
<CAPTION>
Page
----
<C> <S> <C>
SECTION 4.04. Authority Relative to This Agreement and the STC Stock
Option Agreement........................................... 20
SECTION 4.05. No Conflict; Required Filings and Consents.................... 21
SECTION 4.06. Permits; Compliance with Laws................................. 22
SECTION 4.07. SEC Filings; Financial Statements; Projected Cash Balances;
Operating Budget........................................... 23
SECTION 4.08. Absence of Certain Changes or Events.......................... 24
SECTION 4.09. Employee Benefit Plans; Labor Matters......................... 25
SECTION 4.10. Tax Matters................................................... 26
SECTION 4.11. Contracts; Debt Instruments................................... 26
SECTION 4.12. Litigation.................................................... 27
SECTION 4.13. Environmental Matters......................................... 27
SECTION 4.14. Intellectual Property......................................... 27
SECTION 4.15. Taxes......................................................... 28
SECTION 4.16. Opinion of Financial Advisor.................................. 28
SECTION 4.17. Brokers....................................................... 28
SECTION 4.18. Certain Interests............................................. 28
ARTICLE V
REPRESENTATIONS AND WARRANTIES OF CGI AND MERGER SUB
SECTION 5.01. Organization and Qualification; Subsidiaries.................. 29
SECTION 5.02. Certificate of Incorporation and By-laws...................... 30
SECTION 5.03. Capitalization................................................ 30
SECTION 5.04. Authority Relative to This Agreement and the CGI Stock
Option Agreement........................................... 31
SECTION 5.05. No Conflict; Required Filings and Consents.................... 31
SECTION 5.06. Permits; Compliance with Laws................................. 32
SECTION 5.07. SEC Filings; Financial Statements............................. 33
SECTION 5.08. Absence of Certain Changes or Events.......................... 34
SECTION 5.09. Employee Benefit Plans; Labor Matters......................... 34
SECTION 5.10. Tax Matters................................................... 36
SECTION 5.11. Contracts; Debt Instruments................................... 36
SECTION 5.12. Litigation.................................................... 36
SECTION 5.13. Environmental Matters......................................... 37
SECTION 5.14. Intellectual Property......................................... 37
SECTION 5.15. Taxes......................................................... 38
SECTION 5.16. Opinion of Financial Advisor.................................. 38
SECTION 5.17. Brokers....................................................... 38
</TABLE>
ii
<PAGE>
<TABLE>
<CAPTION>
Page
----
<C> <S> <C>
SECTION 5.18. Certain Interests............................................. 38
ARTICLE VI
COVENANTS
SECTION 6.01. Conduct of Business by STC Pending the Closing................ 39
SECTION 6.02. Conduct of Business by CGI Pending the Closing................ 41
SECTION 6.03. Cooperation; Steering Committee............................... 43
SECTION 6.04. Notices of Certain Events..................................... 44
SECTION 6.05. Access to Information; Confidentiality........................ 44
SECTION 6.06. No Solicitation of Transactions............................... 44
SECTION 6.07. Plan of Reorganization........................................ 45
SECTION 6.08. Subsequent Financial Statements............................... 46
SECTION 6.09. Control of Operations......................................... 46
SECTION 6.10. Further Action; Consents; Filings............................. 46
ARTICLE VII
ADDITIONAL AGREEMENTS
SECTION 7.01. Registration Statement; Joint Proxy Statement................. 47
SECTION 7.02. Stockholders' Meetings........................................ 49
SECTION 7.03. Affiliates.................................................... 49
SECTION 7.04. Directors' and Officers' Indemnification and Insurance........ 50
SECTION 7.05. No Shelf Registration......................................... 51
SECTION 7.06. Public Announcements.......................................... 51
SECTION 7.07. Officers and Directors of CGI................................. 51
SECTION 7.08. NMS Listing................................................... 52
SECTION 7.09. Blue Sky...................................................... 52
SECTION 7.10. STC Stock Options............................................. 52
SECTION 7.11. [INTENTIONALLY LEFT BLANK].................................... 53
SECTION 7.12. Bridge Facility............................................... 53
SECTION 7.13. Audited Financial Statements.................................. 54
SECTION 7.14. Liquidity Takedowns; Additional Debt.......................... 55
SECTION 7.15. Collateralization............................................. 56
</TABLE>
iii
<PAGE>
<TABLE>
<CAPTION>
Page
----
<C> <S> <C>
ARTICLE VIII
CONDITIONS TO THE MERGER
SECTION 8.01. Conditions to the Obligations of Each Party to Consummate
the Merger................................................. 56
SECTION 8.02. Conditions to the Obligations of STC.......................... 57
SECTION 8.03. Conditions to the Obligations of CGI.......................... 58
ARTICLE IX
TERMINATION, AMENDMENT AND WAIVER
SECTION 9.01. Termination................................................... 59
SECTION 9.02. Effect of Termination......................................... 61
SECTION 9.03. Amendment..................................................... 62
SECTION 9.04. Waiver........................................................ 62
SECTION 9.05. Expenses...................................................... 62
ARTICLE X
GENERAL PROVISIONS
SECTION 10.01. Non-Survival of Representations and Warranties................ 63
SECTION 10.02. Notices....................................................... 63
SECTION 10.03. Severability.................................................. 63
SECTION 10.04. Assignment; Binding Effect; Benefit........................... 64
SECTION 10.05. Incorporation of Exhibits..................................... 64
SECTION 10.06. Specific Performance.......................................... 64
SECTION 10.07. Governing Law................................................. 64
SECTION 10.08. Waiver of Jury Trial.......................................... 64
SECTION 10.09. Headings...................................................... 64
SECTION 10.10. Counterparts.................................................. 65
SECTION 10.11. Entire Agreement.............................................. 65
</TABLE>
iv
<PAGE>
EXHIBITS
Exhibit 1.00(a) Form of STC Stock Option Agreement
Exhibit 1.00(b) Form of CGI Stock Option Agreement
Exhibit 1.00(c) Form of Bridge Facility Promissory Note
Exhibit 1.01(a) Form of Stockholder Resolution Regarding the CGI Amendment
Exhibit 1.01(b) Form of Stockholder Resolution Regarding the STC Amendment
Exhibit 7.03(a) Form of STC Affiliate Agreement
Exhibit 7.03(b) Form of CGI Affiliate Agreement
v
<PAGE>
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION, dated as of January
12, 1997 (as amended, supplemented or otherwise modified from time to time, this
"Agreement"), among CELL GENESYS, INC., a corporation organized and existing
under the laws of the State of Delaware ("CGI"), S MERGER CORP., a corporation
organized and existing under the laws of the State of Delaware ("Merger Sub")
and a direct wholly owned subsidiary of CGI, and SOMATIX THERAPY CORPORATION, a
corporation organized and existing under the laws of the State of Delaware
("STC");
W I T N E S S E T H:
- - - - - - - - - -
WHEREAS, the boards of directors of CGI, Merger Sub and STC have each
determined that it is fair to and in the best interests of their respective
stockholders for Merger Sub to merge (the "Merger") with and into STC upon the
terms and subject to the conditions set forth herein and in accordance with the
General Corporation Law of the State of Delaware (the "General Corporation
Law");
WHEREAS, concurrently with the execution of this Agreement and as an
inducement to CGI and Merger Sub to enter into this Agreement, CGI, Merger Sub
and STC have entered into a stock option agreement, dated as of the date hereof
(the "STC Stock Option Agreement"), substantially in the form attached hereto as
Exhibit 1.00(a) pursuant to which STC has granted to Purchaser an option to
- ---------------
purchase from STC up to 5,441,480 shares of common stock, par value $.01 per
share, of STC (the "STC Common Stock"), representing approximately 19.9 percent
of the shares of STC Common Stock issued and outstanding on the date hereof, at
a price of $3.51 per Share, all upon the terms and subject to the conditions set
forth therein;
WHEREAS, concurrently with the execution of this Agreement and as an
inducement to STC to enter into this Agreement, CGI and STC have entered into a
stock option agreement, dated as of the date hereof (the "CGI Stock Option
Agreement"), substantially in the form attached hereto as Exhibit 1.00(b)
---------------
pursuant to which CGI has granted to STC an option to purchase from CGI up to
3,286,703 shares of common stock, par value $.001 per share, of CGI (the "CGI
Common Stock"), representing approximately 19.9 percent of the shares of CGI
Common Stock issued and outstanding on the date hereof, at a price of $9.12 per
Share, all upon the terms and subject to the conditions set forth therein;
WHEREAS, concurrently with the execution of this Agreement and as an
inducement to CGI and Merger Sub to enter into this Agreement, STC has made a
promissory note in favor of CGI, dated as of the date hereof (the "Bridge
Facility Promissory Note"), substantially in the form attached hereto as Exhibit
-------
1.00(c) pursuant to which STC has agreed to repay with interest the aggregate
- -------
principal amount of all Advances
<PAGE>
2
(as defined below) made by CGI under the Bridge Facility (as defined below), all
upon the terms and subject to the conditions set forth therein; and
WHEREAS, for United States federal income tax purposes, it is intended
that the Merger qualify as a reorganization under the provisions of Section 368
of the Internal Revenue Code of 1986, as amended (together with the rules and
regulations promulgated thereunder, the "Code");
NOW, THEREFORE, in consideration of the foregoing and the
representations, warranties, covenants and agreements set forth herein, and
other good and valuable consideration, the receipt and adequacy of which are
hereby acknowledged, and intending to be legally bound hereby, the parties
hereto hereby agree as follows:
ARTICLE I
DEFINITIONS
SECTION 1.01. Certain Defined Terms. Unless the context otherwise
requires, the following terms, when used in this Agreement, shall have the
respective meanings specified below:
"Actual Balances" shall mean, on any specified date, the actual
balances of cash, cash equivalents and marketable securities held by STC on such
date.
"affiliate" shall have the meaning specified in Rule 144 promulgated
under the Securities Act.
"Agreement" shall have the meaning specified in the preamble to this
Agreement.
"beneficial owner" shall mean, with respect to any shares of capital
stock, a person who shall be deemed to be the beneficial owner of such shares
(i) which such person or any of its affiliates or associates (as such term is
defined in Rule 12b-2 promulgated under the Exchange Act) beneficially owns,
directly or indirectly, (ii) which such person or any of its affiliates or
associates has, directly or indirectly, (A) the right to acquire (whether such
right is exercisable immediately or subject only to the passage of time),
pursuant to any agreement, arrangement or understanding or upon the exercise of
consideration rights, exchange rights, warrants or options, or otherwise, or (B)
the right to vote pursuant to any agreement, arrangement or understanding, or
(iii) which are beneficially owned, directly or indirectly, by any other persons
with whom such person or any of its affiliates or associates or person with whom
such person or any of its affiliates or associates has any agreement,
<PAGE>
3
arrangement or understanding for the purpose of acquiring, holding, voting or
disposing of any such shares of capital stock.
"Blue Sky Laws" shall mean state securities or "blue sky" laws.
"Bridge Facility" shall mean the loan facility to be provided by CGI
to STC pursuant to, and upon the terms and subject to the conditions set forth
in, Section 7.12 and the Bridge Facility Promissory Note.
"Bridge Facility Maturity Date" shall mean the earliest to occur of
(i) August 31, 1997; (ii) the 20th day after termination of this Agreement for
any reason whatsoever; (iii) notwithstanding the immediately preceding clause
(ii), the first business day after termination of this Agreement by CGI pursuant
to Section 9.01(d); (iv) the first business day after the board of directors of
STC changes, modifies, or withdraws its recommendation of the Merger in a manner
adverse to CGI; and (v) the day on which CGI declares its obligation to make
Advances to be terminated pursuant to the Bridge Facility Promissory Note with
respect to an Event of Default described in subsection (vi) or (vii) of the
definition of Event of Default contained in the Bridge Facility Promissory Note.
"Bridge Facility Promissory Note" shall have the meaning specified
in the recitals to this Agreement.
"business day" shall mean any day on which the principal offices of
the SEC in Washington, D.C. are open to accept filings, or, in the case of
determining a date when any payment is due, any day on which banks are not
required or authorized by law or executive order to close in San Francisco,
California.
"Certificate of Merger" shall have the meaning specified in Section
2.03.
"CGI" shall have the meaning specified in the preamble to this
Agreement.
"CGI Affiliate Agreement" shall have the meaning specified in
Section 7.03(b).
"CGI Amendment" shall mean the proposed amendment, substantially in
the form attached hereto as Exhibit 1.01(a), to the certificate of incorporation
---------------
of CGI, to be included in the Joint Proxy Statement and voted on at CGI
Stockholders' Meeting.
"CGI Benefit Plans" shall have the meaning specified in Section
5.09(a).
"CGI Common Stock" shall have the meaning specified in the recitals
to this Agreement.
<PAGE>
4
"CGI Director" shall mean any person serving as a director of CGI on
the date hereof who remains a director of CGI after the Effective Time or any
other designee selected by CGI.
"CGI Disclosure Schedule" shall mean the disclosure schedule delivered
by CGI to STC prior to the execution of this Agreement and forming a part
hereof.
"CGI Material Adverse Effect" shall mean any change in or effect on
the business of CGI and the CGI Subsidiaries that is, or could reasonably be
expected to be, materially adverse to the business, assets (including intangible
assets), liabilities (contingent or otherwise), condition (financial or
otherwise) or results of operations of CGI and the CGI Subsidiaries taken as a
whole; provided, however, that any change in or effect upon the business of CGI
and the CGI Subsidiaries that directly or indirectly arises out of or is
attributable to (i) any decrease in the market price of CGI Common Stock (but
not any change or effect underlying such decrease to the extent such change or
effect would otherwise constitute a CGI Material Adverse Effect) or (ii)
circumstances or events that generally affect the industries in which CGI or the
CGI Subsidiaries operate, shall not constitute a CGI Material Adverse Effect;
provided further that the foregoing proviso shall not be deemed to cause the
condition contained in Section 8.02(a) or (b) not to have been satisfied.
"CGI Material Contract" shall have the meaning specified in Section
5.11.
"CGI Permits" shall have the meaning specified in Section 5.06(a).
"CGI Reports" shall have the meaning specified in Section 5.07(a).
"CGI Right" shall mean the preferred share purchase right to be issued
with respect to each share of CGI Common Stock issued to holders of STC Capital
Stock pursuant to the Merger as provided in Section 3(b) of the CGI Rights
Agreement.
"CGI Rights Agreement" shall mean the preferred shares rights
agreement, dated as of July 28, 1995, between CGI and The First National Bank of
Boston, as rights agent.
"CGI Stock Option Agreement" shall have the meaning specified in the
recitals to this Agreement.
"CGI Stock Plans" shall mean CGI's 1989 Incentive Stock Plan, as
amended, and 1992 Employee Stock Purchase Plan, as amended.
<PAGE>
5
"CGI Stockholders" Meeting" shall have the meaning specified in
Section 7.01(a).
"CGI Subsidiaries" shall have the meaning specified in Section 5.01.
"Closing" shall have the meaning specified in Section 2.02.
"Code" shall have the meaning specified in the recitals to this
Agreement.
"Commitment Termination Event" shall mean any of (i) termination of
this Agreement or the Bridge Facility Promissory Note for any reason whatsoever;
(ii) the occurrence of an Event of Default under the Bridge Facility Promissory
Note; (iii) a material breach of this Agreement or the Bridge Facility
Promissory Note; and (iv) the exercise of one or more of the Fletcher Put
Options or the consummation of any other Liquidity Takedown; provided that, upon
the occurrence of a Commitment Termination Event described in this clause (iv),
the commitment of CGI under the Bridge Facility shall only be reduced on a
dollar-for-dollar basis equal to the proceeds of any Liquidity Takedown (e.g., a
$2,000,000 Liquidity Takedown would reduce CGI's commitment under the Bridge
Facility to $3,000,000).
"Common Exchange Ratio" shall have the meaning specified in Section
3.01(a).
"Competing Transaction" shall mean any of the following involving CGI
or STC, as the case may be (other than the Merger contemplated by this
Agreement):
(i) any merger, consolidation, share exchange, business
combination or other similar transaction;
(ii) any sale, lease, exchange, mortgage, pledge, transfer or
other disposition of 15 percent or more of the assets of such party and its
subsidiaries, taken as a whole, in a single transaction or series of
transactions;
(iii) any tender offer or exchange offer for 25 percent or more
of the outstanding voting securities of such party or the filing of a
registration statement under the Securities Act in connection therewith; or
(iv) any person having acquired beneficial ownership or the
right to acquire beneficial ownership of, or any "group" (as such term is
defined under Section 13(d) of the Exchange Act) having been formed which
beneficially owns or has the right to acquire beneficial ownership of, 25
percent or more of the outstanding voting securities of such party;
<PAGE>
6
(v) any solicitation by any person (A) proposing any
transaction described in clause (i), (ii), (iii) or (iv) above or (B) who
is not a stockholder of CGI or STC on the date hereof, in opposition to the
approval of this Agreement by the stockholders of CGI or STC; or
(vi) any public announcement of a proposal, plan or intention to
do any of the foregoing or any agreement to engage in any of the foregoing.
"Confidentiality Agreement" shall mean the confidentiality agreement,
dated as of October 14, 1996, between CGI and STC.
"Costs" shall have the meaning specified in Section 7.04(d).
"DEA" the United States Drug Enforcement Administration.
"DLJ" shall mean Donaldson, Lufkin & Jenrette, financial advisors to
STC.
"$" shall mean United States Dollars.
"Effective Time" shall have the meaning specified in Section 2.03.
"Environmental Law" shall mean any Law and any enforceable judicial or
administrative interpretation thereof, including any judicial or administrative
order, consent decree or judgment, relating to pollution or protection of the
environment or natural resources, including, without limitation, those relating
to the use, handling, transportation, treatment, storage, disposal, release or
discharge of Hazardous Material, as in effect as of the date hereof.
"Environmental Permit" shall mean any permit, approval, identification
number, license or other authorization required under or issued pursuant to any
applicable Environmental Law.
"ERISA" shall mean the Employee Retirement Income Security Act of
1974, as amended.
"Event of Default" shall have the meaning specified in the Bridge
Facility Promissory Note.
"Excess Shares" shall have the meaning specified in Section 3.04(b).
"Exchange Act" shall mean the Securities Exchange Act of 1934, as
amended, together with the rules and regulations promulgated thereunder.
<PAGE>
7
"Exchange Agent" shall have the meaning specified in Section 3.02.
"Exchange Fund" shall have the meaning specified in Section 3.02.
"Expenses" shall mean, with respect to any party hereto, all
reasonable out-of-pocket expenses (including, without limitation, all fees and
expenses of counsel, accountants, investment bankers, experts and consultants to
a party hereto and its affiliates) incurred by such party or on its behalf in
connection with or related to the authorization, preparation, negotiation,
execution and performance of its obligations pursuant to this Agreement and the
consummation of the Merger, the preparation, printing, filing and mailing of the
Registration Statement and the Joint Proxy Statement, the solicitation of
shareholder approvals, the filing of HSR Act notice, if any, and all other
matters related to the closing of the Merger.
"FDA" shall mean the United States Food and Drug Administration.
"FDCA" shall mean the Federal Food, Drug, and Cosmetic Act, as
amended.
"Fletcher" shall mean Fletcher International Limited, a company
organized under the laws of the Cayman Islands.
"Fletcher Put Options" shall mean the put options granted by Fletcher
to STC pursuant to Section 1(a) of the subscription agreement, dated September
24, 1996, between STC and Fletcher and upon the terms and subject to the
conditions set forth in Annex A thereto.
"Fletcher Warrant" shall mean the warrant, dated September 25, 1996,
issued by STC to and in the name of Fletcher.
"General Corporation Law" shall have the meaning specified in the
recitals to this Agreement.
"Governmental Entity" shall mean any United States federal, state or
local or any foreign governmental, regulatory or administrative authority,
agency or commission or any court, tribunal or arbitral body.
"Governmental Order" shall mean any order, writ, judgment, injunction,
decree, stipulation, determination or award entered by or with any Governmental
Entity.
"Hazardous Material" shall mean (i) any petroleum, petroleum products,
by-products or breakdown products, radioactive materials, asbestos-containing
materials or polychlorinated biphenyls or (ii) any chemical, material or
substance defined or regulated as
<PAGE>
8
toxic or hazardous or as a pollutant or contaminant or waste under any
applicable Environmental Law.
"HSR Act" shall mean the Hart-Scott-Rodino Antitrust Improvements Act
of 1976, as amended, together with the rules and regulations promulgated
thereunder.
"Indemnified Parties" shall have the meaning specified in Section
7.04(d).
"IRS" shall mean the United States Internal Revenue Service.
"Joint Proxy Statement" shall have the meaning specified in Section
7.01(a).
"Law" shall mean any federal, state or local statute, law, ordinance,
regulation, rule, code, order, other requirement or rule of law of the United
States or any other jurisdiction, including, without limitation, the FDCA, the
Controlled Substances Act, and any other similar act or law.
"Lehman Brothers" shall mean Lehman Brothers, Inc., financial advisors
to CGI.
"Liquidity Notice" shall have the meaning specified in Section
7.12(b).
"Liquidity Takedown" shall have the meaning specified in Section
7.14(a).
"Merger" shall have the meaning specified in the recitals to this
Agreement.
"Merger Sub" shall have the meaning specified in the preamble to this
Agreement.
"NASD" shall mean the National Association of Securities Dealers, Inc.
"New Financing Adjustment Amount" shall mean .3850 minus the quantity
.3850 multiplied by the quotient of (i) (A) the aggregate number of shares of
CGI Common Stock issuable upon conversion of the STC Common Stock and the Series
A Preferred Stock pursuant to Sections 3.01(a) and 3.01(b), respectively, before
giving effect to clause (i), (ii) or (iii) in Section 3.01(a), minus (B) the
aggregate number of shares of CGI Common Stock issuable upon conversion of any
securities of STC issued thereby in connection with any Liquidity Takedown;
divided by (ii) the aggregate number of shares of CGI Common Stock issuable upon
conversion of the STC Common Stock and the Series A Preferred Stock pursuant to
Sections 3.01(a) and 3.01(b), respectively, before giving effect to clause (i),
(ii) or (iii) in Section 3.01(a). The purpose of the New Financing Adjustment
Amount is to ensure, and the New Financing Adjustment Amount shall be construed
so as to ensure, that
<PAGE>
9
the number of shares of CGI Common Stock issuable pursuant to the Merger is the
same whether or not STC shall elect to issue in connection with any Liquidity
Takedown securities of STC convertible into shares of CGI Common Stock pursuant
to the Merger.
"NMS" shall mean the National Association of Securities Dealers
Automated Quotation System/National Market System.
"Operating Budget" shall have the meaning specified in Section
4.07(e).
"Permitted Financing" shall have the meaning specified in Section
7.14(b).
"person" shall mean an individual, corporation, partnership, limited
partnership, limited liability company, syndicate, person (including, without
limitation, a "person" as defined in Section 13(d)(3) of the Exchange Act),
trust, association, entity or government or political subdivision, agency or
instrumentality of a government.
"Presurrender Dividends" shall have the meaning specified in Section
3.02.
"Projected Cash Balances" shall have the meaning specified in Section
4.07(d).
"Registration Statement" shall have the meaning specified in Section
7.01(a).
"Representatives" shall have the meaning specified in Section 6.05(a).
"SEC" shall have the meaning specified in the recitals to this
Agreement.
"Securities Act" shall mean the Securities Act of 1933, as amended,
together with the rules and regulations promulgated thereunder.
"Series A Exchange Ratio" shall have the meaning specified in Section
3.01(b).
"Series A Preferred Stock" shall mean the preferred stock of STC
designated as "Series A-1 Preferred Stock" and "Series A-2 Preferred Stock"
pursuant to the certificate of designation of preferences of preferred shares of
STC filed with the Secretary of State of the State of Delaware on June 29, 1995.
"Series B Adjustment Amount" shall mean .3850 minus the quantity .3850
multiplied by the quotient of (i) (A) the aggregate number of shares of CGI
Common Stock issuable upon conversion of the STC Common Stock and the Series A
Preferred Stock pursuant to Sections 3.01(a) and 3.01(b), respectively, before
giving effect to clause (i), (ii)
<PAGE>
10
or (iii) in Section 3.01(a), minus (B) the product of (1) aggregate number of
shares of Series B Preferred Stock issued and outstanding immediately prior to
the Effective Time multiplied by (2) the Series B Exchange Ratio minus 16.4384;
divided by (ii) the aggregate number of shares of CGI Common Stock issuable upon
conversion of the STC Common Stock and the Series A Preferred Stock pursuant to
Sections 3.01(a) and 3.01(b), respectively, before giving effect to clause (i),
(ii) or (iii) in Section 3.01(a).
"Series B Exchange Ratio" shall have the meaning specified in
Section 3.01(c).
"Series B Preferred Stock" shall mean the preferred stock of STC
designated as "Series B-1 Preferred Stock" pursuant to the certificate of
designation of preferences of preferred shares of STC filed with the Secretary
of State of the State of Delaware on September 25, 1996.
"STC" shall have the meaning specified in the preamble to this
Agreement.
"STC Affiliate Agreement" shall have the meaning specified in
Section 7.05(a).
"STC Amendment" shall mean the proposed amendment, substantially in
the form attached hereto as Exhibit 1.01(b), to the certificate of incorporation
---------------
of STC, to be included in the Joint Proxy Statement and voted on at the STC
Stockholders' Meeting.
"STC Benefit Plans" shall have the meaning specified in
Section 4.09(a).
"STC Capital Stock" shall mean the STC Common Stock, the Series A
Preferred Stock and the Series B Preferred Stock.
"STC Common Stock" shall have the meaning specified in the recitals to
this Agreement.
"STC Director" shall mean any person serving as a director of STC on
the date hereof who becomes a director of CGI at the Effective Time or any other
designee selected by STC.
"STC Disclosure Schedule" shall mean the disclosure schedule delivered
by STC to CGI prior to the execution of this Agreement and forming a part
hereof.
"STC Material Adverse Effect" shall mean any change in or effect on
the business of STC and the STC Subsidiaries that is, or could reasonably be
expected to be, materially adverse to the business, assets (including intangible
assets), liabilities (contingent
<PAGE>
11
or otherwise), condition (financial or otherwise) or results of operations of
STC and the STC Subsidiaries taken as a whole; provided, however, that any
change in or effect upon the business of STC and the STC Subsidiaries that
directly or indirectly arises out of or is attributable to (i) the loss by STC
of any of its corporate partners (including, without limitation, any financial
consequence of such loss of corporate partners) due primarily to the public
announcement of this Agreement and the transactions contemplated hereby, (ii)
any decrease in the market price of the STC Common Stock (but not any change or
effect underlying such decrease to the extent such change or effect would
otherwise constitute an STC Material Adverse Effect), (iii) circumstances or
events that generally affect the industries in which STC or the STC Subsidiaries
operate, (iv) so long as STC has not breached Section 6.01 in any material
respect, any decrease in STC's cash balances and liquidity from the date hereof
and (v) in the event CGI has not, pursuant to Section 7.12, made available to
STC funds which, together with STC's then existing funds, are sufficient to
avoid the triggering of the rights specified in Section 7(B) of the certificate
of designation of STC applicable to the Series A Preferred Stock, the triggering
of such rights, shall not constitute an STC Material Adverse Effect; provided
further that the foregoing proviso shall not be deemed to cause the condition
contained in Section 8.03(a) or (b) not to have been satisfied.
"STC Material Contract" shall have the meaning specified in
Section 4.11.
"STC Permits" shall have the meaning specified in Section 4.06(a).
"STC Reports" shall have the meaning specified in Section 4.07(a).
"STC Stock Option" shall have the meaning specified in Section 3.05.
"STC Stock Option Agreement" shall have the meaning specified in the
recitals to this Agreement.
"STC Stock Plans" shall mean the Hana Biologics, Inc. 1988 Directors
Stock Option Plan, STC's 1988 Stock Option Plan, as amended, the GeneSys
Therapeutic Corporation 1991 Stock Option Plan, STC's 1992 Stock Option Plan, as
amended, and the Merlin Pharmaceutical Corporation 1993 Stock Option Plan.
"STC Stockholders' Meeting" shall have the meaning specified in
Section 7.01(a).
"STC Subsidiaries" shall have the meaning specified in Section 4.01.
"subsidiary" shall mean, with respect to any person, any corporation,
limited liability company, partnership, joint venture or other legal entity of
which such person (either
<PAGE>
12
alone or through or together with any other subsidiary of such person) owns,
directly or indirectly, a majority of the stock or other equity interests, the
holders of which are generally entitled to vote for the election of the board of
directors or other governing body of such corporation or other legal entity.
"Surviving Corporation" shall have the meaning specified in Section
2.01.
"Taxes" shall mean any and all taxes, fees, levies, duties, tariffs,
imposts and other charges of any kind (together with any and all interest,
penalties, additions to tax and additional amounts imposed with respect thereto)
imposed by any Governmental Entity or taxing authority, including, without
limitation, taxes or other charges on or with respect to income, franchises,
windfall or other profits, gross receipts, property, sales, use, capital stock,
payroll, employment, social security, workers' compensation, unemployment
compensation or net worth; taxes or other charges in the nature of excise,
withholding, ad valorem, stamp, transfer, value-added or gains taxes; license,
registration and documentation fees; and customers' duties, tariffs and similar
charges.
"Terminating CGI Breach" shall have the meaning specified in Section
9.01(h).
"Terminating STC Breach" shall have the meaning specified in Section
9.01(g).
"Trust" shall have the meaning specified in Section 3.04(c).
"U.S. GAAP" shall mean United States generally accepted accounting
principles.
ARTICLE II
THE MERGER
SECTION 2.01. The Merger. Upon the terms and subject to the
conditions set forth in this Agreement, and in accordance with the General
Corporation Law, at the Effective Time, Merger Sub shall be merged with and into
STC. As a result of the Merger, the separate corporate existence of Merger Sub
shall cease and STC shall continue as the surviving corporation of the Merger
(the "Surviving Corporation").
SECTION 2.02. Closing. Unless this Agreement shall have been
terminated and the Merger shall have been abandoned pursuant to Section 9.01 and
subject to the satisfaction or waiver of the conditions set forth in Article
VIII, the consummation of the
<PAGE>
13
Merger shall take place as promptly as practicable (and in any event within
three business days) after satisfaction or waiver of the conditions set forth in
Article VIII, at a closing (the "Closing") to be held at the offices of Shearman
& Sterling, 555 California Street, San Francisco, California, unless another
date, time or place is agreed to by STC and CGI.
SECTION 2.03. Effective Time. At the time of the Closing, the
parties shall cause the Merger to be consummated by filing a certificate of
merger (the "Certificate of Merger") with the Secretary of State of the State of
Delaware in such form as required by, and executed in accordance with the
relevant provisions of, the General Corporation Law (the date and time of such
filing being the "Effective Time").
SECTION 2.04. Effect of the Merger. At the Effective Time, the
effect of the Merger shall be as provided in the applicable provisions of the
General Corporation Law. Without limiting the generality of the foregoing, and
subject thereto, at the Effective Time, except as otherwise provided herein, all
the property, rights, privileges, powers and franchises of STC and Merger Sub
shall vest in the Surviving Corporation, and all debts, liabilities and duties
of STC and Merger Sub shall become the debts, liabilities and duties of the
Surviving Corporation.
SECTION 2.05. Certificate of Incorporation; By-laws; Directors ad
Officers of Surviving Corporation. Unless otherwise agreed by STC and CGI prior
to the Effective Time, at the Effective Time:
(a) the certificate of incorporation and by-laws of Merger Sub,
as in effect immediately prior to the Effective Time, shall be the
certificate of incorporation and by-laws of the Surviving Corporation until
thereafter amended as provided by Law and such certificate of incorporation
or by-laws;
(b) the officers of Merger Sub immediately prior to the
Effective Time shall be the initial officers of the Surviving Corporation
until their successors are elected or appointed and qualified or until
their resignation or removal; and
(c) the directors of Merger Sub immediately prior to the
Effective Time shall be the initial directors of the Surviving Corporation
until their successors are elected or appointed and qualified or until
their resignation or removal.
<PAGE>
14
ARTICLE III
CONVERSION OF SECURITIES; EXCHANGE OF CERTIFICATES
SECTION 3.01. Conversion of Securities. At the Effective Time, by
virtue of the Merger and without any action on the part of Merger Sub, STC or
the holders of any of the following securities:
(a) Each share of STC Common Stock issued and outstanding
immediately prior to the Effective Time (other than any shares of STC
Common Stock to be cancelled pursuant to Section 3.01(d)) and all rights in
respect thereof shall forthwith cease to exist and shall be converted into
and become exchangeable for the number of shares of CGI Common Stock (and
associated CGI Rights) equal to .3850 minus (i) in the event that the
Series B Exchange Ratio shall be greater than 16.4384, the Series B
Adjustment Amount, (ii) in the event that the holder(s) of the Fletcher
Warrant shall elect pursuant to the Fletcher Notice and in accordance with
Section 10 of the Fletcher Warrant to put the Fletcher Warrant to, and have
the Fletcher Warrant redeemed by, STC, .0063, and (iii) in the event that
STC shall issue in connection with any Liquidity Takedown any securities
convertible into shares of CGI Common Stock pursuant to this Section 3.01,
the New Financing Adjustment Amount (after giving effect to such
adjustments, if any, the "Common Exchange Ratio");
(b) Each share of Series A Preferred Stock issued and
outstanding immediately prior to the Effective Time (other than any shares
of Series A Preferred Stock to be cancelled pursuant to Section 3.01(d))
and all rights in respect thereof shall forthwith cease to exist and shall
be converted into and become exchangeable for the number of shares of CGI
Common Stock (and associated CGI Rights) equal to the product of 6.25
multiplied by the Common Exchange Ratio (the "Series A Exchange Ratio");
(c) Each share of Series B Preferred Stock issued and
outstanding immediately prior to the Effective Time (other than any shares
of Series B Preferred Stock to be cancelled pursuant to Section 3.01(d))
and all rights in respect thereof shall forthwith cease to exist and shall
be converted into and become exchangeable for the number of shares of CGI
Common Stock (and associated CGI Rights) equal to the quotient of $150.00
divided by the average of the daily closing prices of the CGI Common Stock
over the 30-day period ending three days prior to the Effective Time (the
"Series B Exchange Ratio");
(d) Each share of STC Capital Stock held in the treasury of STC
and each share of STC Capital Stock owned by CGI or any direct or indirect
wholly
<PAGE>
15
owned subsidiary of CGI or of STC immediately prior to the Effective Time
shall be cancelled and extinguished without any conversion thereof and no
payment shall be made with respect thereto; and
(e) Each share of common stock, par value $.01 per share, of
Merger Sub issued and outstanding immediately prior to the Effective Time
and all rights in respect thereof shall forthwith cease to exist and shall
be converted into and become exchangeable for one newly and validly issued,
fully paid and nonassessable share of common stock of the Surviving
Corporation.
SECTION 3.02. Exchange of Shares Other than Treasury Shares. Subject
to the terms and conditions hereof, at or prior to the Effective Time, CGI shall
appoint, and shall retain for a period of at least six months after the
Effective Time, an exchange agent to effect the exchange of shares of STC
Capital Stock for CGI Common Stock (and associated CGI Rights) in accordance
with the provisions of this Article III (the "Exchange Agent"). As soon as
reasonably practicable after the Effective Time, CGI will instruct the Exchange
Agent to mail to each holder of record of STC Capital Stock (i) a letter of
transmittal (which shall specify that delivery shall be effected, and risk of
loss and title to certificates evidencing shares of STC Capital Stock shall
pass, only upon proper delivery of such certificates to the Exchange Agent and
shall be in such form and have such other provisions as CGI may reasonably
specify) and (ii) instructions to effect the surrender of certificates
evidencing shares of STC Capital Stock in exchange for certificates evidencing
shares of CGI Common Stock (and associated CGI Rights) and, in lieu of any
fractional shares thereof, cash. From time to time after the Effective Time,
CGI shall deposit, or cause to be deposited, certificates representing CGI
Common Stock (and associated CGI Rights) for conversion of shares of STC Capital
Stock in accordance with the provisions of Section 3.01 (such certificates,
together with any dividends or distributions with respect thereto, being herein
referred to as the "Exchange Fund"). Commencing immediately after the Effective
Time and until the appointment of the Exchange Agent shall be terminated, each
holder of a certificate or certificates theretofore evidencing shares of STC
Capital Stock may surrender the same, together with a duly executed letter of
transmittal and such other customary documents as CGI may reasonably require, to
the Exchange Agent, and, after the appointment of the Exchange Agent shall be
terminated, any such holder may surrender any such certificate, letter of
transmittal and other documents to CGI. Such holder shall be entitled upon such
surrender to receive in exchange therefor a certificate or certificates
representing the number of full shares of CGI Common Stock (and associated CGI
Rights) into which the shares of STC Capital Stock theretofore represented by
the certificate or certificates so surrendered shall have been converted in
accordance with the provisions of Section 3.01, together with a cash payment in
lieu of fractional shares, if any, in accordance with Section 3.04, and all such
shares of CGI Common Stock (and associated CGI Rights) shall be deemed to have
been issued at the Effective Time. Until so surrendered and exchanged, each
outstanding certificate which, prior to the Effective Time, represented
<PAGE>
16
issued and outstanding shares of STC Capital Stock shall be deemed for all
corporate purposes of CGI, other than the payment of dividends and other
distributions, if any, to evidence ownership of the number of full shares of CGI
Common Stock (and associated CGI Rights) into which the shares of STC Capital
Stock theretofore represented thereby shall have been converted at the Effective
Time. Unless and until any such certificate theretofore representing shares of
STC Capital Stock is so surrendered, no dividend or other distribution, if any,
payable to the holders of record of CGI Common Stock as of any date subsequent
to the Effective Time shall be paid to the holder of such certificate in respect
thereof. Upon the surrender of any such certificate theretofore representing
shares of STC Capital Stock, however, the record holder of the certificate or
certificates representing shares of CGI Common Stock issued in exchange therefor
shall receive from the Exchange Agent or from CGI, as the case may be, payment
of the amount of dividends and other distributions, if any, which as of any date
subsequent to the Effective Time and until such surrender shall have become
payable with respect to such number of shares of CGI Common Stock ("Presurrender
Dividends"). No interest shall be payable with respect to the payment of
Presurrender Dividends upon the surrender of certificates theretofore
representing shares of STC Capital Stock. After the appointment of the Exchange
Agent shall have been terminated, such holders of CGI Common Stock which have
not received payment of Presurrender Dividends shall look only to CGI for
payment thereof. Notwithstanding the foregoing provisions of this Section 3.02,
risk of loss and title to such certificates representing shares of STC Capital
Stock shall pass only upon proper delivery of such certificates to the Exchange
Agent, and neither the Exchange Agent nor any party hereto shall be liable to a
holder of shares of STC Capital Stock for any CGI Common Stock or dividends or
distributions thereon delivered to a public official pursuant to any applicable
abandoned property, escheat or similar law or to a transferee pursuant to
Section 3.03.
SECTION 3.03. Stock Transfer Books. At the Effective Time, the stock
transfer books of STC with respect to shares of STC Capital Stock shall each be
closed, and there shall be no further registration of transfers of shares of STC
Capital Stock thereafter on the records of any such stock transfer books. In
the event of a transfer of ownership of shares of STC Capital Stock that is not
registered in the stock transfer records of STC, at the Effective Time, a
certificate or certificates representing the number of full shares of CGI Common
Stock into which such shares of STC Capital Stock shall have been converted
shall be issued to the transferee together with a cash payment in lieu of
fractional shares, if any, in accordance with Section 3.04, and a cash payment
in the amount of Presurrender Dividends, if any, in accordance with Section
3.02, if the certificate or certificates representing such shares of STC Capital
Stock is or are surrendered as provided in Section 3.02, accompanied by all
documents required to evidence and effect such transfer and by evidence of
payment of any applicable stock transfer tax.
SECTION 3.04. No Fractional Share Certificates. (a) No scrip or
fractional share certificate for CGI Common Stock shall be issued upon the
surrender for exchange of
<PAGE>
17
certificates evidencing shares of STC Capital Stock, and an outstanding
fractional share interest shall not entitle the owner thereof (i) to vote, (ii)
to receive dividends or (iii) to any rights of a stockholder of CGI or of the
Surviving Corporation with respect to such fractional share interest.
(b) As promptly as practicable following the Effective Time, the
Exchange Agent shall determine the excess of (i) the number of full shares of
CGI Common Stock to be issued and delivered to the Exchange Agent pursuant to
Section 3.02 over (ii) the aggregate number of full shares of CGI Common Stock
to be distributed to holders of STC Capital Stock pursuant to Section 3.02 (such
excess being herein called the "Excess Shares"). Following the Effective Time,
the Exchange Agent, as agent for the holders of STC Capital Stock, shall sell
the Excess Shares at then prevailing prices on the NMS, all in the manner
provided in subsection (c) of this Section 3.04.
(c) The sale of the Excess Shares by the Exchange Agent shall be
executed on the NMS through one or more member firms of such exchange and shall
be executed in round lots to the extent practicable. The Exchange Agent shall
use all reasonable efforts to complete the sale of the Excess Shares as promptly
following the Effective Time as, in the Exchange Agent's reasonable judgment, is
practicable consistent with obtaining the best execution of such sales in light
of prevailing market conditions. Until the net proceeds of such sale or sales
have been distributed to the holders of STC Capital Stock, the Exchange Agent
shall hold such proceeds in trust for the holders of STC Capital Stock (the
"Trust"). CGI shall pay all commissions, transfer taxes and other out-of-pocket
transaction costs, including the expenses and compensation of the Exchange
Agent, incurred in connection with such sale of Excess Shares. The Exchange
Agent shall determine the portion of the Trust to which each holder of STC
Capital Stock shall be entitled, if any, by multiplying the amount of the
aggregate net proceeds comprising the Trust by a fraction the numerator of which
is the amount of fractional share interests to which such holder of STC Capital
Stock is entitled (after taking into account all shares of STC Capital Stock
held at the Effective Time by such holder) and the denominator of which is the
aggregate amount of fractional share interests to which all holders of STC
Capital Stock are entitled.
(d) Notwithstanding the provisions of subsections (b) and (c) of this
Section 3.04, CGI may, in lieu of the issuance and sale of Excess Shares and the
making of the payments contemplated in such subsections, pay to the Exchange
Agent an amount in cash sufficient for the Exchange Agent to pay each holder of
STC Capital Stock an amount in cash equal to the product obtained by multiplying
(i) the fractional share interest to which such holder would otherwise be
entitled (after taking into account all shares of STC Capital Stock held at the
Effective Time by such holder) by (ii) the closing price for a share of CGI
Common Stock on the NMS on the first business day immediately following the
Effective Time, and, in such case, all references herein to the cash proceeds of
the sale of the Excess Shares and similar references shall be deemed to mean and
refer to the payments calculated
<PAGE>
18
as set forth in this subsection (d). In such event, Excess Shares shall not be
issued or otherwise transferred to the Exchange Agent pursuant to Section 3.02.
(e) As soon as practicable after the determination of the amount of
cash, if any, to be paid to holders of STC Capital Stock with respect to any
fractional share interests, the Exchange Agent shall make available such
amounts, net of any required withholding, excise or similar tax, to such holders
of STC Capital Stock, subject to and in accordance with the terms of Section
3.02.
(f) Any portion of the Exchange Fund or the Trust which remains
undistributed for six months after the Effective Time shall be delivered to CGI,
and any holder of STC Capital Stock who has not theretofore complied with the
provisions of this Article III shall thereafter look only to CGI for
satisfaction of their claims for CGI Common Stock or any cash in lieu of
fractional shares of CGI Common Stock and any Presurrender Dividends.
SECTION 3.05. Options and Warrants to Purchase STC Common Stock. At
the Effective Time, each option or warrant granted by STC to purchase shares of
STC Common Stock (each, an "STC Stock Option") which is outstanding and
unexercised immediately prior to the Effective Time, shall be assumed by CGI and
converted into an option or warrant to purchase shares of CGI Common Stock in
such number and at such exercise price as provided below and otherwise having
the same terms and conditions as in effect immediately prior to the Effective
Time (except to the extent that such terms, conditions and restrictions may be
altered in accordance with their terms as a result of the Merger):
(a) the number of shares of CGI Common Stock to be subject to
the new option or warrant shall be equal to the product of (i) the number
of shares of STC Common Stock subject to the original option or warrant and
(ii) the Common Exchange Ratio;
(b) the exercise price per share of CGI Common Stock under the
new option or warrant shall be equal to the quotient of (i) the exercise
price per share of STC Common Stock under the original option or warrant
divided by (ii) the Common Exchange Ratio; and
(c) upon each exercise of options or warrants by a holder
thereof, the aggregate number of shares of CGI Common Stock deliverable
upon such exercise shall be rounded down, if necessary, to the nearest
whole share and the aggregate exercise price shall be rounded up, if
necessary, to the nearest cent.
<PAGE>
19
The adjustments provided herein with respect to any options which are "incentive
stock options" (as defined in Section 422 of the Code) shall be effected in a
manner consistent with the requirements of Section 424(a) of the Code.
SECTION 3.06. Certain Adjustments. If between the date of this
Agreement and the Effective Time, the outstanding shares of STC Capital Stock or
CGI Common Stock shall be changed into a different number of shares by reason of
any reclassification, recapitalization, split-up, combination or exchange of
shares, or any dividend payable in stock or other securities shall be declared
thereon with a record date within such period, the exchange ratios established
pursuant to the provisions of Section 3.01 shall be adjusted accordingly to
provide to the holders of STC Capital Stock the same economic effect as
contemplated by this Agreement prior to such reclassification, recapitalization,
split-up, combination, exchange or dividend.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF STC
STC hereby represents and warrants to CGI and Merger Sub that:
SECTION 4.01. Organization and Qualification; Subsidiaries. Each of
STC and each subsidiary of STC (the "STC Subsidiaries") has been duly organized
and is validly existing and in good standing (to the extent applicable) under
the laws of the jurisdiction of its incorporation or organization, as the case
may be, and has the requisite corporate power and authority and all necessary
governmental approvals to own, lease and operate its properties and to carry on
its business as it is now being conducted, except where the failure to be so
organized, existing or in good standing or to have such power, authority and
governmental approvals could not reasonably be expected to have, individually or
in the aggregate, an STC Material Adverse Effect. Each of STC and each STC
Subsidiary is duly qualified or licensed to do business, and is in good standing
(to the extent applicable), in each jurisdiction where the character of the
properties owned, leased or operated by it or the nature of its business makes
such qualification or licensing necessary, except for such failures to be so
qualified or licensed and in good standing that could not reasonably be expected
to have, individually or in the aggregate, an STC Material Adverse Effect.
SECTION 4.02. Certificate of Incorporation and By-laws. The copies
of STC's certificate of incorporation and by-laws that are incorporated by
reference as exhibits to STC's Form 10-K for the period ending June 30, 1996
(the "STC 1996 10-K") are true, complete and correct copies thereof. Such
certificate of incorporation and by-laws are in full force and effect. STC is
not in violation of any of the provisions of its certificate of incorporation or
by-laws.
<PAGE>
20
SECTION 4.03. Capitalization. The authorized capital stock of STC
consists of 40,000,000 shares of STC Common Stock and 1,000,000 shares of
preferred stock. As of January 6, 1997, (i) 27,344,121 shares of STC Common
Stock are issued and outstanding, all of which are validly issued, fully paid
and nonassessable, (ii) no shares of STC Common Stock are held in the treasury
of STC, (iii) no shares of STC Common Stock are held by the STC Subsidiaries,
(iv) 3,052,491 shares of STC Common Stock are reserved for future issuance
pursuant to employee stock options or stock incentive rights granted under the
STC Stock Plans, (v) 5,441,480 shares of STC Common Stock are reserved for
issuance pursuant to the STC Stock Option Agreement, (vi) 2,047,651 shares of
STC Common Stock are reserved for issuance upon conversion of the Series A
Preferred Stock, (vii) 1,500,000 shares of STC Common Stock are reserved for
issuance upon conversion of the Series B Preferred Stock, (viii) 224,000 shares
of Series A-1 Preferred Stock are issued and outstanding, (ix) 23,651 shares of
Series A-2 Preferred Stock are issued and outstanding and (x) 33,333 shares of
Series B Preferred Stock are issued and outstanding. There has been no change
in the capitalization of STC since January 6, 1997, excluding the exercise of
outstanding stock options. Except for the STC Stock Option Agreement and shares
of STC Common Stock issuable pursuant to the STC Stock Plans or pursuant to
agreements or arrangements described in Section 4.03 of the STC Disclosure
Schedule, and the warrants to purchase 889,000 shares of STC Common Stock issued
to holders of the Series A-1 Preferred Stock, there are no options, warrants or
other rights, agreements, arrangements or commitments of any character to which
STC is a party or by which STC is bound relating to the issued or unissued
capital stock of STC or any STC Subsidiary or obligating STC or any STC
Subsidiary to issue or sell any shares of capital stock of, or other equity
interests in, STC or any STC Subsidiary. All shares of STC Common Stock subject
to issuance as aforesaid, upon issuance prior to the Effective Time on the terms
and conditions specified in the instruments pursuant to which they are issuable,
will be duly authorized, validly issued, fully paid and nonassessable. Except
for the Fletcher Warrant, there are no outstanding contractual obligations of
STC or any STC Subsidiary to repurchase, redeem or otherwise acquire any shares
of STC Capital Stock or any capital stock of any STC Subsidiary. Each
outstanding share of capital stock of each STC Subsidiary is duly authorized,
validly issued, fully paid and nonassessable and each such share owned by STC or
another STC Subsidiary is free and clear of all security interests, liens,
claims, pledges, options, rights of first refusal, agreements, limitations on
STC's or such other STC Subsidiary's voting rights, charges and other
encumbrances of any nature whatsoever, except where the failure to own such
shares free and clear could not reasonably be expected to have, individually or
in the aggregate, an STC Material Adverse Effect. Except as set forth in
Section 4.03 of the STC Disclosure Schedule, there are no material outstanding
contractual obligations of STC or any STC Subsidiary to provide funds to, or
make any material investment (in the form of a loan, capital contribution or
otherwise) in, any STC Subsidiary or any other person.
SECTION 4.04. Authority Relative to This Agreement and the STC Sock
Option Agreement. STC has all necessary corporate power and authority to
execute and
<PAGE>
21
deliver this Agreement and the STC Stock Option Agreement, to perform its
obligations hereunder and thereunder and to consummate the transactions
contemplated hereby and thereby. The execution and delivery of this Agreement
and the STC Stock Option Agreement by STC and the consummation by STC of the
transactions contemplated hereby and thereby have been duly and validly
authorized by all necessary corporate action, and no other corporate proceedings
on the part of STC are necessary to authorize this Agreement or the STC Stock
Option Agreement or to consummate such transactions (other than the approval of
this Agreement and the Merger by the holders of a majority of the outstanding
shares of STC Capital Stock and Series A Preferred Stock entitled to vote with
respect thereto at the STC Stockholders' Meeting, in each case voting together
as a single class, and the filing and recordation of the Certificate of Merger
as required by the General Corporation Law). This Agreement and the STC Stock
Option Agreement have been duly executed and delivered by STC and, assuming the
due authorization, execution and delivery by the other parties hereto and
thereto, constitute legal, valid and binding obligations of STC, enforceable
against STC in accordance with their terms.
SECTION 4.05. No Conflict; Required Filings and Consents. (a) The
execution and delivery of this Agreement and the STC Stock Option Agreement by
STC do not, and the performance by STC of its obligations hereunder and
thereunder and the consummation of the Merger will not, (i) conflict with or
violate any provision of the certificate of incorporation or by-laws of STC or
any equivalent organizational documents of any STC Subsidiary, (ii) assuming
that all consents, approvals, authorizations and permits described in Section
4.05(b) have been obtained and all filings and notifications described in
Section 4.05(b) have been made, conflict with or violate any Law applicable to
STC or any STC Subsidiary or by which any property or asset of STC or any STC
Subsidiary is bound or affected or (iii) except as set forth in Section 4.05(a)
of the STC Disclosure Schedule, result in any breach of or constitute a default
(or an event which with the giving of notice or lapse of time or both could
reasonably be expected to become a default) under, or give to others any right
of termination, amendment, acceleration or cancellation of, or result in the
creation of a lien or other encumbrance on any property or asset of STC or any
STC Subsidiary pursuant to, any note, bond, mortgage, indenture, contract,
agreement, lease, license, permit, franchise or other instrument or obligation,
except, with respect to clauses (ii) and (iii), for any such conflicts,
violations, breaches, defaults or other occurrences which could not reasonably
be expected, individually or in the aggregate, (A) to have an STC Material
Adverse Effect or (B) to prevent or materially delay the performance by STC of
its obligations pursuant to this Agreement or the STC Stock Option Agreement or
the consummation of the Merger.
(b) The execution and delivery of this Agreement and the STC Stock
Option Agreement by STC do not, and the performance by STC of its obligations
hereunder and thereunder and the consummation of the Merger will not, require
any consent, approval, authorization or permit of, or filing by STC with or
notification by STC to, any
<PAGE>
22
Governmental Entity except (i) pursuant to applicable requirements of the
Exchange Act, the Securities Act, Blue Sky Laws, the rules and regulations of
the NASD, state takeover laws, the premerger notification requirements of the
HSR Act, if any, and the filing and recordation of the Certificate of Merger as
required by the General Corporation Law, and (ii) where failure to obtain such
consents, approvals, authorizations or permits, or to make such filings or
notifications, could not reasonably be expected, individually or in the
aggregate, (A) to have an STC Material Adverse Effect or (B) to prevent or
materially delay the performance by STC of its obligations pursuant to this
Agreement or the STC Stock Option Agreement or the consummation of the Merger.
SECTION 4.06. Permits; Compliance with Laws. (a) STC and the STC
Subsidiaries are in possession of all franchises, grants, authorizations,
licenses, establishment registrations, product listings, permits, easements,
variances, exceptions, consents, certificates, approvals and orders of any
Governmental Entity, including, without limitation, the FDA, the DEA, and
similar authorities in other jurisdictions, necessary for STC or any STC
Subsidiary to own, lease and operate its properties or to produce, store,
distribute and market its products or otherwise to carry on its business as it
is now being conducted (the "STC Permits"), except where the failure to have, or
the suspension or cancellation of, any of the STC Permits could not reasonably
be expected to have, individually or in the aggregate, an STC Material Adverse
Effect, and, as of the date of this Agreement, no suspension or cancellation of
any of the STC Permits is pending or, to the knowledge of STC, threatened,
except where the failure to have, or the suspension or cancellation of, any of
the STC Permits could not reasonably be expected to have, individually or in the
aggregate, an STC Material Adverse Effect. Neither STC nor any STC Subsidiary
is in conflict with, or in default or violation of, (i) any Law applicable to
STC or any STC Subsidiary or by which any property or asset of STC or any STC
Subsidiary is bound or affected or (ii) any STC Permits, except in the case of
clauses (i) and (ii) for any such conflicts, defaults or violations that could
not reasonably be expected to have, individually or in the aggregate, an STC
Material Adverse Effect.
(b) Except as disclosed in the STC Reports or in Section 4.06(b) of
the STC Disclosure Schedule or as could not reasonably be expected to have,
individually or in the aggregate, an STC Material Adverse Effect:
(i) to the knowledge of STC, all of the clinical studies which
have been, or are being, conducted by or for STC and the STC Subsidiaries
are being conducted in substantial compliance with generally accepted good
clinical practices and all applicable government regulatory requirements;
and
(ii) to the knowledge of STC, none of STC, the STC Subsidiaries
or any of their respective officers, employees or agents (during the term
of such person's employment by STC or any STC Subsidiary or while acting as
an agent of STC or
<PAGE>
23
any STC Subsidiary, or, to STC's knowledge, prior to such employment) has
made any untrue statement of a material fact or fraudulent statement to the
FDA or any similar Governmental Entity, failed to disclose a material fact
required to be disclosed to the FDA or similar Governmental Entity, or
committed an act, made a statement or failed to make a statement that could
reasonably be expected to provide a basis for the FDA or similar
Governmental Entity to invoke its policy respecting "Fraud, Untrue
Statements of Material Facts, Bribery, and Illegal Gratuities" or similar
governmental policy or Law.
SECTION 4.07. SEC Filings; Financial Statements; Projected Cash
alances; Operating Budget. (a) Except as disclosed in Section 4.07 of the STC
Disclosure Schedule, STC has timely filed all forms, reports and documents
required to be filed by it with the SEC and the NASD since June 30, 1994 through
the date of this Agreement (collectively and as amended, the "STC Reports").
Each STC Report (i) was prepared in accordance with the requirements of the
Securities Act, the Exchange Act or the rules and regulations of the NASD, as
the case may be, and (ii) did not at the time it was filed contain any untrue
statement of a material fact or omit to state a material fact required to be
stated therein or necessary in order to make the statements made therein, in the
light of the circumstances under which they were made, not misleading. No STC
Subsidiary is subject to the periodic reporting requirements of the Exchange Act
or required to file any form, report or other document with the SEC, the NASD,
any other stock exchange or any other comparable Governmental Entity.
(b) Each of the consolidated financial statements (including, in each
case, any notes thereto) contained in the STC Reports was prepared, and each of
the consolidated financial statements (including, in each case, the notes
thereto) prepared and delivered pursuant to Section 7.13, if any, will be
prepared, in accordance with U.S. GAAP applied on a consistent basis throughout
the periods indicated (except as may be indicated in the notes thereto) and each
presented or will present fairly, in all material respects, the consolidated
financial position of STC and the consolidated STC Subsidiaries as at the
respective dates thereof and for the respective periods indicated therein,
except as otherwise noted therein (subject, in the case of unaudited statements,
to normal and recurring year-end adjustments which did not have and could not
reasonably be expected to have, individually or in the aggregate, an STC
Material Adverse Effect).
(c) Except as and to the extent set forth or reserved against on the
consolidated balance sheet of STC and the STC Subsidiaries as reported in the
STC Reports, including the notes thereto, none of STC or any STC Subsidiary has
any liabilities or obligations of any nature (whether accrued, absolute,
contingent or otherwise) that would be required to be reflected on a balance
sheet or in notes thereto prepared in accordance with U.S. GAAP, except for
liabilities or obligations incurred in the ordinary course of business
<PAGE>
24
consistent with past practice since June 30, 1996 that have not had and could
not reasonably be expected to have, individually or in the aggregate, an STC
Material Adverse Effect.
(d) Within five days after the date hereof, STC shall furnish CGI
with a detailed schedule of STC's projected balances (the "Projected Cash
Balances") of cash, cash equivalents and marketable securities of STC for each
month during the period from the date hereof through August 31, 1997. The
Projected Cash Balances will be prepared (and any revised Projected Cash
Balances delivered after the date hereof will be prepared) by senior management
of STC on the basis of assumptions and supplemental data which represent a
reasonable basis for such preparation, and will reflect (and any revised
Projected Cash Balances delivered after the date hereof will reflect) the best
currently available estimates and judgment of senior management of STC as to the
expected future balances of cash, cash equivalents and marketable securities of
the STC for the periods included.
(e) Within five days after the date hereof, STC shall furnish CGI
with a detailed schedule of STC's projected operating budget (the "Operating
Budget") of STC for each month during the period from the date hereof through
August 31, 1997. The Operating Budget will be prepared (and any revised
Operating Budget delivered after the date hereof will be prepared) by senior
management of STC on the basis of assumptions and supplemental data which
represent a reasonable basis for such preparation, and will reflect (and any
revised Operating Budget delivered after the date hereof will reflect) the best
currently available estimates and judgment of senior management of STC as to the
future operating expenses of STC expected to be incurred by STC in the ordinary
course consistent with past practice for the periods included.
SECTION 4.08. Absence of Certain Changes or Events. Since June 30,
1996, except as contemplated by or as disclosed in this Agreement, as set forth
in Section 4.08 of the STC Disclosure Schedule or as disclosed in any STC Report
filed since June 30, 1996, STC and the STC Subsidiaries have conducted their
businesses only in the ordinary course consistent with past practice and, since
such date, there has not been (i) any STC Material Adverse Effect excluding any
changes and effects resulting from changes in economic, regulatory or political
conditions or changes in conditions generally applicable to the industries in
which STC and the STC Subsidiaries are involved, (ii) any event that could
reasonably be expected to prevent or materially delay the performance of its
obligations pursuant to this Agreement and the consummation of the Merger by
STC, (iii) any material change by STC in its accounting methods, principles or
practices, (iv) any declaration, setting aside or payment of any dividend or
distribution in respect of the shares of STC Capital Stock or any redemption,
purchase or other acquisition of any of STC's securities or (v) any increase in
the compensation or benefits or establishment of any bonus, insurance,
severance, deferred compensation, pension, retirement, profit sharing, stock
option (including, without limitation, the granting of stock options, stock
appreciation rights, performance awards or restricted stock awards), stock
purchase or other employee benefit
<PAGE>
25
plan, or any other increase in the compensation payable or to become payable to
any executive officers of STC or any STC Subsidiary except in the ordinary
course of business consistent with past practice.
SECTION 4.09. Employee Benefit Plans; Labor Matters. (a) With
respect to each employee benefit plan, program, arrangement and contract
(including, without limitation, any "employee benefit plan", as defined in
Section 3(3) of ERISA) maintained or contributed to by STC or any STC
Subsidiary, or with respect to which STC or any STC Subsidiary could incur
liability under Section 4069, 4212(c) or 4204 of ERISA (the "STC Benefit
Plans"), STC has delivered or made available to CGI a true, complete and correct
copy of (i) such STC Benefit Plan and the most recent summary plan description
related to such STC Benefit Plan, if a summary plan description is required
therefor, (ii) each trust agreement or other funding arrangement relating to
such STC Benefit Plan, (iii) the most recent annual report (Form 5500) filed
with the IRS) with respect to such STC Benefit Plan, (iv) the most recent
actuarial report or financial statement relating to such STC Benefit Plan and
(v) the most recent determination letter issued by the IRS with respect to such
STC Benefit Plan, if it is qualified under Section 401(a) of the Code.
(b) Each STC Benefit Plan has been administered in all material
respects in accordance with its terms and all contributions required to be made
under the terms of any of the STC Benefit Plans as of the date of this Agreement
have been timely made or have been reflected on the most recent consolidated
balance sheet filed or incorporated by reference in the STC Reports prior to the
date of this Agreement. Except as set forth in Section 4.09(b) of the STC
Disclosure Schedule, with respect to the STC Benefit Plans, no event has
occurred and, to the knowledge of STC, there exists no condition or set of
circumstances in connection with which STC or any STC Subsidiary could be
subject to any liability under the terms of such STC Benefit Plans, ERISA, the
Code or any other applicable Law which could reasonably be expected to have,
individually or in the aggregate, an STC Material Adverse Effect.
(c) Except as set forth in Section 4.09(c) of the STC Disclosure
Schedule, neither STC nor any STC Subsidiary is a party to any collective
bargaining or other labor union contract applicable to persons employed by STC
or any STC Subsidiary and no collective bargaining agreement is being negotiated
by STC or any STC Subsidiary. As of the date of this Agreement, there is no
labor dispute, strike or work stoppage against STC or any STC Subsidiary pending
or, to the knowledge of STC, threatened which may interfere with the respective
business activities of STC or any STC Subsidiary, except where such dispute,
strike or work stoppage could not reasonably be expected to have, individually
or in the aggregate, an STC Material Adverse Effect. As of the date of this
Agreement, to the knowledge of STC, none of STC, any STC Subsidiary, or any of
their respective representatives or employees has committed any unfair labor
practice in connection with the operation of the respective businesses of STC or
any STC Subsidiary, and there is no charge
<PAGE>
26
or complaint against STC or any STC Subsidiary by the National Labor Relations
Board or any comparable Governmental Entity pending or threatened in writing,
except where such unfair labor practice, charge or complaint could not
reasonably be expected to have, individually or in the aggregate, an STC
Material Adverse Effect.
(d) Except as set forth in Section 4.09(d) of the STC Disclosure
Schedule, STC has delivered to CGI true, complete and correct copies of (i) all
employment agreements with officers and employees and all consulting agreements
of STC and each STC Subsidiary providing for annual compensation in excess of
$25,000, (ii) all severance plans, agreements, programs and policies of STC and
each STC Subsidiary with or relating to their respective employees or
consultants, and (iii) all plans, programs, agreements and other arrangements of
STC and each STC Subsidiary with or relating to their respective employees or
consultants which contain "change of control" provisions.
(e) Except as provided in Section 4.09(e) of the STC Disclosure
Schedule or as otherwise required by Law, no STC Benefit Plan provides retiree
medical or retiree life insurance benefits to any person.
SECTION 4.10. Tax Matters. Except as disclosed in the STC Reports,
neither STC nor, to the knowledge of STC, any of its affiliates has taken or
agreed to take any action (other than actions contemplated by this Agreement)
that could reasonably be expected to prevent the Merger from constituting a
transaction qualifying under Section 368 of the Code. STC is not aware of any
agreement, plan or other circumstance that could reasonably be expected to
prevent the Merger from so qualifying under Section 368 of the Code.
SECTION 4.11. Contracts; Debt Instruments. Except as disclosed in
the STC Reports or in Section 4.11 of the STC Disclosure Schedule, there is no
contract or agreement that is material to the business, financial condition or
results of operations of STC and the STC Subsidiaries taken as a whole (each, an
"STC Material Contract"). Except as disclosed in the STC Reports or in Section
4.11 of the STC Disclosure Schedule, neither STC nor any STC Subsidiary is in
violation of or in default under (nor does there exist any condition which with
the passage of time or the giving of notice could reasonably be expected to
cause such a violation of or default under) any loan or credit agreement, note,
bond, mortgage, indenture or lease, or any other contract, license, agreement,
arrangement or understanding to which it is a party or by which it or any of its
properties or assets is bound, except for violations or defaults that could not
reasonably be expected to have, individually or in the aggregate, an STC
Material Adverse Effect. Set forth in Section 4.11 of the STC Disclosure
Schedule is a description of any material changes to the amount and terms of the
indebtedness of STC and its subsidiaries as described in the notes to the
financial statements incorporated in STC 1996 10-K.
<PAGE>
27
SECTION 4.12. Litigation. Except as disclosed in the STC Reports or
in Section 4.12 of the STC Disclosure Schedule, there is no suit, claim, action,
proceeding or investigation pending or, to the knowledge of STC, threatened
against STC or any STC Subsidiary before any Governmental Entity that could
reasonably be expected to have, individually or in the aggregate, an STC
Material Adverse Effect, and, except as disclosed to CGI, to the knowledge of
STC, there are no existing facts or circumstances that could reasonably be
expected to result in such a suit, claim, action, proceeding or investigation.
For purposes hereof, nonmeritorious strike-suit litigation challenging the
execution, adoption or performance of this Agreement shall not be deemed
material. Except as disclosed to CGI, STC is not aware of any facts or
circumstances which could reasonably be expected to result in the denial of
insurance coverage under policies issued to STC and the STC Subsidiaries in
respect of such suits, claims, actions, proceedings and investigations, except
in any case as could not reasonably be expected to have, individually or in the
aggregate, an STC Material Adverse Effect. Except as disclosed in the STC
Reports or in Section 4.12 of the STC Disclosure Schedule, neither STC nor any
STC Subsidiary is subject to any outstanding order, writ, injunction or decree
which could reasonably be expected to have, individually or in the aggregate, an
STC Material Adverse Effect.
SECTION 4.13. Environmental Matters. Except as disclosed in the STC
Reports or in Section 4.13 of the STC Disclosure Schedule or as could not
reasonably be expected to have, individually or in the aggregate, an STC
Material Adverse Effect, (i) STC and the STC Subsidiaries are in compliance with
all applicable Environmental Laws; (ii) all past noncompliance of STC or any STC
Subsidiary with Environmental Laws or Environmental Permits has been resolved
without any pending, ongoing or future obligation, cost or liability; and (iii)
neither STC nor any STC Subsidiary has released a Hazardous Material at, or
transported a Hazardous Material to or from, any real property currently or
formerly owned, leased or occupied by STC or any STC Subsidiary, in violation of
any Environmental Law.
SECTION 4.14. Intellectual Property. Except as set forth in Section
4.14 of the STC Disclosure Schedule, or as could not reasonably be expected to
have, individually or in the aggregate, an STC Material Adverse Effect, STC and
the STC Subsidiaries own or possess adequate licenses or other valid rights to
use all patents, patent rights, trademarks, trademark rights, trade names, trade
dress, trade name rights, copyrights, service marks, trade secrets, applications
for trademarks and for service marks, know-how and other proprietary rights and
information used or held for use in connection with the respective businesses of
STC and the STC Subsidiaries as currently conducted, and STC is unaware of any
assertion or claim challenging the validity of any of the foregoing. Section
4.14 of the STC Disclosure Schedule lists all licenses, sublicenses and other
agreements to which STC or any STC Subsidiary is a party and pursuant to which
(i) any third party is authorized to use any intellectual property right of STC
or any STC Subsidiary and (ii) STC or any STC Subsidiary is authorized to use
any intellectual property rights (other than pursuant to shrink-
<PAGE>
28
wrap licenses and noncustomized software licenses) of a third party, and
includes the identity of all parties thereto, a description of the nature and
subject matter thereof, the royalty provisions, if any, therein and the term
thereof. Except as set forth in Section 4.14 of the STC Disclosure Schedule, the
conduct of the respective businesses of STC and the STC Subsidiaries as
currently conducted does not conflict in any way with any patent, patent right,
license, trademark, trademark right, trade dress, trade name, trade name right,
service mark or copyright of any third party that could not reasonably be
expected to have, individually or in the aggregate, an STC Material Adverse
Effect. To the knowledge of STC, there are no infringements of any proprietary
rights owned by or licensed by or to STC or any STC Subsidiary that could
reasonably be expected to have, individually or in the aggregate, an STC
Material Adverse Effect.
SECTION 4.15. Taxes. Except as set forth in Section 4.15 of the STC
Disclosure Schedule and except for such matters as could not reasonably be
expected to have, individually or in the aggregate, an STC Material Adverse
Effect, (i) each of STC and each STC Subsidiary has timely filed or shall timely
file all returns and reports required to be filed by it with any taxing
authority with respect to Taxes for any period ending on or before the Effective
Time, taking into account any extension of time to file granted to or obtained
on behalf of STC and the STC Subsidiaries, (ii) all Taxes shown to be payable on
such returns or reports that are due prior to the Effective Time have been or
will be paid, (iii) as of the date hereof, no deficiency for any amount of Tax
has been asserted or assessed by a taxing authority against STC or any STC
Subsidiary and (iv) each of STC and each STC Subsidiary has provided adequate
reserves in its financial statements for any Taxes that have not been paid,
whether or not shown as being due on any returns.
SECTION 4.16. Opinion of Financial Advisor. DLJ has delivered to the
board of directors of STC its written opinion to the effect that, as of the date
hereof, the Common Exchange Ratio, the Series A Exchange Ratio and the Series B
Exchange Ratio to be offered to the stockholders of STC in the proposed
transaction are fair to such stockholders from a financial point of view. DLJ
has authorized the inclusion of its opinion in the Joint Proxy Statement.
SECTION 4.17. Brokers. No broker, finder or investment banker (other
than DLJ) is entitled to any brokerage, finder's or other fee or commission in
connection with the Merger based upon arrangements made by or on behalf of STC.
STC has heretofore made available to CGI true, complete and correct copies of
all agreements between STC and DLJ pursuant to which such firm would be entitled
to any payment relating to the Merger.
SECTION 4.18. Certain Interests. (a) Except as set forth in Section
4.18(a) of the STC Disclosure Schedule, no officer or director (excluding
outside directors) of STC or any STC Subsidiary, and no relative or spouse (or
relative of such spouse) who resides with, or is a dependent of, any such
officer or director:
<PAGE>
29
(i) has any direct or indirect financial interest in any
competitor of STC; provided, however, that the ownership of securities
representing no more than two percent of the outstanding voting power of
any competitor, supplier or customer, and which are also listed on any
national securities exchange or traded actively in the national over-the-
counter market, shall not be deemed to be a "financial interest" so long as
the person owning such securities has no other connection or relationship
with such competitor, supplier or customer;
(ii) owns, directly or indirectly, in whole or in part, or has
any other interest, in any tangible or intangible property which STC or any
STC Subsidiary uses in the conduct of its business or otherwise; or
(iii) has outstanding any indebtedness to STC or any STC
Subsidiary.
(b) Except as set forth in Section 4.18(b) of the STC Disclosure
Schedule, neither STC nor any STC Subsidiary has any liability or any other
obligation of any nature whatsoever to any officer, director or shareholder of
STC or any STC Subsidiary, or to any relative or spouse (or relative of such
spouse) who resides with, or is a dependent of, any such officer, director or
shareholder, other than immaterial liabilities and obligations incurred in the
ordinary course of business which are reflected in the STC Reports or with
respect to which adequate reserves have been taken.
ARTICLE V
REPRESENTATIONS AND WARRANTIES OF CGI AND MERGER SUB
CGI and Merger Sub hereby jointly and severally represent and warrant
to STC that:
SECTION 5.01. Organization and Qualification; Subsidiaries. Each of
CGI, Merger Sub and each other subsidiary of CGI (the "CGI Subsidiaries") has
been duly organized and is validly existing and in good standing (to the extent
applicable) under the laws of the jurisdiction of its incorporation or
organization, as the case may be, and has the requisite corporate power and
authority and all necessary governmental approvals to own, lease and operate its
properties and to carry on its business as it is now being conducted, except
where the failure to be so organized, existing or in good standing or to have
such power, authority and governmental approvals could not reasonably be
expected to have, individually or in the aggregate, a CGI Material Adverse
Effect. Each of CGI, Merger Sub and each other CGI Subsidiary is duly qualified
or licensed to do business, and is in good standing (to the extent applicable),
in each jurisdiction where the character of the properties
<PAGE>
30
owned, leased or operated by it or the nature of its business makes such
qualification or licensing necessary, except for such failures to be so
qualified or licensed and in good standing that could not reasonably be expected
to have, individually or in the aggregate, a CGI Material Adverse Effect.
SECTION 5.02. Certificate of Incorporation and By-laws. Except as
set forth in Section 5.02 of the CGI Disclosure Schedule, the copies of CGI's
certificate of incorporation and by-laws that are incorporated by reference as
exhibits to CGI's Form 10-K for the period ending December 31, 1995 (the "CGI
1995 10-K") are true, complete and correct copies thereof. CGI has heretofore
furnished STC with true, complete and correct copies of the certificate of
incorporation and by-laws of Merger Sub. Such certificates of incorporation and
by-laws are in full force and effect. Neither CGI nor Merger Sub is in
violation of any of the provisions of its certificate of incorporation or by-
laws.
SECTION 5.03. Capitalization. The authorized capital stock of CGI
consists of 25,000,000 shares of CGI Common Stock and 5,000,000 shares of
preferred stock. As of January 10, 1997, (i) 16,516,0099 shares of CGI Common
Stock are issued and outstanding, all of which are validly issued, fully paid
and nonassessable, (ii) no shares of CGI Common Stock are held in the treasury
of STC, (iii) no shares of CGI Common Stock are held by the CGI Subsidiaries,
(iv) 2,363,240 shares of CGI Common Stock are reserved for future issuance
pursuant to employee stock options or stock incentive rights granted under the
CGI Stock Plans and (v) 3,286,703 shares of CGI Common Stock are reserved for
issuance pursuant to the CGI Stock Option Agreement. As of the date hereof,
there are no shares of preferred stock of CGI issued and outstanding. Except
for the CGI Stock Option Agreement, shares of CGI Common Stock issuable pursuant
to the CGI Stock Plans or pursuant to agreements or arrangements described in
Section 5.03 of the CGI Disclosure Schedule, the CGI Rights issued and issuable
pursuant to the CGI Rights Plan, there are no options, warrants or other rights,
agreements, arrangements or commitments of any character to which CGI is a party
or by which CGI is bound relating to the issued or unissued capital stock of
CGI, Merger Sub or any other CGI Subsidiary or obligating CGI, Merger Sub or any
other CGI Subsidiary to issue or sell any shares of capital stock of, or other
equity interests in, CGI, Merger Sub or any other CGI Subsidiary. All shares of
CGI Common Stock subject to issuance as aforesaid, upon issuance prior to the
Effective Time on the terms and conditions specified in the instruments pursuant
to which they are issuable, will be duly authorized, validly issued, fully paid
and nonassessable. There are no outstanding contractual obligations of CGI,
Merger Sub or any other CGI Subsidiary to repurchase, redeem or otherwise
acquire any shares of CGI Common Stock or any capital stock of any CGI
Subsidiary. Each outstanding share of capital stock of each CGI Subsidiary is
duly authorized, validly issued, fully paid and nonassessable and each such
share owned by CGI or another CGI Subsidiary is free and clear of all security
interests, liens, claims, pledges, options, rights of first refusal, agreements,
limitations on CGI's or such other CGI Subsidiary's voting rights, charges and
other encumbrances of any nature whatsoever, except
<PAGE>
31
where the failure to own such shares free and clear could not reasonably be
expected to have, individually or in the aggregate, a CGI Material Adverse
Effect. Except as set forth in Section 5.03 of the CGI Disclosure Schedule,
there are no material outstanding contractual obligations of CGI, Merger Sub or
any other CGI Subsidiary to provide funds to, or make any material investment
(in the form of a loan, capital contribution or otherwise) in, any CGI
Subsidiary or any other person.
SECTION 5.04. Authority Relative to This Agreement and the CGI Sock
Option Agreement. CGI and Merger Sub have all necessary corporate power and
authority to execute and deliver this Agreement and the CGI Stock Option
Agreement, to perform their respective obligations hereunder and thereunder and
to consummate the transactions contemplated hereby and thereby. The execution
and delivery of this Agreement and the CGI Stock Option Agreement by CGI and
Merger Sub and the consummation by CGI and Merger Sub of the transactions
contemplated hereby and thereby have been duly and validly authorized by all
necessary corporate action, and no other corporate proceedings on the part of
CGI or Merger Sub are necessary to authorize this Agreement or the CGI Stock
Option Agreement or to consummate such transactions (other than the approval of
this Agreement and the Merger by the holders of a majority of the votes cast by
CGI's stockholders with respect thereto at the CGI Stockholders' Meeting and the
filing and recordation of the Certificate of Merger as required by the General
Corporation Law). This Agreement and the CGI Stock Option Agreement have been
duly executed and delivered by CGI and Merger Sub and, assuming the due
authorization, execution and delivery by STC, constitute legal, valid and
binding obligations of CGI and Merger Sub, enforceable against CGI and Merger
Sub in accordance with their terms.
SECTION 5.05. No Conflict; Required Filings and Consents. (a) The
execution and delivery of this Agreement and the CGI Stock Option Agreement by
CGI and Merger Sub do not, and the performance by CGI and Merger Sub of their
obligations hereunder and thereunder and the consummation of the Merger will
not, (i) conflict with or violate any provision of the certificate of
incorporation or by-laws of CGI or Merger Sub or any equivalent organizational
documents of any other CGI Subsidiary, (ii) assuming that all consents,
approvals, authorizations and permits described in Section 5.05(b) have been
obtained and all filings and notifications described in Section 5.05(b) have
been made, conflict with or violate any Law applicable to CGI or any other CGI
Subsidiary or by which any property or asset of CGI, Merger Sub or any other CGI
Subsidiary is bound or affected or (iii) except as set forth in Section 5.05(a)
of the CGI Disclosure Schedule, result in any breach of or constitute a default
(or an event which with the giving of notice or lapse of time or both could
reasonably be expected to become a default) under, or give to others any right
of termination, amendment, acceleration or cancellation of, or result in the
creation of a lien or other encumbrance on any property or asset of CGI, Merger
Sub or any other CGI Subsidiary pursuant to, any note, bond, mortgage,
indenture, contract, agreement, lease, license, permit, franchise or other
instrument or obligation, except, with respect to clauses
<PAGE>
32
(ii) and (iii), for any such conflicts, violations, breaches, defaults or other
occurrences which could not reasonably be expected, individually or in the
aggregate, (A) to have a CGI Material Adverse Effect or (B) to prevent or
materially delay the performance by CGI or Merger Sub of its obligations
pursuant to this Agreement or the CGI Stock Option Agreement or the consummation
of the Merger.
(b) The execution and delivery of this Agreement and the CGI Stock
Option Agreement by CGI and Merger Sub do not, and the performance by CGI and
Merger Sub of their respective obligations hereunder and thereunder and the
consummation of the Merger will not, require any consent, approval,
authorization or permit of, or filing by CGI or Merger Sub with or notification
by CGI or Merger Sub to, any Governmental Entity, except (i) pursuant to
applicable requirements of the Exchange Act, the Securities Act, Blue Sky Laws,
the rules and regulations of the NASD, state takeover laws, the premerger
notification requirements of the HSR Act, if any, and the filing and recordation
of the Certificate of Merger as required by the General Corporation Law and (ii)
where failure to obtain such consents, approvals, authorizations or permits, or
to make such filings or notifications, could not reasonably be expected,
individually or in the aggregate, (A) to have a CGI Material Adverse Effect or
(B) to prevent or materially delay the performance by CGI or Merger Sub of its
obligations pursuant to this Agreement or the CGI Stock Option Agreement or the
consummation of the Merger.
SECTION 5.06. Permits; Compliance with Laws. (a) Each of CGI,
Merger Sub and each other CGI Subsidiary is in possession of all franchises,
grants, authorizations, licenses, establishment registrations, product listings,
permits, easements, variances, exceptions, consents, certificates, approvals and
orders of any Governmental Entity, including, without limitation, the FDA, the
DEA and similar authorities in other jurisdictions, necessary for it to own,
lease and operate its properties or to store, distribute and market its products
or otherwise to carry on its business as it is now being conducted (the "CGI
Permits"), except where the failure to have, or the suspension or cancellation
of, any of the CGI Permits could not reasonably be expected to have,
individually or in the aggregate, a CGI Material Adverse Effect, and, as of the
date of this Agreement, no suspension or cancellation of any of the CGI Permits
is pending or, to the knowledge of CGI, threatened, except where the failure to
have, or the suspension or cancellation of, any of the CGI Permits could not
reasonably be expected to have, individually or in the aggregate, a CGI Material
Adverse Effect. None of CGI, Merger Sub or any other CGI Subsidiary is in
conflict with, or in default or violation of, (i) any Law applicable to CGI,
Merger Sub or any other CGI Subsidiary or by which any property or asset of CGI,
Merger Sub or any other CGI Subsidiary is bound or affected or (ii) any CGI
Permits, except in the case of clauses (i) and (ii) for any such conflicts,
defaults or violations that could not reasonably be expected to have,
individually or in the aggregate, a CGI Material Adverse Effect.
<PAGE>
33
(b) Except as disclosed in the CGI Reports or in Section 5.06(b) of
the CGI Disclosure Schedule or as could not reasonably be expected to have,
individually or in the aggregate, a CGI Material Adverse Effect:
(i) to the knowledge of CGI, all of the clinical studies which
have been, or are being, conducted by or for CGI and the CGI Subsidiaries
are being conducted in substantial compliance with generally accepted good
clinical practices and all applicable government regulatory requirements;
and
(ii) to the knowledge of CGI, none of CGI, the CGI Subsidiaries
or any of their respective officers, employees or agents (during the term
of such person's employment by CGI or any CGI Subsidiary or while acting as
an agent of CGI or any CGI Subsidiary, or, to CGI's knowledge, prior to
such employment) has made any untrue statement of a material fact or
fraudulent statement to the FDA or any similar Governmental Entity, failed
to disclose a material fact required to be disclosed to the FDA or similar
Governmental Entity, or committed an act, made a statement or failed to
make a statement that could reasonably be expected to provide a basis for
the FDA or similar Governmental Entity to invoke its policy respecting
"Fraud, Untrue Statements of Material Facts, Bribery, and Illegal
Gratuities" or similar governmental policy or Law.
SECTION 5.07. SEC Filings; Financial Statements. (a) Except as
disclosed in Section 5.07 of the CGI Disclosure Schedule, CGI has timely filed
all forms, reports and documents required to be filed by it with the SEC and the
NASD since December 31, 1993 through the date of this Agreement (collectively
and as amended, the "CGI Reports"). Each CGI Report (i) was prepared in
accordance with the requirements of the Securities Act, the Exchange Act or the
NASD, as the case may be, and (ii) did not at the time it was filed contain any
untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary in order to make the statements made therein, in
the light of the circumstances under which they were made, not misleading. No
CGI Subsidiary is subject to the periodic reporting requirements of the Exchange
Act or required to file any form, report or other document with the SEC, the
NASD, any other stock exchange or any other comparable Governmental Entity.
(b) Each of the consolidated financial statements (including, in each
case, any notes thereto) contained in the CGI Reports was prepared in accordance
with U.S. GAAP applied on a consistent basis throughout the periods indicated
(except as may be indicated in the notes thereto) and each presented fairly, in
all material respects, the consolidated financial position of CGI and the
consolidated CGI Subsidiaries as at the respective dates thereof and for the
respective periods indicated therein, except as otherwise noted therein
(subject, in the case of unaudited statements, to normal and recurring year-end
<PAGE>
34
adjustments which did not and could not reasonably be expected to have,
individually or in the aggregate, a CGI Material Adverse Effect).
(c) Except as and to the extent set forth or reserved against on the
consolidated balance sheet of CGI and its Subsidiaries as reported in the CGI
Reports, including the notes thereto, none of CGI or any CGI Subsidiary has any
liabilities or obligations of any nature (whether accrued, absolute, contingent
or otherwise) that would be required to be reflected on a balance sheet or in
notes thereto prepared in accordance with U.S. GAAP, except for liabilities or
obligations incurred in the ordinary course of business consistent with past
practice since December 31, 1995 that have not had and could not reasonably be
expected to have, individually or in the aggregate, a CGI Material Adverse
Effect.
SECTION 5.08. Absence of Certain Changes or Events. Since December
31, 1995, except as contemplated by or as disclosed in this Agreement, as set
forth in Section 5.08 of the CGI Disclosure Schedule or as disclosed in any CGI
Report filed since December 31, 1995, CGI and the CGI Subsidiaries have
conducted their businesses only in the ordinary course consistent with past
practice and, since such date, there has not been (i) any CGI Material Adverse
Effect excluding any changes and effects resulting from changes in economic,
regulatory or political conditions or changes in conditions generally applicable
to the industries in which CGI and the CGI Subsidiaries are involved, (ii) any
event that could reasonably be expected to prevent or materially delay the
performance of their obligations pursuant to this Agreement and the consummation
of the Merger by Merger Sub, (iii) any material change by CGI in its accounting
methods, principles or practices, (iv) any declaration, setting aside or payment
of any dividend or distribution in respect of the shares of CGI Common Stock or
any redemption, purchase or other acquisition of any of CGI's securities or (v)
any increase in the compensation or benefits or establishment of any bonus,
insurance, severance, deferred compensation, pension, retirement, profit-
sharing, stock option (including, without limitation, the granting of stock
options, stock appreciation rights, performance awards or restricted stock
awards), stock purchase or other employee benefit plan, or any other increase in
the compensation payable or to become payable to any executive officers of CGI
or any CGI Subsidiary except in the ordinary course of business consistent with
past practice.
SECTION 5.09. Employee Benefit Plans; Labor Matters. (a) With
respect to each employee benefit plan, program, arrangement and contract
(including, without limitation, any "employee benefit plan", as defined in
Section 3(3) of ERISA) maintained or contributed to by CGI or any CGI
Subsidiary, or with respect to which CGI or any CGI Subsidiary could incur
liability under Section 4069, 4212(c) or 4204 of ERISA (the "CGI Benefit Plans",
CGI has delivered or made available to STC a true, complete and correct copy of
(i) such CGI Benefit Plan and the most recent summary plan description related
to such CGI Benefit Plan, if a summary plan description is required therefor,
(ii) each
<PAGE>
35
trust agreement or other funding arrangement relating to such CGI Benefit Plan,
(iii) the most recent annual report (Form 5500) filed with the IRS with respect
to such CGI Benefit Plan, (iv) the most recent actuarial report or financial
statement relating to such CGI Benefit Plan and (v) the most recent
determination letter issued by the IRS with respect to such CGI Benefit Plan, if
it is qualified under Section 401(a) of the Code.
(b) Each CGI Benefit Plan has been administered in all material
respects in accordance with its terms and all contributions required to be made
under the terms of any of the CGI Benefit Plans as of the date of this Agreement
have been timely made or have been reflected on the most recent consolidated
balance sheet filed or incorporated by reference in the CGI Reports prior to the
date of this Agreement. Except as set forth in Section 5.09(b) of the CGI
Disclosure Schedule, with respect to the CGI Benefit Plans, no event has
occurred and, to the knowledge of CGI, there exists no condition or set of
circumstances in connection with which CGI or any CGI Subsidiary could be
subject to any liability under the terms of such CGI Benefit Plans, ERISA, the
Code or any other applicable Law which could reasonably be expected to have,
individually or in the aggregate, a CGI Material Adverse Effect.
(c) Except as set forth in Section 5.09(c) of the CGI Disclosure
Schedule, neither CGI nor any CGI Subsidiary is a party to any collective
bargaining or other labor union contract applicable to persons employed by CGI
or any CGI Subsidiary and no collective bargaining agreement is being negotiated
by CGI or any CGI Subsidiary. As of the date of this Agreement, there is no
labor dispute, strike or work stoppage against CGI or any CGI Subsidiary pending
or, to the knowledge of CGI, threatened which may interfere with the respective
business activities of CGI or any CGI Subsidiary, except where such dispute,
strike or work stoppage could not reasonably be expected to have, individually
or in the aggregate, a CGI Material Adverse Effect. As of the date of this
Agreement, to the knowledge of CGI, none of CGI, any CGI Subsidiary, or any of
their respective representatives or employees has committed any unfair labor
practice in connection with the operation of the respective businesses of CGI or
any CGI Subsidiary, and there is no charge or complaint against CGI or any CGI
Subsidiary by the National Labor Relations Board or any comparable Governmental
Entity pending or threatened in writing, except where such unfair labor
practice, charge or complaint could not reasonably be expected to have,
individually or in the aggregate, a CGI Material Adverse Effect.
(d) CGI has delivered to STC true, complete and correct copies of (i)
all employment agreements with officers of CGI and each CGI Subsidiary providing
for annual compensation in excess of $25,000, (ii) all severance plans,
agreements, programs and policies of CGI and each CGI Subsidiary with or
relating to their respective employees and (iii) all plans, programs, agreements
and other arrangements of CGI and each CGI Subsidiary with or relating to their
respective employees which contain "change of control" provisions.
<PAGE>
36
(e) Except as provided in Section 5.09(e) of the CGI Disclosure
Schedule or as otherwise required by Law, no CGI Benefit Plan provides retiree
medical or retiree life insurance benefits to any person.
SECTION 5.10. Tax Matters. Except as disclosed in the CGI Reports,
neither CGI nor, to the knowledge of CGI, any of its affiliates has taken or
agreed to take any action (other than actions contemplated by this Agreement)
that could reasonably be expected to prevent the Merger from constituting a
transaction qualifying under Section 368 of the Code. CGI is not aware of any
agreement, plan or other circumstance that could reasonably be expected to
prevent the Merger from so qualifying under Section 368 of the Code.
SECTION 5.11. Contracts; Debt Instruments. Except as disclosed in
the CGI Reports or in Section 5.11 of the CGI Disclosure Schedule, there is no
contract or agreement that is material to the business, financial condition or
results of operations of CGI and the CGI Subsidiaries taken as a whole (each, a
"CGI Material Contract"). Except as disclosed in the CGI Reports or in Section
5.11 of the CGI Disclosure Schedule, neither CGI nor any CGI Subsidiary is in
violation of or in default under (nor does there exist any condition which with
the passage of time or the giving of notice could reasonably be expected to
cause such a violation of or default under) any loan or credit agreement, note,
bond, mortgage, indenture or lease, or any other contract, license, agreement,
arrangement or understanding to which it is a party or by which it or any of its
properties or assets is bound, except for violations or defaults that could not
reasonably be expected to have, individually or in the aggregate, a CGI Material
Adverse Effect. Set forth in Section 5.11 of the CGI Disclosure Schedule is a
description of any material changes to the amount and terms of the indebtedness
of CGI and its subsidiaries as described in the notes to the financial
statements incorporated in the CGI 1995 10-K.
SECTION 5.12. Litigation. Except as disclosed in the CGI Reports or
in Section 5.12 of the CGI Disclosure Schedule, there is no suit, claim, action,
proceeding or investigation pending or, to the knowledge of CGI, threatened
against CGI or any CGI Subsidiary before any Governmental Entity that could
reasonably be expected to have, individually or in the aggregate, a CGI Material
Adverse Effect, and, except as disclosed to STC, to the knowledge of CGI, there
are no existing facts or circumstances that could reasonably be expected to
result in such a suit, claim, action, proceeding or investigation. For purposes
hereof, nonmeritorious strike-suit litigation challenging the execution,
adoption or performance of this Agreement shall not be deemed material. Except
as disclosed to STC, CGI is not aware of any facts or circumstances which could
reasonably be expected to result in the denial of insurance coverage under
policies issued to CGI and the CGI Subsidiaries in respect of such suits,
claims, actions, proceedings and investigations, except in any case as could not
reasonably be expected to have, individually or in the aggregate, a CGI Material
Adverse Effect. Except as disclosed in the CGI Reports or in Section 5.12 of
<PAGE>
37
the CGI Disclosure Schedule, neither CGI nor any CGI Subsidiary is subject to
any outstanding order, writ, injunction or decree which could reasonably be
expected to have, individually or in the aggregate, a CGI Material Adverse
Effect.
SECTION 5.13. Environmental Matters. Except as disclosed in the CGI
Reports or in Section 5.13 of the CGI Disclosure Schedule or as could not
reasonably be expected to have, individually or in the aggregate, a CGI Material
Adverse Effect, (i) CGI and the CGI Subsidiaries are in compliance with all
applicable Environmental Laws; (ii) all past noncompliance of CGI or any CGI
Subsidiary with Environmental Laws or Environmental Permits has been resolved
without any pending, ongoing or future obligation, cost or liability; and (iii)
neither CGI nor any CGI Subsidiary has released a Hazardous Material at, or
transported a Hazardous Material to or from, any real property currently or
formerly owned, leased or occupied by CGI or any CGI Subsidiary in violation of
any Environmental Law.
SECTION 5.14. Intellectual Property. Except as disclosed in Section
5.14 of the CGI Disclosure Schedule or as could not reasonably be expected to
have, individually or in the aggregate, a CGI Material Adverse Effect, CGI and
the CGI Subsidiaries own or possess adequate licenses or other valid rights to
use all patents, patent rights, trademarks, trademark rights, trade names, trade
dress, trade name rights, copyrights, service marks, trade secrets, applications
for trademarks and for service marks, know-how and other proprietary rights and
information used or held for use in connection with the respective businesses of
CGI and the CGI Subsidiaries as currently conducted, and CGI is unaware of any
assertion or claim challenging the validity of any of the foregoing. Section
5.14 of the CGI Disclosure Schedule lists all licenses, sublicenses and other
agreements to which CGI or any CGI Subsidiary is a party and pursuant to which
(i) any third party is authorized to use any intellectual property right of CGI
or any CGI Subsidiary and (ii) CGI or any CGI Subsidiary is authorized to use
any intellectual property rights (other than pursuant to shrink-wrap licenses
and noncustomized software licenses) of a third party, and includes the identity
of all parties thereto, a description of the nature and subject matter thereof,
the royalty provisions, if any, therein and the term thereof. Except as set
forth in Section 5.14 of the CGI Disclosure Schedule, the conduct of the
respective businesses of CGI and the CGI Subsidiaries as currently conducted
does not conflict in any way with any patent, patent right, license, trademark,
trademark right, trade dress, trade name, trade name right, service mark or
copyright of any third party that could reasonably be expected to have,
individually or in the aggregate, a CGI Material Adverse Effect. Except as
disclosed in Section 5.14 of the CGI Disclosure Schedule, to the knowledge of
CGI, there are no infringements of any proprietary rights owned by or licensed
by or to CGI or any CGI Subsidiary that could reasonably be expected to have,
individually or in the aggregate, a CGI Material Adverse Effect.
<PAGE>
38
SECTION 5.15. Taxes. Except as set forth in Section 5.15 of the CGI
Disclosure Schedule and except for such matters as could not reasonably be
expected to have, individually or in the aggregate, a CGI Material Adverse
Effect, (i) each of CGI, Merger Sub and each other CGI Subsidiary has timely
filed or shall timely file all returns and reports required to be filed by it
with any taxing authority with respect to Taxes for any period ending on or
before the Effective Time, taking into account any extension of time to file
granted to or obtained on behalf of CGI, Merger Sub and the other CGI
Subsidiaries, (ii) all Taxes shown to be payable on such returns or reports that
are due prior to the Effective Time have been or will be paid, (iii) as of the
date hereof, no deficiency for any amount of Tax has been asserted or assessed
by a taxing authority against CGI, Merger Sub or any other CGI Subsidiary and
(iv) each of CGI, Merger Sub and each other CGI Subsidiary has provided adequate
reserves in its financial statements for any Taxes that have not been paid,
whether or not shown as being due on any returns.
SECTION 5.16. Opinion of Financial Advisor. Lehman Brothers has
delivered to the board of directors of CGI its written opinion to the effect
that, as of the date hereof, each of the Common Exchange Ratio, the Series A
Exchange Ratio and the Series B Exchange Ratio is fair to the holders of shares
of CGI Common Stock from a financial point of view. Lehman Brothers has
authorized the inclusion of its opinion in the Joint Proxy Statement.
SECTION 5.17. Brokers. No broker, finder or investment banker (other
than Lehman Brothers) is entitled to any brokerage, finder's or other fee or
commission in connection with the Merger based upon arrangements made by or on
behalf of CGI. CGI has heretofore made available to STC true, complete and
correct copies of all agreements between CGI and Lehman Brothers pursuant to
which such firm would be entitled to any payment relating to the Merger.
SECTION 5.18. Certain Interests. (a) Except as set forth in Section
5.18(a) of the CGI Disclosure Schedule or in the CGI SEC Reports, no officer or
director (excluding outside directors) of CGI or any CGI Subsidiary, and no
relative or spouse (or relative of such spouse) who resides with, or is a
dependent of, any such shareholder, officer or director:
(i) has any direct or indirect financial interest in any
competitor; provided, however, that the ownership of securities
representing no more than two percent of the outstanding voting power of
any competitor, supplier or customer, and which are also listed on any
national securities exchange or traded actively in the national over-the-
counter market, shall not be deemed to be a "financial interest" so long as
the person owning such securities has no other connection or relationship
with such competitor, supplier or customer;
<PAGE>
39
(ii) owns, directly or indirectly, in whole or in part, or has
any other interest in any tangible or intangible property which CGI or any
CGI Subsidiary uses in the conduct of its business or otherwise; or
(iii) has outstanding any indebtedness to CGI or any CGI
Subsidiary.
(b) Except as set forth in Section 5.18(b) of the CGI Disclosure
Schedule, neither CGI nor any CGI Subsidiary has any liability or any other
material obligation of any nature whatsoever to any officer or director of CGI
or any CGI Subsidiary, or to any relative or spouse (or relative of such spouse)
who resides with, or is a dependent of, any such officer or director, other than
immaterial liabilities and obligations incurred in the ordinary course of
business which are reflected in the CGI Reports or with respect to which
adequate reserves have been taken.
ARTICLE VI
COVENANTS
SECTION 6.01. Conduct of Business by STC Pending the Closing. STC
agrees that, between the date of this Agreement and the Effective Time, except
as set forth in Section 6.01 of the STC Disclosure Schedule or as expressly
contemplated by any other provision of this Agreement, unless CGI shall
otherwise agree in writing, (x) the respective businesses of STC and the STC
Subsidiaries shall be conducted only in, and STC and the STC Subsidiaries shall
not take any action except in, the ordinary course of business consistent with
past practice and (y) STC shall use all reasonable efforts to keep available the
services of such of the current officers, employees and consultants of STC and
the STC Subsidiaries and to preserve the current relationships of STC and the
STC Subsidiaries with such of the corporate partners, customers, suppliers and
other persons with which STC or any STC Subsidiary has significant business
relations in order to preserve substantially intact its business organization.
By way of amplification and not limitation, except as set forth in Section 6.01
of the STC Disclosure Schedule or as expressly contemplated by any other
provision of this Agreement and the STC Stock Option Agreement, neither STC nor
any STC Subsidiary shall, between the date of this Agreement and the Effective
Time, directly or indirectly, do, or agree to do, any of the following without
the prior written consent of CGI, which consent shall not be unreasonably
withheld or delayed:
(a) amend or otherwise change its certificate of incorporation
or by-laws or equivalent organizational documents;
(b) issue, sell, pledge, dispose of, grant, transfer, lease,
license, guarantee or encumber, or authorize the issuance, sale, pledge,
disposition, grant,
<PAGE>
40
transfer, lease, license or encumbrance of, (i) any shares of capital stock
of STC or any STC Subsidiary of any class, or securities convertible into
or exchangeable or exercisable for any shares of such capital stock, or any
options, warrants or other rights of any kind to acquire any shares of such
capital stock, or any other ownership interest (including, without
limitation, any phantom interest), of STC or any STC Subsidiary, except for
(A) issuances of STC Common Stock pursuant to options and warrants thereon
outstanding on the date hereof and described in Section 4.03 and (B)
issuances of non-cash dividends required to be made under the terms of the
certificate of designation of STC applicable to the Series A Preferred
Stock, or (ii) any property or assets of STC or any STC Subsidiary;
(c) (i) acquire (including, without limitation, by merger,
consolidation, or acquisition of stock or assets) any interest in any
corporation, partnership, other business organization or person or any
division thereof or any assets, other than acquisitions of assets; (ii)
incur any indebtedness for borrowed money or issue any debt securities or
assume, guarantee or endorse, or otherwise as an accommodation become
responsible for, the obligations of any person for borrowed money; (iii)
terminate, cancel or request any material change in, or agree to any
material change in, any STC Material Contract or enter into any corporate
partnering transaction or similar arrangement or any other contract or
agreement material to the business, results of operations or financial
condition of STC and the STC Subsidiaries taken as a whole; (iv) make or
authorize any capital expenditure, except for capital expenditures not in
excess of $5,000 individually and $50,000 in the aggregate; provided that
CGI will not unreasonably withhold its consent to reasonable expenditures
in excess thereof; or (v) enter into or amend any contract, agreement,
commitment or arrangement that, if fully performed, would not be permitted
under this Section 6.01(c);
(d) declare, set aside, make or pay any dividend or other
distribution, payable in cash, stock, property or otherwise, with respect
to any of its capital stock or the Fletcher Warrant, except that any STC
Subsidiary may pay dividends or make other distributions to STC or any
other STC Subsidiary and may pay noncash dividends required to be made
under the terms of the certificate of designation of STC applicable to the
Series A Preferred Stock;
(e) reclassify, combine, split, subdivide or redeem, purchase
or otherwise acquire, directly or indirectly, any of its capital stock;
(f) increase the compensation payable or to become payable to
its officers, consultants or employees, or grant any rights to severance or
termination pay to, or enter into any employment or severance agreement
which provides benefits upon a change in control of STC that would be
triggered by the Merger with, any
<PAGE>
41
director, officer, consultant or other employee of STC or any STC
Subsidiary who is not currently entitled to such benefits from the Merger,
or establish, adopt, enter into or amend any collective bargaining, bonus,
profit-sharing, thrift, compensation, stock option, restricted stock,
pension, retirement, deferred compensation, employment, termination,
severance or other plan, agreement, trust, fund, policy or arrangement for
the benefit of any director, officer, consultant or employee of STC or any
STC Subsidiary, except to the extent required by applicable Law or the
terms of a collective bargaining agreement;
(g) take any action with respect to accounting policies or
procedures, other than actions in the ordinary course of business
consistent with past practice or as required by U.S. GAAP;
(h) make any tax election or settle or compromise any material
federal, state or local United States income tax liability, or any income
tax liability of any other jurisdiction, other than those made in the
ordinary course of business consistent with past practice and those for
which specific reserves have been recorded on the consolidated balance
sheet of STC and the consolidated STC Subsidiaries dated as of June 30,
1996 included in the 1996 STC 10-K and only to the extent of such reserves;
or
(i) authorize or enter into any formal or informal agreement or
otherwise make any commitment to do any of the foregoing.
SECTION 6.02. Conduct of Business by CGI Pending the Closing. CGI
agrees that, between the date of this Agreement and the Effective Time, except
as set forth in Section 6.02 of the CGI Disclosure Schedule or as expressly
contemplated by any other provision of this Agreement, unless STC shall
otherwise agree in writing, (x) the respective businesses of CGI and the CGI
Subsidiaries shall be conducted only in, and CGI and the CGI Subsidiaries shall
not take any action except in, the ordinary course of business consistent with
past practice and (y) CGI shall use all reasonable efforts to keep available the
services of such of the current officers, significant employees and consultants
of CGI and the CGI Subsidiaries and to preserve the current relationships of CGI
and the CGI Subsidiaries with such of the corporate partners, customers,
suppliers and other persons with which CGI or any CGI Subsidiary has significant
business relations as CGI deems reasonably necessary in order to preserve
substantially intact its business organization. By way of amplification and not
limitation, except as set forth in Section 6.02 of the CGI Disclosure Schedule
or as expressly contemplated by any other provision of this Agreement and the
CGI Stock Option Agreement, neither CGI nor any CGI Subsidiary shall, between
the date of this Agreement and the Effective Time, directly or indirectly, do,
or agree to do, any of the following without the prior written consent of STC,
which consent shall not be unreasonably withheld or delayed:
<PAGE>
42
(a) amend or otherwise change its certificate of incorporation
or by-laws or equivalent organizational documents;
(b) issue, sell, pledge, dispose of, grant, transfer, lease,
license, guarantee or encumber, or authorize the issuance, sale, pledge,
disposition, grant, transfer, lease, license or encumbrance of, (i) any
shares of capital stock of CGI or any CGI Subsidiary of any class, or
securities convertible into or exchangeable or exercisable for any shares
of such capital stock, or any options, warrants or other rights of any kind
to acquire any shares of such capital stock, or any other ownership
interest (including, without limitation, any phantom interest), of CGI or
any CGI Subsidiary, except for (A) issuances of CGI Common Stock pursuant
to options and warrants thereon outstanding on the date hereof and
described in Section 5.03, (B) issuances of options to new hires of CGI and
(C) issuances of options to employees, officers and directors of CGI
consistent with past practice, or (ii) any property or assets of CGI or any
CGI Subsidiary, except in the ordinary course of business consistent with
past practice and pursuant to any existing CGI Material Contract or in an
aggregate amount not in excess of $10,000,000;
(c) (i) acquire (including, without limitation, by merger,
consolidation or acquisition of stock or assets) any interest in any
corporation, partnership, other business organization or person or any
division thereof or any assets, other than acquisitions of assets
(excluding the acquisition of a business or substantially all of the stock
or assets thereof) in the ordinary course of business consistent with past
practice, and any acquisitions for consideration, calculated as of the date
of execution of the definitive agreement for any such acquisition, that is
not, in the aggregate for all such acquisitions, in excess of 10 percent of
the market value of CGI of the date of the execution of any contract
related thereto; (ii) incur any indebtedness for borrowed money or issue
any debt securities or assume, guarantee or endorse, or otherwise as an
accommodation become responsible for, the obligations of any person for
borrowed money; (iii) terminate, cancel or request any material change in,
or agree to any material change in, any CGI Material Contract or enter into
any contract or agreement material to the business, results of operations
or financial condition of CGI and the CGI Subsidiaries taken as a whole, in
either case other than in the ordinary course of business consistent with
past practice; (iv) make or authorize any capital expenditure, other than
capital expenditures in the ordinary course of business consistent with
past practice; or (v) enter into or amend any contract, agreement,
commitment or arrangement that, if fully performed, would not be permitted
under this Section 6.02(c);
(d) declare, set aside, make or pay any dividend or other
distribution, payable in cash, stock, property or otherwise, with respect
to any of its
<PAGE>
43
capital stock, except that any CGI Subsidiary may pay dividends or make
other distributions to CGI or any other CGI Subsidiary;
(e) reclassify, combine, split, subdivide or redeem, purchase
or otherwise acquire, directly or indirectly, any of its capital stock;
(f) increase the compensation payable or to become payable to
its officers or employees, except for increases in accordance with past
practices in salaries or wages of employees or officers of CGI or any CGI
Subsidiary (including, without limitation, annual merit increases and
bonuses), or grant any rights to severance or termination pay to, or enter
into any employment or severance agreement which provides benefits upon a
change in control of CGI that would be triggered by the Merger with, any
director, officer or other employee of CGI or any CGI Subsidiary who is not
currently entitled to such benefits upon the Merger, or establish, adopt,
enter into or amend any collective bargaining, bonus, profit-sharing,
thrift, compensation, stock option, restricted stock, pension, retirement,
deferred compensation, employment, termination, severance or other plan,
agreement, trust, fund, policy or arrangement for the benefit of any
director, officer or employee of CGI or any CGI Subsidiary, except to the
extent required by applicable Law or the terms of a collective bargaining
agreement;
(g) take any action with respect to accounting policies or
procedures, other than actions in the ordinary course of business
consistent with past practice or as required by U.S. GAAP;
(h) make any tax election or settle or compromise any material
federal, state or local United States income tax liability, or any income
tax liability of any other jurisdiction, other than those made in the
ordinary course of business consistent with past practice and those for
which specific reserves have been recorded on the consolidated balance
sheet of CGI and the consolidated CGI Subsidiaries dated as of December 31,
1995 included in the 1995 CGI 10-K and only to the extent of such reserves;
or
(i) authorize or enter into any formal or informal agreement or
otherwise make any commitment to do any of the foregoing.
SECTION 6.03. Cooperation; Steering Committee. Upon the execution
and delivery of this Agreement, CGI and STC shall establish a committee (the
"Steering Committee") for the purpose of, to the extent permitted by applicable
Laws, facilitating the efficient transition and combination of the respective
businesses of CGI and STC as promptly as practicable following the Effective
Time. The Steering Committee shall consist of up to 10 individuals to be
designated from time to time by the Chairman of CGI in consultation
<PAGE>
44
with the Chairman of STC, and shall be chaired by CGI. The Steering Committee
shall be dissolved as of the Effective Time.
SECTION 6.04. Notices of Certain Events. Each of CGI and STC shall
give prompt notice to the other of (i) any notice or other communication from
any person alleging that the consent of such person is or may be required in
connection with the Merger; (ii) any notice or other communication from any
Governmental Entity in connection with the Merger; (iii) any actions, suits,
claims, investigations or proceedings commenced or, to its knowledge, threatened
against, relating to or involving or otherwise affecting CGI, STC, the CGI
Subsidiaries or the STC Subsidiaries that relate to the consummation of the
Merger; (iv) the occurrence of a default or event that, with the giving of
notice or lapse of time or both, will become a default under any STC Material
Contract or CGI Material Contract; and (v) any change that could reasonably be
expected to have an STC Material Adverse Effect or a CGI Material Adverse Effect
or to delay or impede the ability of either STC or CGI to perform its
obligations pursuant to this Agreement, the STC Stock Option Agreement or the
CGI Stock Option Agreement and to effect the consummation of the Merger.
SECTION 6.05. Access to Information; Confidentiality. (a) Except as
required pursuant to any confidentiality agreement or similar agreement or
arrangement to which CGI or STC or any of the CGI Subsidiaries or the STC
Subsidiaries is a party or pursuant to applicable Law or the regulations or
requirements of any stock exchange or other regulatory organization with whose
rules a party hereto is required to comply, from the date of this Agreement to
the Effective Time, CGI and STC shall (and shall cause the CGI Subsidiaries and
the STC Subsidiaries, respectively, to) (i) provide to the other (and its
officers, directors, employees, accountants, consultants, legal counsel, agents
and other representatives (collectively, "Representatives")) access at
reasonable times upon prior notice to its and its subsidiaries' officers,
employees, agents, properties, offices and other facilities and to the books and
records thereof, and (ii) furnish promptly such information concerning its and
its subsidiaries' business, properties, contracts, assets, liabilities and
personnel as the other party or its Representatives may reasonably request. No
investigation conducted pursuant to this Section 6.05 shall affect or be deemed
to modify any representation or warranty made in this Agreement.
(b) The parties hereto shall comply with, and shall cause their
respective Representatives to comply with, all of their respective obligations
under the Confidentiality Agreement with respect to the information disclosed
pursuant to this Section 6.05.
SECTION 6.06. No Solicitation of Transactions. Each party to this
Agreement shall not, directly or indirectly, and shall instruct its officers,
directors, employees, subsidiaries, agents or advisors or other representatives
(including, without limitation, any investment banker, attorney or accountant
retained by it), not to, directly or indirectly, solicit, initiate or knowingly
encourage (including by way of furnishing nonpublic
<PAGE>
45
information), or take any other action knowingly to facilitate, any inquiries or
the making of any proposal or offer (including, without limitation, any proposal
or offer to its stockholders) that constitutes, or may reasonably be expected to
lead to, any Competing Transaction, or enter into or maintain or continue
discussions or negotiate with any person in furtherance of such inquiries or to
obtain a Competing Transaction, or agree to or endorse any Competing
Transaction, or authorize or permit any of the officers, directors or employees
of such party or any of its subsidiaries, or any investment banker, financial
advisor, attorney, accountant or other representative retained by such party or
any of such party's subsidiaries, to take any such action; provided, however,
that nothing contained in this Section 6.06 shall prohibit the board of
directors of CGI or STC from (i) complying with Rule 14e-2 promulgated under the
Exchange Act with regard to a tender or exchange offer or (ii) after receiving
the advice of outside counsel to the effect that the board of directors of STC
or CGI, as the case may be, is required to do so in order to discharge properly
its fiduciary duties, considering, negotiating and approving and recommending to
the shareholders of STC or CGI, as the case may be, an unsolicited bona fide
written acquisition proposal which (A) was not received in violation of this
Section 6.06, (B) if executed or consummated would be a Competing Transaction,
(C) is not subject to financing and (D) the board of directors of STC or CGI, as
the case may be, determines in good faith, after consultation with its financial
advisors, would result in a transaction more favorable to STC's or CGI's
stockholders, as the case may be, than the transaction contemplated by this
Agreement (any such acquisition proposal, a "Superior Proposal"). Each party
hereto shall notify the other parties hereto promptly if any proposal or offer,
or any inquiry or contact with any person with respect thereto, regarding such
an acquisition proposal or a Competing Transaction is made. Each party hereto
immediately shall cease and cause to be terminated all existing discussions or
negotiations with any parties conducted heretofore with respect to a Competing
Transaction. None of the parties hereto shall release any third party from, or
waive any provision of, any confidentiality or standstill agreement to which it
is a party. Each party hereto shall use its best efforts to ensure that its
officers, directors, employees and subsidiaries and any investment banker or
other advisor or representative retained by such party are aware of the
restrictions described in this Section 6.06.
SECTION 6.07. Plan of Reorganization. This Agreement is intended to
constitute a "plan of reorganization" within the meaning of Section 1.368-2(g)
of the income tax regulations promulgated under the Code. From and after the
date of this Agreement, each party hereto shall use all reasonable efforts to
cause the Merger to qualify, and shall not, without the prior written consent of
the other parties hereto, knowingly take any actions or cause any actions to be
taken which could reasonably be expected to prevent the Merger from qualifying,
as a reorganization under the provisions of Section 368 of the Code. In the
event that the Merger shall fail to qualify as a reorganization under the
provisions of Section 368 of the Code, then the parties hereto agree to
negotiate in good faith to restructure the Merger in order that shall qualify as
tax-free transaction under the Code. Following the Effective Time, and
consistent with any such consent, neither the Surviving
<PAGE>
46
Corporation nor CGI nor any of their respective affiliates knowingly and
voluntarily shall take any action or cause any action to be taken which could
reasonably be expected to cause the Merger to fail to qualify as a
reorganization under Section 368 of the Code.
SECTION 6.08. Subsequent Financial Statements. Prior to the
Effective Time, each of STC and CGI (i) shall consult with the other prior to
making publicly available its financial results for any period and (ii) shall
consult with the other prior to the filing of, and shall timely file with the
SEC, each Annual Report on Form 10-K, Quarterly Report on Form 10-Q and Current
Report on Form 8-K required to be filed by such party under the Exchange Act and
shall promptly deliver to the other copies of each such report filed with the
SEC.
SECTION 6.09. Control of Operations. Nothing contained in this
Agreement shall give CGI, directly or indirectly, the right to control or direct
the operations of STC and the STC Subsidiaries prior to the Effective Time.
Prior to the Effective Time, each of CGI and STC shall exercise, consistent with
the terms and conditions of this Agreement, complete control and supervision
over its respective operations.
SECTION 6.10. Further Action; Consents; Filings. Upon the terms and
subject to the conditions hereof, each of the parties hereto shall use all
reasonable efforts to (i) take, or cause to be taken, all appropriate action,
and do, or cause to be done, all things necessary, proper or advisable under
applicable Law or otherwise to consummate and make effective the Merger, (ii)
obtain from Governmental Entities any consents, licenses, permits, waivers,
approvals, authorizations or orders required to be obtained or made by CGI,
Merger Sub, STC or the Surviving Corporation or any of their respective
subsidiaries in connection with the authorization, execution and delivery of
this Agreement and the consummation of the Merger and (iii) make all necessary
filings, and thereafter make any other required or appropriate submissions, with
respect to this Agreement and the Merger required under (A) the rules and
regulations of the NASD, (B) the Securities Act, the Exchange Act and any other
applicable federal or state securities Laws, (C) the HSR Act, if any, and (D)
any other applicable Law. The parties hereto shall cooperate and consult with
each other in connection with the making of all such filings, including by
providing copies of all such documents to the nonfiling parties and their
advisors prior to filing, and none of the parties shall file any such document
if any of the other parties shall have reasonably objected to the filing of such
document. No party shall consent to any voluntary extension of any statutory
deadline or waiting period or to any voluntary delay of the consummation of the
Merger at the behest of any Governmental Entity without the consent and
agreement of the other parties hereto, which consent shall not be unreasonably
withheld or delayed.
<PAGE>
47
ARTICLE VII
ADDITIONAL AGREEMENTS
SECTION 7.01. Registration Statement; Joint Proxy Statement. (a) As
promptly as practicable after the execution of this Agreement, CGI and STC shall
jointly prepare and STC and CGI shall file with the SEC a document or documents
that will constitute (i) the prospectus forming part of the registration
statement on Form S-4 of CGI (together with all amendments thereto, the
"Registration Statement"), in connection with the registration under the
Securities Act of the CGI Common Stock to be issued to STC's stockholders
pursuant to the Merger and (ii) the Joint Proxy Statement with respect to the
Merger relating to the special meeting of each of STC's stockholders (the "STC
Stockholders' Meeting") and CGI's stockholders (the "CGI Stockholders' Meeting")
to be held to consider approval of this Agreement and the Merger contemplated
hereby (together with any amendments thereto, the "Joint Proxy Statement").
Copies of the Joint Proxy Statement shall be provided to the NASD in accordance
with its rules with respect to the NMS. Each of the parties hereto shall use all
reasonable efforts to cause the Registration Statement to become effective as
promptly as practicable after this date hereof, and, prior to the effective date
of the Registration Statement, the parties hereto shall take all action required
under any applicable Laws in connection with the issuance of shares of CGI
Common Stock pursuant to the Merger. CGI or STC, as the case may be, shall
furnish all information concerning itself as the other party may reasonably
request in connection with such actions and the preparation of the Registration
Statement and Joint Proxy Statement. As promptly as practicable after the
effective date of the Registration Statement, the Joint Proxy Statement shall be
mailed to the stockholders of CGI and STC. Each of the parties hereto shall
cause the Joint Proxy Statement to comply as to form and substance in all
material respects with the applicable requirements of (i) the Exchange Act, (ii)
the Securities Act, (iii) the rules and regulations of the NASD and (iv) the
General Corporation Law.
(b) The Joint Proxy Statement shall include (i) (A) subject to the
provisos contained in the first sentence of Section 6.06, the approval of the
Merger and the STC Amendment and recommendation of the board of directors of STC
to the stockholders of STC that they vote in favor of approval of this Agreement
and the Merger contemplated hereby and the STC Amendment, and (B) the opinion of
DLJ referred to in Section 4.18, and (ii) (A) subject to the provisos contained
in the first sentence of Section 6.06, the approval of the Merger and the CGI
Amendment and recommendation of the board of directors of CGI to the
stockholders of CGI that they vote in favor of approval of this Agreement and
the Merger contemplated hereby and the CGI Amendment, and (B) the opinion of
Lehman Brothers referred to in Section 5.18.
(c) No amendment or supplement to the Joint Proxy Statement or the
Registration Statement shall be made without the approval of CGI and STC, which
approval
<PAGE>
48
shall not be unreasonably withheld or delayed. Each of the parties hereto shall
advise the other parties hereto, promptly after it receives notice thereof, of
the time when the Registration Statement has become effective or any supplement
or amendment has been filed, of the issuance of any stop order, of the
suspension of the qualification of the CGI Common Stock issuable in connection
with the Merger for offering or sale in any jurisdiction, or of any request by
the SEC or the NASD for amendment of the Joint Proxy Statement or the
Registration Statement or comments thereon and responses thereto or requests by
the SEC for additional information.
(d) The information supplied by STC for inclusion in the Registration
Statement and the Joint Proxy Statement shall not, at (i) the time the
Registration Statement is filed with the SEC, (ii) if different, the time the
Registration Statement is declared effective, (iii) the time the Joint Proxy
Statement (or any amendment thereof or supplement thereto) is first mailed to
the stockholders of STC and CGI, (iv) the time of the STC Stockholders' Meeting,
(v) the time of the CGI Stockholders' Meeting and (vi) the Effective Time,
contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not
misleading. If at any time prior to the Effective Time any event or
circumstance relating to STC or any STC Subsidiary, or their respective officers
or directors, should be discovered by STC that should be set forth in an
amendment or a supplement to the Registration Statement or Joint Proxy
Statement, STC shall promptly inform CGI. All documents that STC is responsible
for filing with the SEC in connection with the Merger will comply as to form in
all material respects with the applicable requirements of the rules and
regulations of the NASD, the General Corporation Law, the Securities Act and the
Exchange Act.
(e) The information supplied by CGI for inclusion in the Registration
Statement and the Joint Proxy Statement shall not, at (i) the time the
Registration Statement is filed with the SEC, (ii) if different, the time the
Registration Statement is declared effective, (iii) the time the Joint Proxy
Statement (or any amendment thereof or supplement thereto) is first mailed to
the stockholders of CGI and STC, (iv) the time of the STC Stockholders' Meeting,
(v) the time of the CGI Stockholders' Meeting and (vi) the Effective Time,
contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not
misleading. If, at any time prior to the Effective Time, any event or
circumstance relating to CGI or any CGI Subsidiary, or their respective officers
or directors, should be discovered by CGI that should be set forth in an
amendment or a supplement to the Registration Statement or Joint Proxy
Statement, CGI shall promptly inform STC. All documents that CGI is responsible
for filing with the SEC in connection with the Merger will comply as to form in
all material respects with the applicable requirements of the rules and
regulations of the NASD, the General Corporation Law, the Securities Act and the
Exchange Act.
<PAGE>
49
SECTION 7.02. Stockholders' Meetings. STC shall call and hold the
STC Stockholders' Meeting and CGI shall call and hold the CGI Stockholders'
Meeting as promptly as practicable after the date hereof for the purpose of
voting upon the approval of this Agreement pursuant to the Joint Proxy Statement
and the Merger contemplated hereby, and each of CGI and STC shall use all
reasonable efforts to hold the CGI Stockholders' Meeting and the STC
Stockholders' Meeting on the same day and as soon as practicable after the date
on which the Registration Statement becomes effective. STC shall use all
reasonable efforts to solicit from its stockholders proxies in favor of the
approval of this Agreement and the Merger contemplated hereby and the Amendment
pursuant to the Joint Proxy Statement and shall take all other action necessary
or advisable to secure the vote or consent of stockholders required by the
General Corporation Law or applicable stock exchange requirements to obtain such
approval. CGI shall use all reasonable efforts to solicit from its stockholders
proxies in favor of the approval of this Agreement and the Merger contemplated
hereby pursuant to the Joint Proxy Statement, and shall take all other action
necessary or advisable to secure the vote or consent of stockholders required by
the General Corporation Law or applicable stock exchange requirements to obtain
such approval. Each of the parties hereto shall take all other action necessary
or, in the opinion of the other parties hereto, advisable to promptly and
expeditiously secure any vote or consent of stockholders required by applicable
Law and such party's certificate of incorporation and by-laws to effect the
Merger.
SECTION 7.03. Affiliates. (a) Not fewer than 45 days prior to the
Effective Time, STC shall deliver to CGI a list of names and addresses of each
person who was, in STC's reasonable judgment, at the record date for the STC
Stockholders' Meeting, an affiliate of STC. STC shall provide CGI such
information and documents as CGI shall reasonably request for purposes of
reviewing such list. STC shall use all reasonable efforts to deliver or cause
to be delivered to CGI, prior to the Effective Time, an affiliate agreement in
the form attached hereto as Exhibit 7.03(a) (each, an "STC Affiliate
---------------
Agreement"), executed by each of the affiliates of STC identified in the above-
referenced list. The foregoing notwithstanding, CGI shall be entitled to place
legends as specified in the form of STC Affiliate Agreement on the certificates
evidencing any of the CGI Common Stock to be received by (i) any affiliate of
STC or (ii) any person CGI reasonably identifies (by written notice to STC) as
being a person who may be deemed an "affiliate" within the meaning of Rule 145
promulgated under the Securities Act, and to issue appropriate stop transfer
instructions to the transfer agent for such CGI Common Stock, consistent with
the terms of the form of STC Affiliate Agreement, regardless of whether such
person has executed an STC Affiliate Agreement and regardless of whether such
person's name and address appear on Section 4.16 of the STC Disclosure Schedule.
(b) CGI shall use all reasonable efforts to obtain or cause to be
obtained, prior to the Effective Time, an affiliate agreement in the form
attached hereto as Exhibit 7.03(b) (each, a "CGI Affiliate Agreement"), executed
---------------
by each person who was, in CGI's
<PAGE>
50
reasonable judgment, at the record date for the CGI Stockholders' Meeting, an
affiliate of CGI.
SECTION 7.04. Directors' and Officers' Indemnification and Insurnce.
(a) The certificate of incorporation and by-laws of the Surviving Corporation
shall contain provisions no less favorable with respect to indemnification than
are set forth in the certificate of incorporation and by-laws of STC on the date
hereof, which provisions shall not be amended, repealed or otherwise modified
for a period of six years from the Effective Time in any manner that would
affect adversely the rights thereunder of individuals who at the Effective Time
were directors, officers, employees, fiduciaries or agents of STC, unless such
modification shall be required by law.
(b) STC shall, to the fullest extent permitted under applicable law
and regardless of whether the Merger shall become effective, indemnify and hold
harmless, and, after the Effective Time, the Surviving Corporation shall, to the
fullest extent permitted under applicable law, indemnify and hold harmless, each
present and former director, officer, employee, fiduciary and agent of STC and
each STC Subsidiary (collectively, the "Indemnified Parties") against all costs
and expenses (including attorneys' fees), judgments, fines, losses, claims,
damages, liabilities and settlement amounts paid in connection with any claim,
action, suit, proceeding or investigation (whether arising before or after the
Effective Time), whether civil, criminal, administrative or investigative,
arising out of or pertaining to any action or omission in their capacity as an
officer, director, employee, fiduciary or agent, whether occurring before or
after the Effective Time, for a period of six years after the date hereof. In
the event of any such claim, action, suit, proceeding or investigation, (i) STC
or the Surviving Corporation, as the case may be, shall pay the reasonable fees
and expenses of counsel selected by the Indemnified Parties, which counsel shall
be reasonably satisfactory to STC or the Surviving Corporation, promptly after
statements therefor are received and (ii) STC and the Surviving Corporation
shall cooperate in the defense of any such matter; provided, however, that
neither STC nor the Surviving Corporation shall be liable for any settlement
effected without its written consent (which consent shall not be unreasonably
withheld); provided further that neither STC nor the Surviving Corporation shall
be obligated pursuant to this Section 7.04(b) to pay the fees and expenses of
more than one counsel for all Indemnified Parties in any single action; provided
further that, in the event that any claim for indemnification is asserted or
made within such six-year period, all rights to indemnification in respect of
such claim shall continue until the disposition of such claim.
(c) The Surviving Corporation shall use all reasonable efforts to
maintain in effect for three years from the Effective Time, if available, the
current directors' and officers' liability insurance policies maintained by STC
(provided that the Surviving Corporation may substitute therefor policies of at
least the same coverage containing terms and conditions which are not materially
less favorable) with respect to matters occurring prior to the Effective Time;
provided, however, that in no event shall the Surviving
<PAGE>
51
Corporation be required to expend pursuant to this Section 7.04(c) more than an
amount per year equal to 125% of current annual premiums paid by STC for such
insurance.
(d) In the event STC or the Surviving Corporation or any of their
respective successors or assigns (i) consolidates with or merges into any other
person and shall not be the continuing or surviving corporation or entity of
such consolidation or merger or (ii) transfers all or substantially all of its
properties and assets to any person, then, and in each such case, proper
provision shall be made so that the successors and assigns of STC or the
Surviving Corporation, as the case may be, or at CGI's option, CGI, shall assume
the obligations set forth in this Section 7.04.
SECTION 7.05. No Shelf Registration. CGI shall not be required to
amend or maintain the effectiveness of the Registration Statement for the
purpose of permitting resale of the shares of CGI Common Stock received pursuant
hereto by the persons who may be deemed to be "affiliates" of STC or CGI within
the meaning of Rule 145 promulgated under the Securities Act.
SECTION 7.06. Public Announcements. The initial press release
concerning the Merger shall be a joint press release and, thereafter, CGI and
STC shall consult with each other before issuing any press release or otherwise
making any public statements with respect to this Agreement or the Merger and
shall not issue any such press release or make any such public statement without
the prior written approval of the other, except to the extent required by
applicable Law or the requirements of the rules and regulations of the NASD, in
which case the issuing party shall use all reasonable efforts to consult with
the other party before issuing any such release or making any such public
statement.
SECTION 7.07. Officers and Directors of CGI. (a) At the Effective
Time, subject to the certificate of incorporation and by-laws of CGI, Stephen A.
Sherwin, M.D. shall continue to hold the offices of Chairman, President and
Chief Executive Officer of CGI.
(b) Immediately after the Effective Time, the total number of persons
serving on the board of directors of CGI shall be nine (unless otherwise agreed
in writing by STC and CGI prior to the Effective Time), and shall consist of the
following individuals:
David W. Carter
James M. Gower
Raju S. Kucherlapati, Ph.D.
Joseph E. Maroun
John T. Potts, Jr., M.D.
Thomas E. Shenk, Ph.D.
Stephen A. Sherwin, M.D.
<PAGE>
52
Eugene L. Step
Inder M. Verma, Ph.D.
In the event that, prior to the Effective Time, any person so selected to serve
on the board of directors of CGI is unable or unwilling to serve in such
position, the party with which such person was affiliated prior to the date
hereof shall designate another person to serve in such person's stead in
accordance with the provisions of the immediately preceding sentence; provided
that any such designee shall be reasonably satisfactory to each of CGI and STC.
From and after the Effective Time, the composition of the board of directors
shall be determined in accordance with the certificate of incorporation and by-
laws of CGI.
SECTION 7.08. NMS Listing. Each of the parties hereto shall use all
reasonable efforts to obtain, prior to the Effective Time, the approval for
listing on the NMS, effective upon official notice of issuance, of the shares of
CGI Common Stock into which the shares of STC Capital Stock will be converted
pursuant to Article III.
SECTION 7.09. Blue Sky. Each of the parties hereto shall use all
reasonable efforts to obtain, prior to the Effective Time, all necessary blue
sky permits and approvals required under Blue Sky Laws to permit the
distribution of the shares of CGI Common Stock to be issued in accordance with
the provisions of this Agreement.
SECTION 7.10. STC Stock Options. At the Effective Time, CGI shall
assume, by virtue of this Agreement and without any further action on the part
of STC, all of STC's obligations with respect to each outstanding STC Stock
Option, whether vested or unvested. STC shall take all corporate action
necessary to ensure that, unless otherwise elected by CGI prior to the Effective
Time, CGI shall make such assumption in such manner that CGI (i) is a
corporation "assuming a stock option in a transaction to which Section 424(a)
applies" within the meaning of Section 424 of the Code or (ii) to the extent
that Section 424 of the Code does not apply to such STC Stock Option, would be
such a corporation were Section 424 of the Code applicable to such STC Stock
Option; and, if not so otherwise elected, after the Effective Time, all
references to STC in the STC Stock Plans and the applicable STC Stock Option
agreements shall be deemed to refer to CGI, which shall have assumed the STC
Stock Plans as of the Effective Time by virtue of this Agreement and without any
further action on the part of STC or CGI. Each STC Stock Option so assumed by
CGI under this Agreement shall continue to have, and be subject to, the same
terms and conditions set forth in the applicable STC Stock Plan and the
applicable STC Stock Option as in effect immediately prior to the Effective
Time, except as otherwise provided in Section 3.05. CGI shall use all
reasonable efforts to ensure that the STC Stock Options intended to qualify as
incentive stock options under Section 422 of the Code prior to the Effective
Time continue to so qualify after the Effective Time. As soon as practicable
after the Effective Time, CGI shall file with the SEC and use its best efforts
to have declared
<PAGE>
53
effective a registration statement on Form S-8 with respect to the shares of CGI
Common Stock issuable under the assumed STC Stock Plans.
SECTION 7.11. [INTENTIONALLY LEFT BLANK]
SECTION 7.12. Bridge Facility. (a) Pursuant to Section 6.01(b), STC
is prohibited from, among other things, exercising the Fletcher Put Options.
(b) During the term of this Agreement, STC shall promptly notify CGI
if the Projected Cash Balances are (i) then forecast by senior management of STC
to fall below $5,000,000 within 30 days or (ii) then below $5,000,000. Such
notice (a "Liquidity Notice") shall include, without limitation, the date on
which the Projected Cash Balances are forecast to fall below $5,000,000. STC
shall use all reasonable efforts to prevent the Actual Balances from falling
below $5,000,000. At CGI's request, STC shall borrow under the Bridge Facility
to prevent the Actual Balances from falling below $5,000,000 if sufficient funds
for such purpose are not available to STC in connection with one or more
Liquidity Takedowns; provided, however, that if STC is required by CGI to borrow
under this Section 7.12, then CGI shall not have the option pursuant to Section
1(c) of the license agreement related to the Bridge Facility Promissory Note to
forgive in full the Advances and activate such license agreement.
(c) Upon receipt of a Liquidity Notice from STC and so long as a
Commitment Termination Event shall not have occurred, if so requested by STC,
CGI shall lend STC funds under the Bridge Facility as provided in subsection (d)
of this Section 7.12 in amounts sufficient to prevent the Projected Cash
Balances from falling below $5,000,000. All funds provided to STC under the
Bridge Facility shall be used solely to fund ordinary and necessary operating
expenses in accordance with the then current Operating Budget.
(d) In the event that STC elects to borrow funds pursuant to
subsection (c) of this Section 7.12 and provided that no Commitment Termination
Event shall have occurred, CGI shall, upon the terms and subject to the
conditions set forth herein and in the Bridge Facility Promissory Note, make
advances (the "Advances") to STC from time to time on any business day during
the period from the date hereof through the earlier to occur of June 30, 1997
and any Commitment Termination Event in an aggregate principal amount not to
exceed at any time outstanding $5,000,000. Each Advance shall be in an amount
not less than $50,000 or an integral multiple of $25,000 in excess thereof.
Each Advance shall be made upon notice (which notice may be included in a
Liquidity Notice) given by STC to CGI not later than 11:00 a.m. San Francisco
time on the second business day prior to the date of the proposed Advance. Such
notice shall specify the date and amount of the proposed Advance. Not later
than 2:00 p.m. San Francisco time on the date of such Advance and upon
fulfillment of the applicable conditions set forth in subsection (e) of this
Section 7.12,
<PAGE>
54
CGI shall make such Advance available to STC in same day funds at CGI's address
specified above.
(e) (i) The obligation of CGI to make its initial Advance
under the Bridge Facility shall be subject to the condition precedent that CGI
shall have received, on or before the day of such initial Advance, a certificate
of the Secretary or an Assistant Secretary of STC dated the day of such initial
Advance, in form and substance satisfactory to CGI, certifying (A) copies of the
resolutions of the board of directors of STC approving the Bridge Facility
Promissory Note, and of all documents evidencing other necessary corporate
action and governmental approvals, if any, with respect to the Bridge Facility
Promissory Note, and (B) the names and true signatures of the officers of STC
authorized to sign the Bridge Facility Promissory Note and the other documents
to be delivered hereunder.
(ii) The obligation of CGI to make each Advance (including the initial
Advance) shall be subject to the further conditions precedent that (A) this
Agreement shall have been executed and delivered by the parties hereto and shall
be in full force and effect; (B) the representations and warranties contained in
the Bridge Facility Promissory Note shall be, and CGI shall have received a
certificate signed by a duly authorized officer of STC, dated the date of such
Advance, certifying that such representations and warranties are, true, complete
and correct in all material respects on and as of the date of such Advance,
before and after giving effect to such Advance and to the application of the
proceeds therefrom, as though made on and as of such date; (C) no event shall
have occurred and be continuing, or be reasonably likely to result from such
Advance or from the application of the proceeds therefrom, which constitutes an
Event of Default or would constitute an Event of Default but for the requirement
that notice be given or time elapse or both; and (D) CGI shall have received a
certificate signed by a duly authorized officer of STC, dated the date of such
Advance, certifying the then Projected Cash Balances and Actual Cash Balances.
(f) STC shall, in consultation with the Steering Committee, revise
the Projected Cash Balances and the Operating Budget from time to time, but in
no event less frequently than monthly; provided, however, that in the event STC
delivers to CGI a revised Operating Budget materially adversely different than
the Operating Budget delivered on the date hereof without the prior written
consent of CGI, CGI's obligations under the Bridge Facility shall be suspended
until such time as the parties hereto agree to a revised Operating Budget.
SECTION 7.13. Audited Financial Statements. As soon as practicable
after the date hereof or, in the case of the fiscal quarter of STC ending March
31, 1997, as soon as practicable after March 31, 1997 if CGI does not then
reasonably expect the Effective Time to occur within 45 days of such date, STC
shall cause its independent certified public accountants to prepare and audit
balance sheets of STC at and as of December 31, 1996 and March 31, 1997,
respectively, and related statements of income, retained earnings,
<PAGE>
55
shareholders' equity and changes in financial position of STC for the six-month
period ended December 31, 1996 and the nine-month period ending March 31, 1997,
respectively, and to render its unqualified report thereon. Within one business
day of receipt of the above described audited consolidated financial statements
of STC, STC shall deliver to CGI true, complete and correct copies of such
financial statements, together with the auditor's reports thereon.
SECTION 7.14. Liquidity Takedowns; Additional Debt. (a)
Notwithstanding the restrictions contained in Section 6.01 and the provisions of
the Bridge Facility referred to in Section 7.12, STC may issue additional shares
of STC Capital Stock (including pursuant to the Fletcher Put Options) if, and
only if, the following conditions shall have been satisfied to the reasonable
satisfaction of CGI on or prior to the date of issuance of such shares of STC
Capital Stock (a transaction meeting all of the following conditions being
referred to as a "Liquidity Takedown"):
(i) STC shall have given CGI not fewer than two business days'
notice of its intention to enter into an agreement to sell any STC Capital
Stock;
(ii) such sale shall be made only by a private placement to 10
or fewer "accredited investors";
(iii) such accredited investor(s) shall have received a copy of
the Registration Statement and Joint Proxy Statement (or the most recent
version thereof filed with the SEC);
(iv) any shares of STC Capital Stock so issued will, by their
terms, be converted into shares of CGI Common Stock pursuant to the Merger;
(v) such accredited investor(s) shall have delivered to CGI and
STC an irrevocable proxy to vote all shares of STC Capital Stock held
thereby in favor of the Merger; and
(vi) the other terms and conditions thereof shall be reasonably
satisfactory to CGI; provided that any term that creates any right
whatsoever in any asset or property of STC, or any ongoing obligation or
liability on STC or CGI after consummation of the Merger, shall be
conclusively not satisfactory; provided further that contractual
obligations with respect to the Fletcher Put Options in existence on the
date hereof shall be deemed reasonable.
(b) Notwithstanding the restrictions contained in Section 6.01 and
the provisions of the Bridge Facility referred to in Section 7.12, STC may incur
indebtedness in addition to that in effect on the date hereof in a principal
amount not in excess of $2,000,000
<PAGE>
56
if, and only if, the following conditions shall have been satisfied to the
reasonable satisfaction of CGI on or prior to the date of incurrence of such
additional indebtedness (a transaction meeting all of the following conditions
being referred to as a "Permitted Financing"):
(i) STC shall have given CGI not fewer than two business days'
notice of its intention to enter into an agreement to incur any additional
indebtedness;
(ii) such additional indebtedness shall be unsecured;
(iii) any shares of STC Capital Stock (or warrants, options or
similar securities convertible into or exchangeable for STC Capital Stock)
issued in connection with such additional indebtedness will, by their
terms, be converted into shares of CGI Common Stock pursuant to the Merger;
and
(iv) the other terms and conditions thereof shall be reasonably
satisfactory to CGI; provided that any term that creates any right
whatsoever in any asset or property of STC, or any ongoing obligation or
liability on STC or CGI after repayment in full of such additional
indebtedness, shall be conclusively not satisfactory.
(c) All funds provided to STC under any Liquidity Takedown or
Permitted Financing shall be used solely to fund ordinary and necessary
operating expenses in accordance with the then current Operating Budget.
SECTION 7.15. Collateralization. Promptly after the date hereof, the
parties hereto shall meet and negotiate in good faith towards securing the
Bridge Facility Promissory Note with the assets referred to in the license
agreement related thereto in the circumstances where STC is required to borrow
under Section 7.12(b). Such good faith negotiations shall involve negotiating a
customary security interest and security agreement. CGI and STC shall use all
reasonable efforts to conclude such negotiations by January 31, 1997.
ARTICLE VIII
CONDITIONS TO THE MERGER
SECTION 8.01. Conditions to the Obligations of Each Party to
Consummate the Merger. The obligations of the parties hereto to consummate the
Merger, or to permit the consummation of the Merger, are subject to the
satisfaction or, if permitted by applicable Law, waiver of the following
conditions:
<PAGE>
57
(a) the Registration Statement shall have been declared
effective by the SEC under the Securities Act and no stop order suspending
the effectiveness of the Registration Statement shall have been issued by
the SEC and no proceeding for that purpose shall have been initiated by the
SEC and not concluded or withdrawn;
(b) (i) this Agreement and the Merger shall have been duly
approved by the requisite vote of the stockholders of each of STC and CGI
and (ii) the CGI Amendment shall have been duly approved by the requisite
vote of the stockholders of CGI, in each case in accordance with the
General Corporation Law;
(c) no court of competent jurisdiction shall have issued or
entered any order, writ, injunction or decree, and no other Governmental
Entity shall have issued any order, which is then in effect and has the
effect of making the Merger illegal or otherwise prohibiting its
consummation;
(d) any waiting period (and any extension thereof) applicable
to the consummation of the Merger under the HSR Act or any other applicable
competition, merger control or similar Law shall have expired or been
terminated;
(e) all consents, approvals and authorizations legally required
to be obtained to consummate the Merger shall have been obtained from all
Governmental Entities, except where the failure to obtain any such consent,
approval or authorization could not reasonably be expected to result in a
change in or have an effect on the business of STC or CGI that is
materially adverse to the business, assets (including intangible assets),
liabilities (contingent or otherwise), condition (financial or otherwise)
or results of operations of CGI and its subsidiaries, taken as a whole; and
(f) the shares of CGI Common Stock into which the shares of STC
Capital Stock will be converted pursuant to Article III and the shares of
CGI Common Stock issuable upon the exercise of options pursuant to Section
3.05 shall have been authorized for listing on the NMS, subject to official
notice of issuance.
SECTION 8.02. Conditions to the Obligations of STC. The obligations
of STC to consummate the Merger, or to permit the consummation of the Merger,
are subject to the satisfaction or, if permitted by applicable Law, waiver of
the following further conditions:
(a) each of the representations and warranties of CGI contained
in this Agreement that is qualified by materiality shall be true, complete
and correct at and as of the Effective Time as if made at and as of such
time (other than representations and warranties which address matters only
as of a certain date which
<PAGE>
58
shall be true, complete and correct as of such certain date) and each of
the representations and warranties that is not so qualified shall be true,
complete and correct in all material respects at and as of the Effective
Time as if made at and as of such time (other than representations and
warranties which address matters only as of a certain date which shall be
true, complete and correct in all material respects as of such certain
date), in each case except as contemplated or permitted by this Agreement,
and STC shall have received a certificate of the Chairman or President and
Chief Financial Officer of CGI to such effect;
(b) CGI shall have performed or complied in all material
respects with all material agreements and covenants required by this
Agreement to be performed or complied with by it on or prior to the
Effective Time and STC shall have received a certificate of the Chairman or
President and Chief Financial Officer of CGI to that effect; and
(c) Brobeck, Phleger & Harrison, special counsel to STC, shall
have issued its opinion, such opinion dated on or about the date of the
Closing, addressed to STC, and reasonably satisfactory to it, based upon
customary representations of STC and customary assumptions (including
delivery and non-withdrawal of the opinion referred to in subsection (c) of
Section 8.03), to the effect that the Merger will be treated for federal
income tax purposes as a reorganization qualifying under the provisions of
Section 368 of the Code and that each of STC, Merger Sub and CGI will be a
party to the reorganization within the meaning of Section 368(b) of the
Code, which opinions shall not have been withdrawn or modified in any
material respect.
SECTION 8.03. Conditions to the Obligations of CGI. The obligations
of CGI to consummate the Merger, or to permit the consummation of the Merger,
are subject to the satisfaction or, if permitted by applicable Law, waiver of
the following further conditions:
(a) each of the representations and warranties of STC contained
in this Agreement that is qualified by materiality shall be true, complete
and correct at and as of the Effective Time as if made at and as of such
time (other than representations and warranties which address matters only
as of a certain date which shall be true, complete and correct as of such
certain date) and each of the representations and warranties that is not so
qualified shall be true, complete and correct in all material respects at
and as of the Effective Time as if made at and as of such time (other than
representations and warranties which address matters only as of a certain
date which shall be true, complete and correct in all material respects as
of such certain date), in each case except as contemplated or permitted by
this
<PAGE>
59
Agreement, and CGI shall have received a certificate of the Chairman
or President and Chief Financial Officer of STC to such effect;
(b) STC shall have performed or complied in all material
respects with all material agreements and covenants required by this
Agreement to be performed or complied with by it on or prior to the
Effective Time and CGI shall have received a certificate of the Chairman or
President and Chief Financial Officer of STC to that effect;
(c) Shearman & Sterling, special counsel to CGI, shall have
issued its opinion, such opinion dated on or about the date of the Closing,
addressed to CGI, and reasonably satisfactory to it, based upon customary
representations of CGI and customary assumptions (including delivery and
non-withdrawal of the opinion referred to in subsection (c) of Section
8.02), to the effect that the Merger will be treated for federal income tax
purposes as a reorganization qualifying under the provisions of Section 368
of the Code and that each of CGI, Merger Sub and STC will be a party to the
reorganization within the meaning of Section 368(b) of the Code, which
opinions shall not have been withdrawn or modified in any material respect;
(d) the STC Amendment shall have been duly approved by the
requisite vote of the stockholders of STC in accordance with the General
Corporation Law;
(e) STC shall have executed and delivered the Bridge Facility
Promissory Note and the license agreement referred to therein; and
(f) the holder(s) of the Fletcher Warrant shall have elected
pursuant to the Fletcher Notice and in accordance with Section 10 of the
Fletcher Warrant either (i) to resell the Fletcher Warrant to STC for cash
or (ii) to permit CGI to assume the Fletcher Warrant pursuant to Section
3.05; provided, however, that any disagreement between STC and Fletcher as
to the cash amount so required to be paid shall not constitute a failure of
this condition.
ARTICLE IX
TERMINATION, AMENDMENT AND WAIVER
SECTION 9.01. Termination. This Agreement may be terminated and the
Merger may be abandoned at any time prior to the Effective Time, notwithstanding
any requisite adoption and approval of this Agreement, as follows:
<PAGE>
60
(a) by mutual written consent duly authorized by the boards of
directors of each of CGI and STC;
(b) by either CGI or STC, if the Effective Time shall not have
occurred on or before August 31, 1997; provided, however, that the right to
terminate this Agreement under this Section 9.01(b) shall not be available
to any party whose failure to fulfill any obligation under this Agreement
shall have caused, or resulted in, the failure of the Effective Time to
occur on or before such date;
(c) by either CGI or STC, if any Governmental Order, writ,
injunction or decree preventing the consummation of the Merger shall have
been entered by any court of competent jurisdiction and shall have become
final and nonappealable;
(d) by CGI, if (i) the board of directors of STC withdraws,
modifies or changes its recommendation of this Agreement, the Merger or the
Amendment in a manner adverse to CGI or its stockholders or shall have
resolved to do so, (ii) the board of directors of STC shall have
recommended to the stockholders of STC a Competing Transaction or shall
have resolved to do so or (iii) a tender offer or exchange offer for 15
percent or more of the outstanding shares of capital stock of STC shall
have been commenced and the board of directors of STC shall have failed to
recommend against acceptance of such tender offer or exchange offer by its
stockholders (including by taking no position with respect to the
acceptance of such tender offer or exchange offer by its stockholders);
(e) by STC, if (i) the board of directors of CGI withdraws,
modifies or changes its recommendation of this Agreement or the Merger in a
manner adverse to STC or its stockholders or shall have resolved to do so,
(ii) the board of directors of CGI shall have recommended to the
stockholders of CGI a Competing Transaction or shall have resolved to do so
or (iii) a tender offer or exchange offer for 15 percent or more of the
outstanding shares of capital stock of CGI shall have been commenced and
the board of directors of CGI shall have failed to recommend against
acceptance of such tender offer or exchange offer by its stockholders
(including by taking no position with respect to the acceptance of such
tender offer or exchange offer by its stockholders);
(f) by CGI or STC, if (i) this Agreement and the Merger shall
fail to receive the requisite votes for approval at the STC Stockholders'
Meeting or any adjournment or postponement thereof or (ii) if this
Agreement and the Merger shall fail to receive the requisite votes for
approval at the CGI Stockholders' Meeting or any adjournment or
postponement thereof;
<PAGE>
61
(g) by CGI, upon a breach of any representation, warranty,
covenant or agreement on the part of STC set forth in this Agreement, or if
any representation or warranty of STC shall have become untrue, incomplete
or incorrect, in either case such that the conditions set forth in Section
8.03 would not be satisfied (a "Terminating STC Breach"); provided,
however, that, if such Terminating STC Breach is curable by STC through the
exercise of its reasonable efforts within 60 days and for so long as STC
continues to exercise such reasonable efforts, CGI may not terminate this
Agreement under this Section 9.01(g); and provided further that the
preceding proviso shall not in any event be deemed to extend any date set
forth in paragraph (b) of this Section 9.01;
(h) by STC, upon breach of any representation, warranty,
covenant or agreement on the part of CGI set forth in this Agreement, or if
any representation or warranty of CGI shall have become untrue, incomplete
or incorrect, in either case such that the conditions set forth in Section
8.02 would not be satisfied (a "Terminating CGI Breach"); provided,
however, that, if such Terminating CGI Breach is curable by CGI through the
exercise of its reasonable efforts within 60 days and for so long as CGI
continues to exercise such reasonable efforts, STC may not terminate this
Agreement under this Section 9.01(h); and provided further that the
preceding proviso shall not in any event be deemed to extend any date set
forth in paragraph (b) of this Section 9.01;
(i) by STC, if (A) the board of directors of STC shall have
resolved to accept, accepted or recommended to the shareholders of STC, a
Superior Proposal, and (B) in the case of the termination of this Agreement
under this Section 9.01(i) by STC, STC shall have paid to CGI all amounts
owing by STC to CGI under Section 9.05(b); and
(j) by CGI, if (A) the board of directors of CGI shall have
resolved to accept, accepted or recommended to the shareholders of CGI, a
Superior Proposal, and (B) in the case of the termination of this Agreement
under this Section 9.01(j) by CGI, CGI shall have paid to STC all amounts
owing by CGI to STC under Section 9.05(c).
SECTION 9.02. Effect of Termination. Except as provided in Section
9.05, in the event of termination of this Agreement pursuant to Section 9.01,
this Agreement shall forthwith become void, there shall be no liability under
this Agreement on the part of CGI or STC or any of their respective officers or
directors, and all rights and obligations of each party hereto shall cease,
subject to the remedies of the parties hereto set forth in Section 9.05(b), (c),
(d) and (e); provided, however, that nothing herein shall relieve any party
hereto from liability for the willful or intentional breach of any of its
representations and warranties or the willful or intentional breach of any of
its covenants or agreements set forth in this Agreement.
<PAGE>
62
SECTION 9.03. Amendment. This Agreement may be amended by the
parties hereto by action taken by or on behalf of their respective boards of
directors at any time prior to the Effective Time; provided, however, that,
after the approval of this Agreement by the stockholders of STC or CGI, as the
case may be, no amendment may be made, except such amendments as have received
the requisite stockholder approval and such amendments as are permitted to be
made without stockholder approval under the General Corporation Law. This
Agreement may not be amended except by an instrument in writing signed by the
parties hereto.
SECTION 9.04. Waiver. At any time prior to the Effective Time, any
party hereto may (a) extend the time for or waive compliance with the
performance of any obligation or other act of any other party hereto or (b)
waive any inaccuracy in the representations and warranties contained herein or
in any document delivered pursuant hereto. Any such extension or waiver shall
be valid if set forth in an instrument in writing signed by the party or parties
to be bound thereby.
SECTION 9.05. Expenses. (a) Except as set forth in this Section
9.05, all Expenses incurred in connection with this Agreement, the STC Stock
Option Agreement, the CGI Stock Option Agreement and the Merger shall be paid by
the party incurring such Expenses, whether or not the Merger is consummated,
except that CGI and STC each shall pay one-half of all Expenses incurred solely
for printing, filing and mailing the Registration Statement and the Joint Proxy
Statement and all SEC and other regulatory filing fees incurred in connection
with the Registration Statement and the Joint Proxy Statement and any fees
required to be paid under the HSR Act.
(b) In the event that CGI shall terminate this Agreement pursuant to
Section 9.01(d), (f)(i) or (g), or STC shall terminate this Agreement pursuant
to Section 9.01(f)(i) or (i), then STC shall pay to CGI an amount equal to
$3,000,000 plus all of CGI's Expenses.
(c) In the event that STC shall terminate this Agreement pursuant to
Section 9.01(e), (f)(ii) or (h) or CGI shall terminate this Agreement pursuant
to Section 9.01(f)(ii) or (j), CGI shall pay to STC an amount equal to
$3,000,000 plus all of STC's Expenses.
(d) Any payment required to be made pursuant to Section 9.05(b) or
(c) shall be made to the party entitled to receive such payment not later than
two business days after delivery to the other party of notice of demand for
payment and shall be made by wire transfer of immediately available funds to an
account designated by the party entitled to receive payment in the notice of
demand for payment delivered pursuant to this Section 9.05(d); provided,
however, that, in the event both CGI and STC would otherwise be entitled to
payments under this Section 9.05 in connection with the termination of this
<PAGE>
63
Agreement pursuant to both Sections 9.01(f)(i) and (f)(ii), neither party shall
be required to make any payment under this Section 9.05.
(e) In the event that CGI or STC, as the case may be, shall fail
timely to make any payment on Expense reimbursement required to be made pursuant
to Section 9.05(b) or (c), the amount of any such required payment on Expense
reimbursement shall be increased to include the costs and expenses actually
incurred or accrued by the other (including, without limitation, fees and
expenses of counsel) in connection with the collection under and enforcement of
this Section 9.05, together with interest on such unpaid Expense reimbursement,
commencing on the date that such Expense reimbursement became due, at a rate
equal to the rate of interest publicly announced by Citibank, N.A., from time to
time, in The City of New York, from time to time, as such bank's base rate plus
3.00 percent per annum.
ARTICLE X
GENERAL PROVISIONS
SECTION 10.01. NonSurvival of Representations and Warranties. The
representations and warranties in this Agreement shall terminate at the
Effective Time or upon the termination of this Agreement pursuant to Section
9.01, as the case may be. Each party agrees that, except for the
representations and warranties contained in this Agreement and the CGI
Disclosure Schedule and the STC Disclosure Schedule, no party hereto has made
any other representations and warranties, and each party hereby disclaims any
other representations and warranties made by itself or any of its officers,
directors, employees, agents, financial and legal advisors or other
representatives, with respect to the execution and delivery of this Agreement or
the Merger contemplated herein, notwithstanding the delivery or disclosure to
any other party or any party's representatives of any documentation or other
information with respect to any one or more of the foregoing.
SECTION 10.02. Notices. All notices, requests, claims, demands and
other communications hereunder shall be in writing and shall be given (and shall
be deemed to have been duly given upon receipt) by delivery in person, by
telecopy or facsimile, by registered or certified mail (postage prepaid, return
receipt requested) or by a nationally recognized courier service to the
respective parties at their addresses set forth on the signature pages to this
Agreement (or at such other address for a party as shall be specified in a
notice given in accordance with this Section 10.02).
SECTION 10.03. Severability. If any term or other provision of this
Agreement is invalid, illegal or incapable of being enforced by any rule of Law
or public policy, all other conditions and provisions of this Agreement shall
nevertheless remain in full force and effect so long as the economic or legal
substance of the Merger is not affected in
<PAGE>
64
any manner materially adverse to any party. Upon such determination that any
term or other provision is invalid, illegal or incapable of being enforced, the
parties hereto shall negotiate in good faith to modify this Agreement so as to
effect the original intent of the parties as closely as possible in a mutually
acceptable manner to the fullest extent permitted by applicable Law in order
that the Merger may be consummated as originally contemplated to the fullest
extent possible.
SECTION 10.04. Assignment; Binding Effect; Benefit. Neither this
Agreement nor any of the rights, interests or obligations hereunder shall be
assigned by any of the parties hereto (whether by operation of Law or otherwise)
without the prior written consent of the other parties hereto. Subject to the
preceding sentence, this Agreement shall be binding upon and shall inure to the
benefit of the parties hereto and their respective successors and permitted
assigns. Notwithstanding anything contained in this Agreement to the contrary,
other than Section 7.06, nothing in this Agreement, expressed or implied, is
intended to confer on any person other than the parties hereto or their
respective successors and permitted assigns any rights or remedies under or by
reason of this Agreement.
SECTION 10.05. Incorporation of Exhibits. The CGI Disclosure
Schedule, the STC Disclosure Schedule and all Exhibits attached hereto and
referred to herein are hereby incorporated herein and made a part of this
Agreement for all purposes as if fully set forth herein.
SECTION 10.06. Specific Performance. The parties hereto agree that
irreparable damage would occur in the event any provision of this Agreement were
not performed in accordance with the terms hereof and that the parties shall be
entitled to specific performance of the terms hereof, in addition to any other
remedy at law or in equity.
SECTION 10.07. Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY,
AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF
DELAWARE, WITHOUT REGARD TO PRINCIPLES OF CONFLICT OF LAWS.
SECTION 10.08. Waiver of Jury Trial. EACH PARTY HERETO HEREBY
IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY PROCEEDING (WHETHER BASED
ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR
ANY TRANSACTION OR AGREEMENT CONTEMPLATED HEREBY OR THE ACTIONS OF ANY PARTY
HERETO IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE OR ENFORCEMENT HEREOF.
SECTION 10.09. Headings. The descriptive headings contained in this
Agreement are included for convenience of reference only and shall not affect in
any way the meaning or interpretation of this Agreement.
<PAGE>
65
SECTION 10.10. Counterparts. This Agreement may be executed and
delivered (including by facsimile transmission) in one or more counterparts, and
by the different parties hereto in separate counterparts, each of which when
executed and delivered shall be deemed to be an original but all of which taken
together shall constitute one and the same agreement.
SECTION 10.11. Entire Agreement. This Agreement (including the
Exhibits, the CGI Disclosure Schedule and the STC Disclosure Schedule), the STC
Stock Option Agreement and the CGI Stock Option Agreement constitute the entire
agreement among the parties with respect to the subject matter hereof and
supersede all prior agreements and understandings among the parties with respect
thereto. No addition to or modification of any provision of this Agreement
shall be binding upon any party hereto unless made in writing and signed by all
parties hereto.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
<PAGE>
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
executed as of the date first written above by their respective officers
thereunto duly authorized.
CELL GENESYS, INC.
By: /s/ STEPHEN A. SHERWIN
-------------------------------------
Stephen A. Sherwin, M.D.
Chairman of the Board, President and
Chief Executive Officer
322 Lakeside Drive
Foster City, California 94404
Telephone: (415) 358-9600
Telecopy: (415) 358-0230
Attention: Kathleen Sereda Glaub
with a copy to:
Shearman & Sterling
555 California Street
San Francisco, California 94104-1522
Telephone: (415) 616-1100
Telecopy: (415) 616-1199
Attention: Michael J. Kennedy
S MERGER CORP.
By: /s/ KATHLEEN SEREDA GLAUB
-------------------------------------
Kathleen Sereda Glaub
Chairman of the Board and President
c/o Cell Genesys, Inc.
322 Lakeside Drive
Foster City, California 94404
Telephone: (415) 358-9600
Telecopy: (415) 358-0230
Attention: Kathleen Sereda Glaub
<PAGE>
SOMATIX THERAPY CORPORATION
By: \s\ EDWARD O. LANPHIER
------------------------
Edward O. Lanphier II
Executive Vice President and
Chief Financial Officer
950 Marina Village Parkway
Suite 100
Alameda, California 94501
Telephone: (510) 748-3000
Telecopy: (510) 814-8002
Attention: Edward O. Lanphier
with a copy to:
Brobeck, Phleger & Harrison
2200 Geng Road
Palo Alto, California 94303
Telephone: (415) 424-0160
Telecopy: (415) 496-2885
Attention: J. Stephan Dolezalek
<PAGE>
EXHIBIT 10.1
CONFORMED COPY
STOCK OPTION AGREEMENT
STOCK OPTION AGREEMENT, dated as of January 12, 1997 (as amended,
restated, supplemented or otherwise modified from time to time, this
"Agreement"), between CELL GENESYS, INC., a corporation organized and existing
under the laws of the State of Delaware ("CGI"), as the grantee hereunder (the
"Grantee"), and SOMATIX THERAPY CORPORATION, a corporation organized and
existing under the laws of the State of Delaware ("STC"), as the grantor
hereunder (the "Grantor");
W I T N E S S E T H:
- - - - - - - - - -
WHEREAS, CGI, S Merger Corp., a corporation organized and existing
under the laws of the State of Delaware and a direct wholly owned subsidiary of
CGI, and STC have entered into an agreement and plan of merger and
reorganization, dated as of January 12, 1997 (the "Merger Agreement"; terms used
and not otherwise defined herein are used herein as defined in the Merger
Agreement); and
WHEREAS, as a condition to the willingness of CGI to enter into the
Merger Agreement and the CGI Stock Option Agreement, CGI has required that STC
agree, and in order to induce CGI to enter into the Merger Agreement and the CGI
Stock Option Agreement, STC has agreed to grant CGI an option, upon the terms
and subject to the conditions set forth in this Agreement, to purchase up to
5,441,480 newly issued shares of common stock, par value $.01 per share, of STC
(the "Grantor Common Stock"), representing approximately 19.9% of the shares of
Grantor Common Stock issued and outstanding on the date hereof;
NOW, THEREFORE, in consideration of the foregoing and the
representations, warranties, covenants and agreements set forth herein and in
the Merger Agreement, and other good and valuable consideration, the receipt and
adequacy of which are hereby acknowledged, and intending to be legally bound
hereby, the parties hereto hereby agree as follows:
SECTION 1. Grant of Stock Option. The Grantor hereby grants to the
Grantee an irrevocable option (the "Stock Option") to purchase up to 5,441,480
shares of Grantor Common Stock (the "Option Shares") at a purchase price of
$3.51 per Option Share (the "Purchase Price").
SECTION 2. Exercise of Stock Option. (a) Subject to the conditions
set forth in Section 3, the Stock Option may be exercised by the Grantee, in
whole or in part, at any
<PAGE>
2
time or from time to time after the occurrence of an Exercise Event (as defined
below) and prior to the Termination Date (as defined below).
(b) An "Exercise Event" shall occur for purposes of this Agreement
upon the occurrence of any event or circumstance which obligates the Grantor,
or, in the case of Section 9.05(b)(ii) of the Merger Agreement, may obligate the
Grantor in the event a Competing Transaction is consummated within the 12-month
period referred to therein, to pay to the Grantee any amount specified pursuant
to Section 9.05 of the Merger Agreement.
(c) The "Termination Date" shall occur for purposes of this
Agreement upon the first to occur of any of (i) the Effective Time; (ii) the
termination of this Agreement pursuant to Section 10; or (iii) the date which is
90 days after the occurrence of an Exercise Event.
(d) In the event the Grantee wishes to exercise the Stock Option,
the Grantee shall send a written notice (a "Stock Exercise Notice") to the
Grantor specifying the total number of Option Shares the Grantee wishes to
purchase, the denominations of the certificate or certificates evidencing such
Option Shares which the Grantee wishes to receive, a date (a "Closing Date"),
which shall be a business day which is at least five and not more than 10
business days after delivery of such notice, and place for the closing of such
purchase (a "Closing"). Upon receipt of a Stock Exercise Notice, the Grantor
shall be obligated to deliver to the Grantee a certificate or certificates
evidencing the number of Option Shares specified therein, in accordance with the
terms of this Agreement, on the later of (i) the date specified in such Stock
Exercise Notice and (ii) the first business day on which the conditions
specified in Section 3 shall be satisfied; provided, however, that
notwithstanding the foregoing, the Grantor shall have the right, exercisable by
written notice to the Grantee within three business days after receipt of a
Stock Exercise Notice, to elect to treat such Stock Exercise Notice as a Cash
Exercise Notice pursuant to Section 2(e) for all purposes of this Agreement, and
to pay to the Grantee an amount in cash equal to the Spread (as defined below)
within 10 business days following receipt of such Stock Exercise Notice.
(e) If at any time the Stock Option is then exercisable pursuant to
the terms of Section 2(a), the Grantee may elect, in lieu of exercising the
Stock Option to purchase Option Shares as provided in Section 2(a), to send a
written notice to the Grantor (a "Cash Exercise Notice"; either a Cash Exercise
Notice or a Stock Exercise Notice, an "Exercise Notice") specifying a date which
shall be a business day which is at least five and not more than 10 business
days following the date such notice is given on which date the Grantor shall pay
to the Grantee an amount in cash equal to the Spread (as defined below)
multiplied by such number of Option Shares as the Grantee shall specify. As
used herein, "Spread" shall mean the excess, if any, over the Purchase Price of
the higher of (i) if applicable, the highest price per share of Grantor Common
Stock paid by any person in a Competing Transaction (the "Competing Purchase
Price") or (ii) the closing price of the shares of Grantor Common
<PAGE>
3
Stock on the NMS on the last trading day immediately prior to the date of the
Cash Exercise Notice (the "Closing Price"). If the Competing Purchase Price
includes any property other than cash, the Competing Purchase Price shall be the
sum of (i) the fixed cash amount, if any, included in the Competing Purchase
Price plus (ii) the fair market value of such other property. If such other
property consists of securities with an existing public trading market, the
average of the closing prices (or the average of the closing bid and asked
prices if closing prices are unavailable) for such securities in their principal
public trading market on the five trading days ending one trading day prior to
the date of the Cash Exercise Notice shall be deemed to equal the fair market
value of such property. If such other property consists of something other than
cash or securities with an existing public trading market and, as of the payment
date for the Spread, agreement on the value of such other property has not been
reached, the Competing Purchase Price shall be deemed to be the amount of any
cash included in the Competing Purchase Price plus the fair market value of such
other property (as determined by a nationally recognized investment banking firm
jointly selected by the Grantor and the Grantee). For this purpose, the parties
shall use commercially reasonable efforts to cause any determination of the fair
market value of such other property to be made within three business days after
the date of delivery of the Cash Exercise Notice. Upon exercise of its right to
receive the Spread pursuant to this Section 2(e) or the Grantor electing to
treat a Stock Exercise Notice as a Cash Exercise Notice pursuant to Section
2(d), the obligations of the Grantor to deliver Option Shares pursuant to
Section 3 shall be terminated with respect to such number of Option Shares for
which the Grantee shall have elected to be paid the Spread. If at the time
payment of the Spread by the Grantor is due, the Grantor shall not have
consummated a Competing Transaction, the Grantor may elect to pay the Spread in
cash or in shares of Grantor Common Stock, valued at the closing price of shares
of Grantor Common Stock on the NMS on the business day prior to such payment
(the "Closing Date Price").
SECTION 3. Conditions to Delivery of Option Shares. The obligation
of the Grantor to deliver Option Shares upon any exercise of the Stock Option is
subject to the following conditions:
(a) Such delivery or payment shall not in any material respect
violate, or otherwise cause the material violation of, the rules and
regulations of the NASD or any material Law, including, without limitation,
the HSR Act, applicable to such exercise of the Stock Option and the
delivery of the Option Shares or payment of the Spread in respect of such
exercise; and
(b) There shall be no preliminary or permanent injunction or
other order by any court of competent jurisdiction preventing or
prohibiting such exercise of the Stock Option or the delivery of the Option
Shares or payment of the Spread in respect of such exercise.
<PAGE>
4
SECTION 4. Closings. (a) At each Closing pursuant to Section 2(d),
the Grantor shall deliver to the Grantee a certificate or certificates
evidencing the number of Option Shares specified in the applicable Stock
Exercise Notice (in the denominations specified therein), and the Grantee shall
purchase each such Option Share from the Grantor at the Purchase Price.
(b) At each Closing pursuant to Section 2(e), the Grantor shall
deliver to the Grantee cash in an amount determined pursuant to Section 2(e).
(c) (i) Certificates evidencing Option Shares delivered hereunder
may, at the election of the Grantor, contain the following legend:
THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS,
AND MAY NOT BE TRANSFERRED, SOLD, ASSIGNED, PLEDGED, HYPOTHECATED OR
OTHERWISE DISPOSED OF, AND NO REGISTRATION OF TRANSFER OF SUCH SECURITIES
WILL BE MADE ON THE BOOKS OF THE ISSUER, UNLESS SUCH TRANSFER, SALE,
ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSAL IS MADE IN CONNECTION
WITH AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933,
AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS OR IS EXEMPT FROM THE
REGISTRATION REQUIREMENTS OF SUCH ACT, THE RULES AND REGULATIONS IN EFFECT
THEREUNDER AND ANY APPLICABLE STATE SECURITIES LAWS.
(ii) The Grantor shall, upon the written request of the holder thereof,
issue such holder a new certificate evidencing such Option Shares without such
legend in the event (A) such Option Shares have been registered pursuant to the
Securities Act, (B) such Option Shares have been sold in reliance on and in
accordance with Rule 144 promulgated under the Securities Act or (C) such holder
shall have delivered to the Grantor an opinion of counsel, in form and substance
reasonably satisfactory to the Grantor, to the effect that subsequent transfers
of such Option Shares may be effected without registration under the Securities
Act.
(d) All payments made pursuant to this Section 4 shall be made by
wire transfer of immediately available funds.
SECTION 5. Adjustments upon Share Issuances, Changes in
Capitalization, Etc. (a) In the event of any change in the Grantor Common
Stock or in the number of outstanding shares of Grantor Common Stock by reason
of a stock dividend, split-up, recapitalization, combination, exchange of shares
or similar transaction or any other change
<PAGE>
5
in the corporate or capital structure of the Grantor (including, without
limitation, the declaration or payment of an extraordinary dividend of cash,
securities or other property), the type and number of shares or securities to be
issued by the Grantor upon exercise of the Stock Option shall be adjusted
appropriately, and proper provision shall be made in the agreements governing
such transaction, so that the Grantee shall receive upon exercise of the Stock
Option the number and class of shares or other securities or property that the
Grantee would have received in respect of the Grantor Common Stock if the Stock
Option had been exercised immediately prior to such event, or the record date
therefor, as applicable, and elected to the fullest extent it would have been
permitted to elect to receive such securities, cash or other property.
(b) In the event that the Grantor shall enter into an agreement (i)
to consolidate with or merge into any person, other than the Grantee or any of
its subsidiaries, and shall not be the continuing or surviving corporation of
such consolidation or merger, (ii) to permit any person, other than the Grantee
or any of its subsidiaries, to merge into the Grantor and the Grantor shall be
the continuing or surviving corporation, but, in connection with such merger,
the then outstanding shares of Grantor Common Stock shall be changed into or
exchanged for stock or other securities of the Grantor or any other person or
cash or any other property or then outstanding shares of Grantor Common Stock
would after such merger represent less than a majority of the outstanding shares
and share equivalents of the surviving corporation or (iii) to sell or otherwise
transfer all or substantially all of its assets to any person, other than the
Grantee or any of its subsidiaries, then, and in each such case, proper
provision shall be made in the agreements governing such transaction so that the
Grantee shall receive upon exercise of the Stock Option the number and class of
shares or other securities or property that the Grantee would have received in
respect of the Grantor Common Stock if the Stock Option had been exercised
immediately prior to such transaction, or the record date therefor, as
applicable, and elected to the fullest extent it would have been permitted to
elect to receive such securities, cash or other property.
(c) All of the provisions of this Agreement shall apply with
appropriate adjustments to any securities for which the Stock Option becomes
exercisable pursuant to this Section 5.
SECTION 6. Representations and Warranties of the Grantor. The
Grantor hereby represents and warrants to the Grantee as follows:
(a) Organization; Authority Relative to This Agreement. The
Grantor has been duly organized and is validly existing and in good
standing under the laws of the State of Delaware. The Grantor has all
necessary corporate power and authority to execute and deliver this
Agreement, to perform its obligations hereunder and to consummate the
transactions contemplated hereby. The execution and delivery of this
Agreement by the Grantor and the consummation by the Grantor
<PAGE>
6
of the transactions contemplated hereby have been duly and validly
authorized by the board of directors of the Grantor, and no other corporate
proceedings on the part of the Grantor are necessary to authorize this
Agreement or to consummate such transactions. This Agreement has been duly
and validly executed and delivered by the Grantor and, assuming the due
authorization, execution and delivery by the Grantee, constitutes a legal,
valid and binding obligation of the Grantor, enforceable against the
Grantor in accordance with its terms. The Grantor has taken all appropriate
actions so that the restrictions on business combinations contained in
Section 203 of the General Corporation Law will not apply with respect to
or as a result of the transactions contemplated hereby.
(b) Authority to Issue Shares. The Grantor has taken all
necessary corporate action to authorize and reserve and permit it to issue,
and at all times from the date hereof through the Termination Date shall
have reserved, all the Option Shares issuable pursuant to this Agreement,
and the Grantor will take all necessary corporate action to authorize and
reserve and permit it to issue all additional shares of Grantor Common
Stock or other securities which may be issued pursuant to Section 4, all of
which, upon their issuance and delivery in accordance with the terms of
this Agreement, will be duly authorized, validly issued, fully paid and
nonassessable, will be delivered free and clear of all security interests,
liens, claims, pledges, options, rights of first refusal, agreements,
limitations on the Grantee's voting rights, charges and other encumbrances
of any nature whatsoever (other than this Agreement) and will not be
subject to any preemptive rights.
(c) No Conflict; Required Filings and Consents. The execution
and delivery of this Agreement by the Grantor do not, and the performance
of this Agreement by the Grantor will not, (i) require any consent,
approval, authorization or permit of, or filing with or notification to any
Governmental Entity, other than pursuant to the HSR Act, (ii) conflict with
or violate any provision of the certificate of incorporation or by-laws or
equivalent organizational documents of the Grantor or any material
subsidiary thereof, (iii) conflict with or violate any Law applicable to
the Grantor or any material subsidiary thereof or by which any property or
asset of the Grantor or any material subsidiary thereof is bound or
affected, or (iv) result in any breach of or constitute a default (or an
event which with notice or lapse of time or both would become a default)
under, or give to others any right of termination, amendment, acceleration
or cancellation of, or result in the creation of a lien or other
encumbrance of any nature whatsoever on any property or asset of the
Grantor or any material subsidiary thereof pursuant to, any note, bond,
mortgage, indenture, contract, agreement, lease, license, permit, franchise
or other instrument or obligation to which the Grantor or any material
subsidiary thereof is a party or by which the Grantor or any material
subsidiary thereof or any property or asset of the Grantor or any material
subsidiary thereof is bound or affected, except, in the case of clauses
(i),
<PAGE>
7
(iii) and (iv), for any such conflicts, violations, breaches, defaults
or other occurrences which could not reasonably be expected to prevent or
delay in any material respect the exercise by the Grantee of the Stock
Option or any other right of the Grantee under this Agreement.
SECTION 7. Covenants of the Grantor. (a) Listing; Other Action.
(i) The Grantor shall, at its expense, use its best efforts to cause the Option
Shares to be listed for quotation on the NMS, subject to notice of issuance, as
promptly as practicable following the date of this Agreement, and will provide
prompt notice to the NASD of the issuance of each Option Share.
(ii) The Grantor shall use its best efforts to take, or cause to be taken,
all appropriate action, and to do, or cause to be done, all things necessary,
proper or advisable under applicable Law to consummate and make effective the
transactions contemplated hereunder, including, without limitation, using all
commercially reasonable efforts to obtain all licenses, permits, consents,
approvals, authorizations, qualifications and orders of Governmental Entities.
Without limiting the generality of the foregoing, the Grantor shall, when
required in order to effect the transactions contemplated hereunder, make all
necessary filings and any other required or appropriate submissions under the
HSR Act as promptly as practicable.
(iii) The Grantor shall not take any action in order to intentionally
cause the exercise of the Stock Option to violate, or to require the vote of the
stockholders of the Grantor in order not to violate, any rules or regulations of
the NASD.
(b) Registration. Upon the request of the Grantee at any time and
from time to time within three years of the first Closing, the Grantor shall (i)
effect, as promptly as practicable, up to two registrations under the Securities
Act covering any part or all (as may be requested by the Grantee) of the Option
Shares or other securities that have been acquired by or are issuable to the
Grantee upon exercise of the Stock Option, and to use its best efforts to
qualify such Option Shares or other securities under any applicable state
securities laws and (ii) include any part or all of the Option Shares or such
other securities in any registration statement for common stock filed by the
Grantor under the Securities Act in which such inclusion is permitted under
applicable rules and regulations, and to use its best efforts to keep each such
registration described in clauses (i) and (ii) effective for a period of not
less than six months. If the managing underwriter of a proposed offering of
securities by the Grantor shall advise the Grantor in writing that, in the
reasonable opinion of the managing underwriter, the distribution of the Option
Shares requested by the Grantee to be included in a registration statement
concurrently with securities being registered for sale by the Grantor would
adversely affect the distribution of such securities by the Grantor, then the
Grantor shall either (i) include such Option Shares in the registration
statement, but the Grantee shall agree to delay the offering and sale for such
period of time as the managing
<PAGE>
8
underwriter may reasonably request (provided that the Grantee may at any time
withdraw its request to include Option Shares in such offering) or (ii) include
such portion of the Option Shares in the registration statement as the managing
underwriter advises may be so included for sale simultaneously with sales by the
Grantor. The registrations effected under this Section 7(b) shall be effected at
the Grantor's expense except for underwriting commissions allocable to the
Option Shares and the fees and disbursements of the Grantee's counsel. The
Grantor shall indemnify and hold harmless the Grantee, its affiliates and
controlling persons and their respective officers, directors, agents and
representatives from and against any and all losses, claims, damages,
liabilities and expenses (including, without limitation, all out-of-pocket
expenses, investigation expenses, expenses incurred with respect to any judgment
and fees and disbursements of counsel and accountants) arising out of or based
upon any statements contained in, or omissions or alleged omissions from, each
registration statement (and related prospectus) filed pursuant to this Section
7(b); provided, however, that the Grantor shall not be liable in any such case
to the Grantee or any affiliate or controlling person of the Grantee or any of
their respective officers, directors, agents or representatives to the extent
that any such loss, claim, damage, liability (or action or proceeding in respect
thereof) or expense arises out of or is based upon an untrue statement or
omission made in such registration statement or prospectus in reliance upon, and
in conformity with, written information with respect to the Grantee or any such
affiliate, controlling person, officer, director, agent or representative
thereof, as the case may be, furnished by the Grantee or any such other person
to the Grantor for use in the preparation of such registration statement.
SECTION 8. Representations and Warranties of the Grantee. The
Grantee hereby represents and warrants to the Grantor as follows:
(a) Organization; Authority Relative to This Agreement. The
Grantee has been duly organized and is validly existing and in good
standing under the laws of the State of Delaware. The Grantee has all
necessary corporate power and authority to execute and deliver this
Agreement, to perform its obligations hereunder and to consummate the
transactions contemplated hereby. The execution and delivery of this
Agreement by the Grantee and the consummation by the Grantee of the
transactions contemplated hereby have been duly and validly authorized by
the board of directors of the Grantee, and no other corporate proceedings
on the part of the Grantee are necessary to authorize this Agreement or to
consummate such transactions. This Agreement has been duly and validly
executed and delivered by the Grantee and, assuming the due authorization,
execution and delivery by the Grantor, constitutes a legal, valid and
binding obligation of the Grantee, enforceable against the Grantee in
accordance with its terms.
(b) No Conflict; Required Filings and Consents. The execution
and delivery of this Agreement by the Grantee do not, the performance of
this Agreement by the Grantee will not, (i) require any consent, approval,
authorization or permit of,
<PAGE>
9
or filing with or notification to any Governmental Entity, other than
pursuant to the HSR Act, (ii) conflict with or violate any provision of the
certificate of incorporation or by-laws or equivalent organizational
documents of the Grantee, (iii) conflict with or violate any Law applicable
to the Grantee or by which any property or asset of the Grantee is bound or
affected, or (iv) result in any breach of or constitute a default (or an
event which with notice or lapse of time or both would become a default)
under, or give to others any right of termination, amendment, acceleration
or cancellation of, or result in the creation of a lien or other
encumbrance of any nature whatsoever on any property or asset of the
Grantee pursuant to, any note, bond, mortgage, indenture, contract,
agreement, lease, license, permit, franchise or other instrument or
obligation to which the Grantee is a party or by which the Grantee or any
property or asset of the Grantee is bound or affected, except, in the case
of clauses (i), (iii) and (iv), for any such conflicts, violations,
breaches, defaults or other occurrences which could not reasonably be
expected, individually or in the aggregate, (A) to prevent or delay in any
material respect the exercise by the Grantor of any right of the Grantor
under this Agreement or (B) to have an STC Material Adverse Effect.
SECTION 9. Covenants of the Grantee. The Grantee shall acquire the
Option Shares for investment purposes only and not with a view to any
distribution thereof in violation of the Securities Act, and shall not sell any
Option Shares purchased pursuant to this Agreement except in compliance with the
Securities Act.
SECTION 10. Termination. This Agreement, other than the rights and
obligations of the Grantor and the Grantee under Sections 7, 9 and 11 shall
terminate on February 12, 1998.
SECTION 11. Miscellaneous. (a) Expenses. Except as otherwise
provided herein or in the Merger Agreement, all costs and expenses incurred in
connection with the transactions contemplated by this Agreement shall be paid by
the party incurring such expenses.
(b) Notices. All notices and other communications given or made
pursuant hereto shall be in writing and shall be deemed to have been duly given
or made as of the date delivered, mailed or transmitted, and shall be effective
upon receipt, if delivered personally, mailed by registered or certified mail
(postage prepaid, return receipt requested) to the respective parties at their
addresses as specified in the Merger Agreement or sent by electronic
transmission to the respective parties at their telecopier numbers as specified
in Section 10.02 of the Merger Agreement.
(c) Assignment. This Agreement may not be assigned by operation of
law or otherwise without the express written consent of each party hereto (which
consent may be granted or withheld in the sole discretion of each such party);
provided, however, that the
<PAGE>
10
Grantee may assign all or any of its rights and obligations hereunder to any
wholly owned subsidiary of the Grantee; provided further that no such assignment
shall relieve the Grantee of its obligations hereunder if such assignee does not
perform such obligations.
(d) Amendment; Waiver. This Agreement may not be amended except by
an instrument in writing signed by the parties hereto. Any party hereto may (i)
extend the time for the performance of any obligation or other act of any other
party hereto, (ii) waive any inaccuracy in the representations and warranties
contained herein or in any document delivered pursuant hereto and (iii) waive
compliance with any agreement or condition contained herein. Any such extension
or waiver shall be valid if set forth in an instrument in writing signed by the
party or parties to be bound thereby. No failure or delay by any party in
exercising any right, power or privilege hereunder shall operate as a waiver
thereof nor shall any single or partial exercise thereof preclude any other or
further exercise thereof or the exercise of any other right, power or privilege.
The rights and remedies herein provided shall be cumulative and not exclusive of
any rights or remedies provided by law.
(e) Successors and Assigns. The provisions of this Agreement shall
be binding upon and inure to the benefit of the parties hereto and their
respective successors and permitted assigns.
(f) No Third Party Beneficiaries. Nothing herein, express or impled,
is intended to or shall confer upon any person, other than the parties hereto
and their respective successors and assigns, any legal or equitable right,
benefit or remedy of any nature whatsoever, under or by reason of this
Agreement.
(g) Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY, AND
CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF DELAWARE,
WITHOUT REGARD TO THE PRINCIPLES THEREOF REGARDING CONFLICT OF LAWS.
(h) Waiver of Jury Trial. EACH PARTY HERETO HEREBY IRREVOCABLY
WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY PROCEEDING (WHETHER BASED ON CONTRACT,
TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY
TRANSACTION OR AGREEMENT CONTEMPLATED HEREBY OR THE ACTIONS OF ANY PARTY HERETO
IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE OR ENFORCEMENT HEREOF.
(i) Specific Performance. The parties hereto agree that irreparabe
damage would occur in the event any provision of this Agreement was not
performed in accordance with the terms hereof and that the parties shall be
entitled to specific performance of the terms hereof, in addition to any other
remedy at law or in equity.
<PAGE>
11
(j) Severability. If it shall be determined by court order not
subject to appeal or discretionary review that any provision or wording of this
Agreement shall be invalid or unenforceable under applicable law, such
invalidity or unenforceability shall not invalidate the entire Agreement and
shall be construed so as to limit any term or provision so as to make it
enforceable or valid within the requirements of applicable law, and, in the
event such term or provision cannot be so limited, this Agreement shall be
construed to omit such invalid or unenforceable provisions.
(k) Entire Agreement. This Agreement and the Merger Agreement,
including any exhibits or schedules hereto or thereto, or any other instruments,
agreements or documents referenced herein or therein, constitute the entire
agreement among the parties hereto with respect to the subject matter hereof,
and supersede all other prior agreements or undertakings with respect thereto,
both written and oral.
(l) Headings. The headings contained in this Agreement are for
reerence purposes only and shall not affect in any way the meaning or
interpretation of this Agreement.
(m) Counterparts. This Agreement may be executed in one or more
counterparts, and by the different parties hereto in separate counterparts, each
of which when executed shall be deemed to be an original but all of which taken
together shall constitute one and the same agreement.
(n) Further Assurances. Each party hereto shall execute,
acknowledge, deliver, file, record and publish such further certificates,
instruments, documents and amendments, and do all such further acts and things
as may be required by law or to carry out the intent and purposes of this
Agreement.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
<PAGE>
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
executed as of the date first written above by their respective officers
thereunto duly authorized.
CELL GENESYS, INC.
By: \s\ STEPHEN A. SHERWIN
------------------------------------
Stephen A. Sherwin, M.D.
Chairman of the Board, President and
Chief Executive Officer
SOMATIX THERAPY CORPORATION
By: \s\ EDWARD O. LANPHIER
------------------------------------
Edward O. Lanphier II
Executive Vice President and
Chief Financial Officer
<PAGE>
EXHIBIT 10.2
CONFORMED COPY
STOCK OPTION AGREEMENT
STOCK OPTION AGREEMENT, dated as of January 12, 1997 (as amended,
restated, supplemented or otherwise modified from time to time, this
"AGREEMENT"), between CELL GENESYS, INC., a corporation organized and existing
under the laws of the State of Delaware ("CGI"), as the grantor hereunder (the
"GRANTOR"), and SOMATIX THERAPY CORPORATION, a corporation organized and
existing under the laws of the State of Delaware ("STC"), as the grantee
hereunder (the "GRANTEE");
W I T N E S S E T H:
- - - - - - - - - -
WHEREAS, CGI, S Merger Corp., a corporation organized and existing
under the laws of the State of Delaware and a direct wholly owned subsidiary of
CGI, and STC have entered into an agreement and plan of merger and
reorganization, dated as of January 12, 1997 (the "MERGER AGREEMENT"; terms used
and not otherwise defined herein are used herein as defined in the Merger
Agreement); and
WHEREAS, as a condition to the willingness of STC to enter into the
Merger Agreement and the STC Stock Option Agreement, STC has required that CGI
agree, and in order to induce STC to enter into the Merger Agreement and the STC
Stock Option Agreement, CGI has agreed to grant STC an option, upon the terms
and subject to the conditions set forth in this Agreement, to purchase up to
3,286,703 newly issued shares of common stock, par value $.001 per share, of CGI
(the "GRANTOR COMMON STOCK"), representing approximately 19.9% of the shares of
Grantor Common Stock issued and outstanding on the date hereof;
NOW, THEREFORE, in consideration of the foregoing and the
representations, warranties, covenants and agreements set forth herein and in
the Merger Agreement, and other good and valuable consideration, the receipt and
adequacy of which are hereby acknowledged, and intending to be legally bound
hereby, the parties hereto hereby agree as follows:
SECTION 1. Grant of Stock Option. The Grantor hereby grants to the
Grantee an irrevocable option (the "STOCK OPTION") to purchase up to 3,286,703
shares of Grantor Common Stock (the "OPTION SHARES") at a purchase price of
$9.12 per Option Share (the "PURCHASE PRICE").
SECTION 2. Exercise of Stock Option. (a) Subject to the conditions
set forth in Section 3, the Stock Option may be exercised by the Grantee, in
whole or in part, at any
<PAGE>
2
time or from time to time after the occurrence of an Exercise Event (as defined
below) and prior to the Termination Date (as defined below).
(b) An "EXERCISE EVENT" shall occur for purposes of this Agreement
upon the occurrence of any event or circumstance which obligates the Grantor,
or, in the case of Section 9.05(c)(ii) of the Merger Agreement, may obligate the
Grantor in the event a Competing Transaction is consummated within the 12-month
period referred to therein, to pay to the Grantee any amount specified pursuant
to Section 9.05 of the Merger Agreement.
(c) The "TERMINATION DATE" shall occur for purposes of this Agreement
upon the first to occur of any of (i) the Effective Time; (ii) the termination
of this Agreement pursuant to Section 10; or (iii) the date which is 90 days
after the occurrence of an Exercise Event.
(d) In the event the Grantee wishes to exercise the Stock Option, the
Grantee shall send a written notice (a "STOCK EXERCISE NOTICE") to the Grantor
specifying the total number of Option Shares the Grantee wishes to purchase, the
denominations of the certificate or certificates evidencing such Option Shares
which the Grantee wishes to receive, a date (a "CLOSING DATE"), which shall be a
business day which is at least five and not more than 10 business days after
delivery of such notice, and place for the closing of such purchase (a
"CLOSING"). Upon receipt of a Stock Exercise Notice, the Grantor shall be
obligated to deliver to the Grantee a certificate or certificates evidencing the
number of Option Shares specified therein, in accordance with the terms of this
Agreement, on the later of (i) the date specified in such Stock Exercise Notice
and (ii) the first business day on which the conditions specified in Section 3
shall be satisfied; provided, however, that notwithstanding the foregoing, the
Grantor shall have the right, exercisable by written notice to the Grantee
within three business days after receipt of a Stock Exercise Notice, to elect to
treat such Stock Exercise Notice as a Cash Exercise Notice pursuant to Section
2(e) for all purposes of this Agreement, and to pay to the Grantee an amount in
cash equal to the Spread (as defined below) within 10 business days following
receipt of such Stock Exercise Notice.
(e) If at any time the Stock Option is then exercisable pursuant to
the terms of Section 2(a), the Grantee may elect, in lieu of exercising the
Stock Option to purchase Option Shares as provided in Section 2(a), to send a
written notice to the Grantor (a "CASH EXERCISE NOTICE"; either a Cash Exercise
Notice or a Stock Exercise Notice, an "EXERCISE NOTICE") specifying a date which
shall be a business day which is at least five and not more than 10 business
days following the date such notice is given on which date the Grantor shall pay
to the Grantee an amount in cash equal to the Spread (as defined below)
multiplied by such number of Option Shares as the Grantee shall specify. As
used herein, "SPREAD" shall mean the excess, if any, over the Purchase Price of
the higher of (i) if applicable, the highest price per share of the Grantor
Common Stock paid by any person in a Competing Transaction (the "COMPETING
PURCHASE PRICE") or (ii) the closing price of the shares of
<PAGE>
3
Grantor Common Stock on the NMS on the last trading day immediately prior to the
date of the Cash Exercise Notice (the "CLOSING PRICE"). If the Competing
Purchase Price includes any property other than cash, the Competing Purchase
Price shall be the sum of (i) the fixed cash amount, if any, included in the
Competing Purchase Price plus (ii) the fair market value of such other property.
If such other property consists of securities with an existing public trading
market, the average of the closing prices (or the average of the closing bid and
asked prices if closing prices are unavailable) for such securities in their
principal public trading market on the five trading days ending one trading day
prior to the date of the Cash Exercise Notice shall be deemed to equal the fair
market value of such property. If such other property consists of something
other than cash or securities with an existing public trading market and, as of
the payment date for the Spread, agreement on the value of such other property
has not been reached, the Competing Purchase Price shall be deemed to be the
amount of any cash included in the Competing Purchase Price plus the fair market
value of such other property (as determined by a nationally recognized
investment banking firm jointly selected by the Grantor and the Grantee). For
this purpose, the parties shall use commercially reasonable efforts to cause any
determination of the fair market value of such other property to be made within
three business days after the date of delivery of the Cash Exercise Notice.
Upon exercise of its right to receive the Spread pursuant to this Section 2(e)
or the Grantor electing to treat a Stock Exercise Notice as a Cash Exercise
Notice pursuant to Section 2(d), the obligations of the Grantor to deliver
Option Shares pursuant to Section 3 shall be terminated with respect to such
number of Option Shares for which the Grantee shall have elected to be paid the
Spread. If at the time payment of the Spread by the Grantor is due, the Grantor
shall not have consummated a Competing Transaction, the Grantor may elect to pay
the Spread in cash or in shares of Grantor Common Stock, valued at the closing
price of shares of Grantor Common Stock on the NMS on the business day prior to
such payment (the "CLOSING DATE PRICE").
SECTION 3. Conditions to Delivery of Option Shares. The obligation
of the Grantor to deliver Option Shares upon any exercise of the Stock Option is
subject to the following conditions:
(a) Such delivery or payment shall not in any material respect
violate, or otherwise cause the material violation of, the rules and
regulations of the NASD or any material Law, including, without limitation,
the HSR Act, applicable to such exercise of the Stock Option and the
delivery of the Option Shares or payment of the Spread in respect of such
exercise; and
(b) There shall be no preliminary or permanent injunction or
other order by any court of competent jurisdiction preventing or
prohibiting such exercise of the Stock Option or the delivery of the Option
Shares or payment of the Spread in respect of such exercise.
<PAGE>
4
SECTION 4. Closings. (a) At each Closing pursuant to Section 2(d),
the Grantor shall deliver to the Grantee a certificate or certificates
evidencing the number of Option Shares specified in the applicable Stock
Exercise Notice (in the denominations specified therein), and the Grantee shall
purchase each such Option Share from the Grantor at the Purchase Price.
(b) At each Closing pursuant to Section 2(e), the Grantor shall
deliver to the Grantee cash in an amount determined pursuant to Section 2(e).
(c) (i) Certificates evidencing Option Shares delivered hereunder
may, at the election of the Grantor, contain the following legend:
THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS,
AND MAY NOT BE TRANSFERRED, SOLD, ASSIGNED, PLEDGED, HYPOTHECATED OR
OTHERWISE DISPOSED OF, AND NO REGISTRATION OF TRANSFER OF SUCH SECURITIES
WILL BE MADE ON THE BOOKS OF THE ISSUER, UNLESS SUCH TRANSFER, SALE,
ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSAL IS MADE IN CONNECTION
WITH AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933,
AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS OR IS EXEMPT FROM THE
REGISTRATION REQUIREMENTS OF SUCH ACT, THE RULES AND REGULATIONS IN EFFECT
THEREUNDER AND ANY APPLICABLE STATE SECURITIES LAWS.
(ii) The Grantor shall, upon the written request of the holder thereof,
issue such holder a new certificate evidencing such Option Shares without such
legend in the event (A) such Option Shares have been registered pursuant to the
Securities Act, (B) such Option Shares have been sold in reliance on and in
accordance with Rule 144 promulgated under the Securities Act or (C) such holder
shall have delivered to the Grantor an opinion of counsel, in form and substance
reasonably satisfactory to the Grantor, to the effect that subsequent transfers
of such Option Shares may be effected without registration under the Securities
Act.
(d) All payments made pursuant to this Section 4 shall be made by wire
transfer of immediately available funds.
SECTION 5. Adjustments upon Share Issuances, Changes in
Capitalization, Etc. (a) In the event of any change in the Grantor Common
Stock or in the number of outstanding shares of Grantor Common Stock by reason
of a stock dividend, split-up, recapitalization, combination, exchange of shares
or similar transaction or any other change
<PAGE>
5
in the corporate or capital structure of the Grantor (including, without
limitation, the declaration or payment of an extraordinary dividend of cash,
securities or other property), the type and number of shares or securities to be
issued by the Grantor upon exercise of the Stock Option shall be adjusted
appropriately, and proper provision shall be made in the agreements governing
such transaction, so that the Grantee shall receive upon exercise of the Stock
Option the number and class of shares or other securities or property that the
Grantee would have received in respect of the Grantor Common Stock if the Stock
Option had been exercised immediately prior to such event, or the record date
therefor, as applicable, and elected to the fullest extent it would have been
permitted to elect to receive such securities, cash or other property.
(b) In the event that the Grantor shall enter into an agreement (i) to
consolidate with or merge into any person, other than the Grantee or any of its
subsidiaries, and shall not be the continuing or surviving corporation of such
consolidation or merger, (ii) to permit any person, other than the Grantee or
any of its subsidiaries, to merge into the Grantor and the Grantor shall be the
continuing or surviving corporation, but, in connection with such merger, the
then outstanding shares of Grantor Common Stock shall be changed into or
exchanged for stock or other securities of the Grantor or any other person or
cash or any other property or then outstanding shares of Grantor Common Stock
would after such merger represent less than a majority of the outstanding shares
and share equivalents of the surviving corporation or (iii) to sell or otherwise
transfer all or substantially all of its assets to any person, other than the
Grantee or any of its subsidiaries, then, and in each such case, proper
provision shall be made in the agreements governing such transaction so that the
Grantee shall receive upon exercise of the Stock Option the number and class of
shares or other securities or property that the Grantee would have received in
respect of the Grantor Common Stock if the Stock Option had been exercised
immediately prior to such transaction, or the record date therefor, as
applicable, and elected to the fullest extent it would have been permitted to
elect to receive such securities, cash or other property.
(c) All of the provisions of this Agreement shall apply with
appropriate adjustments to any securities for which the Stock Option becomes
exercisable pursuant to this Section 5.
SECTION 6. Representations and Warranties of the Grantor. The
Grantor hereby represents and warrants to the Grantee as follows:
(a) Organization; Authority Relative to This Agreement. The
Grantor has been duly organized and is validly existing and in good
standing under the laws of the State of Delaware. The Grantor has all
necessary corporate power and authority to execute and deliver this
Agreement, to perform its obligations hereunder and to consummate the
transactions contemplated hereby. The execution and delivery of this
Agreement by the Grantor and the consummation by the Grantor
<PAGE>
6
of the transactions contemplated hereby have been duly and validly
authorized by the board of directors of the Grantor, and no other corporate
proceedings on the part of the Grantor are necessary to authorize this
Agreement or to consummate such transactions. This Agreement has been duly
and validly executed and delivered by the Grantor and, assuming the due
authorization, execution and delivery by the Grantee, constitutes a legal,
valid and binding obligation of the Grantor, enforceable against the
Grantor in accordance with its terms. The Grantor has taken all
appropriate actions so that the restrictions on business combinations
contained in Section 203 of the General Corporation Law will not apply with
respect to or as a result of the transactions contemplated hereby.
(b) Authority to Issue Shares. The Grantor has taken all
necessary corporate action to authorize and reserve and permit it to issue,
and at all times from the date hereof through the Termination Date shall
have reserved, all the Option Shares issuable pursuant to this Agreement,
and the Grantor will take all necessary corporate action to authorize and
reserve and permit it to issue all additional shares of Grantor Common
Stock or other securities which may be issued pursuant to Section 4, all of
which, upon their issuance and delivery in accordance with the terms of
this Agreement, will be duly authorized, validly issued, fully paid and
nonassessable, will be delivered free and clear of all security interests,
liens, claims, pledges, options, rights of first refusal, agreements,
limitations on the Grantee's voting rights, charges and other encumbrances
of any nature whatsoever (other than this Agreement) and will not be
subject to any preemptive rights.
(c) No Conflict; Required Filings and Consents. The execution
and delivery of this Agreement by the Grantor do not, and the performance
of this Agreement by the Grantor will not, (i) require any consent,
approval, authorization or permit of, or filing with or notification to any
Governmental Entity, other than pursuant to the HSR Act, (ii) conflict with
or violate any provision of the certificate of incorporation or by-laws or
equivalent organizational documents of the Grantor or any material
subsidiary thereof, (iii) conflict with or violate any Law applicable to
the Grantor or any material subsidiary thereof or by which any property or
asset of the Grantor or any material subsidiary thereof is bound or
affected, or (iv) result in any breach of or constitute a default (or an
event which with notice or lapse of time or both would become a default)
under, or give to others any right of termination, amendment, acceleration
or cancellation of, or result in the creation of a lien or other
encumbrance of any nature whatsoever on any property or asset of the
Grantor or any material subsidiary thereof pursuant to, any note, bond,
mortgage, indenture, contract, agreement, lease, license, permit, franchise
or other instrument or obligation to which the Grantor or any material
subsidiary thereof is a party or by which the Grantor or any material
subsidiary thereof or any property or asset of the Grantor or any material
subsidiary thereof is bound or affected, except, in the case of clauses
(i),
<PAGE>
7
(iii) and (iv), for any such conflicts, violations, breaches, defaults or
other occurrences which could not reasonably be expected to prevent or
delay in any material respect the exercise by the Grantee of the Stock
Option or any other right of the Grantee under this Agreement.
SECTION 7. Covenants of the Grantor. (a) Listing; Other Action.
(i) The Grantor shall, at its expense, use its best efforts to cause the Option
Shares to be listed for quotation on the NMS, subject to notice of issuance, as
promptly as practicable following the date of this Agreement, and will provide
prompt notice to the NASD of the issuance of each Option Share.
(ii) The Grantor shall use its best efforts to take, or cause to be taken,
all appropriate action, and to do, or cause to be done, all things necessary,
proper or advisable under applicable Law to consummate and make effective the
transactions contemplated hereunder, including, without limitation, using all
commercially reasonable efforts to obtain all licenses, permits, consents,
approvals, authorizations, qualifications and orders of Governmental Entities.
Without limiting the generality of the foregoing, the Grantor shall, when
required in order to effect the transactions contemplated hereunder, make all
necessary filings and any other required or appropriate submissions under the
HSR Act as promptly as practicable.
(iii) The Grantor shall not take any action in order to intentionally
cause the exercise of the Stock Option to violate, or to require the vote of the
stockholders of the Grantor in order not to violate, any rules or regulations of
the NASD.
(b) Registration. Upon the request of the Grantee at any time and
from time to time within three years of the first Closing, the Grantor shall (i)
effect, as promptly as practicable, up to two registrations under the Securities
Act covering any part or all (as may be requested by the Grantee) of the Option
Shares or other securities that have been acquired by or are issuable to the
Grantee upon exercise of the Stock Option, and to use its best efforts to
qualify such Option Shares or other securities under any applicable state
securities laws and (ii) include any part or all of the Option Shares or such
other securities in any registration statement for common stock filed by the
Grantor under the Securities Act in which such inclusion is permitted under
applicable rules and regulations, and to use its best efforts to keep each such
registration described in clauses (i) and (ii) effective for a period of not
less than six months. If the managing underwriter of a proposed offering of
securities by the Grantor shall advise the Grantor in writing that, in the
reasonable opinion of the managing underwriter, the distribution of the Option
Shares requested by the Grantee to be included in a registration statement
concurrently with securities being registered for sale by the Grantor would
adversely affect the distribution of such securities by the Grantor, then the
Grantor shall either (i) include such Option Shares in the registration
statement, but the Grantee shall agree to delay the offering and sale for such
period of time as the managing
<PAGE>
8
underwriter may reasonably request (provided that the Grantee may at any time
withdraw its request to include Option Shares in such offering) or (ii) include
such portion of the Option Shares in the registration statement as the managing
underwriter advises may be so included for sale simultaneously with sales by the
Grantor. The registrations effected under this Section 7(b) shall be effected
at the Grantor's expense except for underwriting commissions allocable to the
Option Shares and the fees and disbursements of the Grantee's counsel. The
Grantor shall indemnify and hold harmless the Grantee, its affiliates and
controlling persons and their respective officers, directors, agents and
representatives from and against any and all losses, claims, damages,
liabilities and expenses (including, without limitation, all out-of-pocket
expenses, investigation expenses, expenses incurred with respect to any judgment
and fees and disbursements of counsel and accountants) arising out of or based
upon any statements contained in, or omissions or alleged omissions from, each
registration statement (and related prospectus) filed pursuant to this Section
7(b); provided, however, that the Grantor shall not be liable in any such case
to the Grantee or any affiliate or controlling person of the Grantee or any of
their respective officers, directors, agents or representatives to the extent
that any such loss, claim, damage, liability (or action or proceeding in respect
thereof) or expense arises out of or is based upon an untrue statement or
omission made in such registration statement or prospectus in reliance upon, and
in conformity with, written information with respect to the Grantee or any such
affiliate, controlling person, officer, director, agent or representative
thereof, as the case may be, furnished by the Grantee or any such other person
to the Grantor for use in the preparation of such registration statement.
SECTION 8. Representations and Warranties of the Grantee. The
Grantee hereby represents and warrants to the Grantor as follows:
(a) Organization; Authority Relative to This Agreement. The
Grantee has been duly organized and is validly existing and in good
standing under the laws of the State of Delaware. The Grantee has all
necessary corporate power and authority to execute and deliver this
Agreement, to perform its obligations hereunder and to consummate the
transactions contemplated hereby. The execution and delivery of this
Agreement by the Grantee and the consummation by the Grantee of the
transactions contemplated hereby have been duly and validly authorized by
the board of directors of the Grantee, and no other corporate proceedings
on the part of the Grantee are necessary to authorize this Agreement or to
consummate such transactions. This Agreement has been duly and validly
executed and delivered by the Grantee and, assuming the due authorization,
execution and delivery by the Grantor, constitutes a legal, valid and
binding obligation of the Grantee, enforceable against the Grantee in
accordance with its terms.
(b) No Conflict; Required Filings and Consents. The execution
and delivery of this Agreement by the Grantee do not, the performance of
this Agreement by the Grantee will not, (i) require any consent, approval,
authorization or permit of,
<PAGE>
9
or filing with or notification to any Governmental Entity, other than
pursuant to the HSR Act, (ii) conflict with or violate any provision of the
certificate of incorporation or by-laws or equivalent organizational
documents of the Grantee, (iii) conflict with or violate any Law applicable
to the Grantee or by which any property or asset of the Grantee is bound or
affected, or (iv) result in any breach of or constitute a default (or an
event which with notice or lapse of time or both would become a default)
under, or give to others any right of termination, amendment, acceleration
or cancellation of, or result in the creation of a lien or other
encumbrance of any nature whatsoever on any property or asset of the
Grantee pursuant to, any note, bond, mortgage, indenture, contract,
agreement, lease, license, permit, franchise or other instrument or
obligation to which the Grantee is a party or by which the Grantee or any
property or asset of the Grantee is bound or affected, except, in the case
of clauses (i), (iii) and (iv), for any such conflicts, violations,
breaches, defaults or other occurrences which could not reasonably be
expected, individually or in the aggregate, (A) to prevent or delay in any
material respect the exercise by the Grantor of any right of the Grantor
under this Agreement or (B) to have a CGI Material Adverse Effect.
SECTION 9. Covenants of the Grantee. The Grantee shall acquire the
Option Shares for investment purposes only and not with a view to any
distribution thereof in violation of the Securities Act, and shall not sell any
Option Shares purchased pursuant to this Agreement except in compliance with the
Securities Act.
SECTION 10. Termination. This Agreement, other than the rights and
obligations of the Grantor and the Grantee under Sections 7, 9 and 11 shall
terminate on February 12, 1998.
SECTION 11. Miscellaneous. (a) Expenses. Except as otherwise
provided herein or in the Merger Agreement, all costs and expenses incurred in
connection with the transactions contemplated by this Agreement shall be paid by
the party incurring such expenses.
(b) Notices. All notices and other communications given or made
pursuant hereto shall be in writing and shall be deemed to have been duly given
or made as of the date delivered, mailed or transmitted, and shall be effective
upon receipt, if delivered personally, mailed by registered or certified mail
(postage prepaid, return receipt requested) to the respective parties at their
addresses as specified in the Merger Agreement or sent by electronic
transmission to the respective parties at their telecopier numbers as specified
in Section 10.02 of the Merger Agreement.
(c) Assignment. This Agreement may not be assigned by operation of
law or otherwise without the express written consent of each party hereto (which
consent may be granted or withheld in the sole discretion of each such party);
provided, however, that the
<PAGE>
10
Grantee may assign all or any of its rights and obligations hereunder to any
wholly owned subsidiary of the Grantee; provided further that no such assignment
shall relieve the Grantee of its obligations hereunder if such assignee does not
perform such obligations.
(d) Amendment; Waiver. This Agreement may not be amended except by an
instrument in writing signed by the parties hereto. Any party hereto may (i)
extend the time for the performance of any obligation or other act of any other
party hereto, (ii) waive any inaccuracy in the representations and warranties
contained herein or in any document delivered pursuant hereto and (iii) waive
compliance with any agreement or condition contained herein. Any such extension
or waiver shall be valid if set forth in an instrument in writing signed by the
party or parties to be bound thereby. No failure or delay by any party in
exercising any right, power or privilege hereunder shall operate as a waiver
thereof nor shall any single or partial exercise thereof preclude any other or
further exercise thereof or the exercise of any other right, power or privilege.
The rights and remedies herein provided shall be cumulative and not exclusive of
any rights or remedies provided by law.
(e) Successors and Assigns. The provisions of this Agreement shall be
binding upon and inure to the benefit of the parties hereto and their respective
successors and permitted assigns.
(f) No Third Party Beneficiaries. Nothing herein, express or implied,
is intended to or shall confer upon any person, other than the parties hereto
and their respective successors and assigns, any legal or equitable right,
benefit or remedy of any nature whatsoever, under or by reason of this
Agreement.
(g) Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED
AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF DELAWARE, WITHOUT
REGARD TO THE PRINCIPLES THEREOF REGARDING CONFLICT OF LAWS.
(h) Waiver of Jury Trial. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES
ALL RIGHT TO TRIAL BY JURY IN ANY PROCEEDING (WHETHER BASED ON CONTRACT, TORT OR
OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY TRANSACTION OR
AGREEMENT CONTEMPLATED HEREBY OR THE ACTIONS OF ANY PARTY HERETO IN THE
NEGOTIATION, ADMINISTRATION, PERFORMANCE OR ENFORCEMENT HEREOF.
(i) Specific Performance. The parties hereto agree that irreparable
damage would occur in the event any provision of this Agreement was not
performed in accordance with the terms hereof and that the parties shall be
entitled to specific performance of the terms hereof, in addition to any other
remedy at law or in equity.
<PAGE>
11
(j) Severability. If it shall be determined by court order not
subject to appeal or discretionary review that any provision or wording of this
Agreement shall be invalid or unenforceable under applicable law, such
invalidity or unenforceability shall not invalidate the entire Agreement and
shall be construed so as to limit any term or provision so as to make it
enforceable or valid within the requirements of applicable law, and, in the
event such term or provision cannot be so limited, this Agreement shall be
construed to omit such invalid or unenforceable provisions.
(k) Entire Agreement. This Agreement and the Merger Agreement,
including any exhibits or schedules hereto or thereto, or any other instruments,
agreements or documents referenced herein or therein, constitute the entire
agreement among the parties hereto with respect to the subject matter hereof,
and supersede all other prior agreements or undertakings with respect thereto,
both written and oral.
(l) Headings. The headings contained in this Agreement are for
reference purposes only and shall not affect in any way the meaning or
interpretation of this Agreement.
(m) Counterparts. This Agreement may be executed in one or more
counterparts, and by the different parties hereto in separate counterparts, each
of which when executed shall be deemed to be an original but all of which taken
together shall constitute one and the same agreement.
(n) Further Assurances. Each party hereto shall execute, acknowledge,
deliver, file, record and publish such further certificates, instruments,
documents and amendments, and do all such further acts and things as may be
required by law or to carry out the intent and purposes of this Agreement.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
<PAGE>
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
executed as of the date first written above by their respective officers
thereunto duly authorized.
CELL GENESYS, INC.
By: \s\ STEPHEN A. SHERWIN
------------------------
Stephen A. Sherwin, M.D.
Chairman of the Board, President and
Chief Executive Officer
SOMATIX THERAPY CORPORATION
By: \s\ EDWARD O. LANPHIER
------------------------
Edward O. Lanphier II
Executive Vice President and
Chief Financial Officer
<PAGE>
EXHIBIT 99.1
Contacts: Kathleen Sereda Glaub Edward O. Lanphier II
- -------- Senior Vice President and Executive Vice President and
Chief Financial Officer Chief Financial Officer
Cell Genesys, Inc. Somatix Therapy Corporation
415-358-9600, X242 510-748-3032
CELL GENESYS AND SOMATIX AGREE TO MERGE
MERGER WILL ESTABLISH LEADING GENE THERAPY COMPANY
FOSTER CITY and ALAMEDA, Calif., January 13, 1997 -- Cell Genesys, Inc. (Nasdaq:
CEGE) and Somatix Therapy Corporation (Nasdaq: SOMA) have signed a definitive
agreement to merge, establishing a leadership position in the field of gene
therapy. The merger is expected to significantly strengthen key research and
development programs, open up prospects for new forms of gene therapies, and
expand corporate partnering opportunities.
"This merger will enhance our competitive position and our ability to make gene
therapy a commercial reality," said Stephen A. Sherwin, M.D., chairman and chief
executive officer of Cell Genesys. "Gene therapy offers extraordinary
opportunities to intervene at the most basic levels of the disease process and
apply our increasing knowledge of the relationship of genes to disease. By
capitalizing on the strengths of our two companies and taking advantage of
extensive synergies in technologies and therapeutic programs, we believe we will
create a gene therapy powerhouse in terms of scientific talent, intellectual
property and commercial opportunities in this innovative field of medical
research."
"Our research and development programs are highly complementary," Dr. Sherwin
said. "Cell Genesys is focused on the treatment of AIDS and cancer. Somatix is
focused on cancer, central nervous system diseases and other disorders. In
addition, we will bring together two strong portfolios of gene delivery
technologies involving both viral and nonviral gene delivery systems. We plan
to use this 'toolbox' to create multiple product development opportunities by
matching specific therapeutic genes to the appropriate gene delivery system."
"For the last six years, Somatix has had in place a strategic objective to
'build the leading gene therapy company through a combination of mergers,
acquisitions and internal development.' This transaction allows us to realize
that strategic goal," said David W. Carter, chairman and chief executive officer
of Somatix. "We believe the new company will provide the management structure
and capital that will permit the science of Somatix to flourish and the
extensive intellectual property we have accumulated to be fully capitalized on.
We also believe the combined entity will have the critical mass and financial
staying power to see its technology through to profitable commercialization."
MERGER TERMS
- ------------
Under the terms of the agreement unanimously approved by the boards of both
companies, Somatix will become a wholly owned subsidiary of Cell Genesys in a
tax-free reorganization
-more-
<PAGE>
"Cell Genesys and Somatix Agree to Merge"
Page 2
and stock-for-stock merger. Pending approval by stockholders of both companies,
Somatix stockholders will receive 0.385 shares of Cell Genesys stock for each
share of Somatix stock, subject to adjustment under certain circumstances. Cell
Genesys stockholders, who will retain their current shares of stock, will own
approximately 61 percent of the combined company.
Completion of the merger is anticipated in April. The combined entity will be
located at existing Cell Genesys facilities in Foster City, California.
Somatix's Alameda site will be closed as soon as practical. A reduction of this
administrative infrastructure should lead to a significant reduction in costs
for the combined entity, and most importantly, allow the companies to quickly
and more completely integrate operations. A layoff of approximately 20 percent
of the total workforce is expected, largely due to the closure of the Alameda
site, but also to the consolidation of research and development programs during
the coming months.
RESEARCH AND DEVELOPMENT PROGRAMS
- ---------------------------------
"A key driver in future research and development efforts will be the ability to
finance gene therapy programs through corporate partners," Dr. Sherwin said.
"Cell Genesys' programs will continue in AIDS gene therapy, which is currently
supported through a worldwide collaboration with Hoechst Marion Roussel, and in
cancer gene therapy. We believe Somatix's central nervous system program, which
includes gene therapy for Parkinson's Disease, represents a significant asset,
and we are evaluating a strategy to build value through licensing or a joint
venture arrangement."
"A new configuration of Somatix's GVAX(TM) cancer vaccine will begin clinical
trials in lung cancer this year, with the goal of identifying a more attractive
economic profile for this product candidate," Dr. Sherwin said. "While we will
continue to evaluate efficacy data from recently completed clinical trials of
the current GVAX(TM) product configuration, we do not plan to initiate new
trials including a potential Phase III trial for melanoma. Furthermore, we plan
to combine the Cell Genesys and Somatix stem cell programs into a broader
research effort and focus this effort on major unmet medical needs including
AIDS and cancer. Over the course of the next three months, we will evaluate
partnering opportunities for these programs and finalize our research and
development strategy."
MANAGEMENT AND DIRECTORS
- ------------------------
Subject to stockholder approval, Cell Genesys' executive officers will serve as
the management team of the combined entity. Stephen A. Sherwin, M.D., will
continue as
-more-
<PAGE>
"Cell Genesys and Somatix Agree to Merge"
Page 3
chairman, president and chief executive officer. Other members of the senior
management team will include Kathleen Sereda Glaub, chief financial officer;
Daniel F. Hoth, M.D., chief medical officer; Bruce A. Hironaka, vice president
of corporate development; Mitchell Finer, Ph.D., vice president of research;
Bridget P. Binko, vice president of regulatory affairs; David Broad, Ph.D., vice
president of process development; and Christine McKinley, vice president of
human resources.
A number of executive officers of Somatix are expected to continue in a
transition capacity during the first year of combined operations. David W.
Carter, who is currently chairman and chief executive officer of Somatix, will
be elected to the new board of directors. Other board members will include
James M. Gower, Raju S. Kucherlapati, Ph.D., Joseph E. Maroun, Stephen A.
Sherwin, M.D. (chairman) and Eugene L. Step from Cell Genesys, and John T. Potts
Jr., M.D., Thomas E. Shenk, Ph.D., and Inder Verma, Ph.D. from Somatix.
In addition, Somatix has built a prominent Scientific Advisory Board comprised
of major leaders in the gene therapy field, who will continue to provide their
insight and perspective to the combined entity. Among them are Richard
Mulligan, Ph.D., Investigator, Howard Hughes Medical Institute at Children's
Hospital and Mallinckrodt Professor of Genetics, Harvard Medical School; Inder
Verma, Ph.D., Professor of Molecular Biology and Virology, The Salk Institute;
and Thomas E. Shenk, Ph.D., Investigator, Howard Hughes Medical Institute and
Professor, Princeton University. Raju S. Kucherlapati, Ph.D., Chairman of the
Department of Molecular Genetics, Albert Einstein College of Medicine, will be
joining this Scientific Advisory Board as part of his ongoing relationship with
Cell Genesys.
FINANCIAL IMPACT OF THE MERGER
- ------------------------------
The merger will be accounted for as a purchase for accounting and financial
purposes. The majority of the transaction price is expected to be characterized
as "in-process research and development," which will involve a one-time charge
during the quarter in which stockholders approve the merger.
"By capitalizing on the synergies between Cell Genesys and Somatix and by
rationalizing the businesses, we believe we can substantially reduce overall
projected net cash expenditures and maintain our current financial strength as
the best-financed independent gene therapy company in the industry," said
Kathleen Sereda Glaub, chief financial officer of Cell Genesys. "Excluding one-
time merger-related expenses, we anticipate that the net burn rate of the
combined entity will be approximately $20 million in 1997. As in the past, our
management team will focus resources on proprietary research and development
programs that have the greatest scientific merit and the greatest probability of
corporate partnering."
-more-
<PAGE>
"Cell Genesys and Somatix Agree to Merge"
Page 4
ADDITIONAL COMPANY BACKGROUND
- -----------------------------
Cell Genesys, which is headquartered in Foster City, California, is focused on
the development and commercialization of ex vivo and in vivo gene therapies to
treat major, life-threatening diseases and disorders. AIDS gene therapy is in
Phase II human clinical testing and is being developed through a worldwide
collaboration with Hoechst Marion Roussel. Cancer gene therapy, for which Cell
Genesys currently has worldwide rights, is in preclinical testing for colon,
ovarian and other specific types of cancer. These and other gene therapy
programs utilize proprietary, engineered genes and gene delivery systems. The
company's assets outside of gene therapy include its Abgenix, Inc. subsidiary,
which is focused on developing and commercializing antibody therapies for
inflammation, autoimmune disorders and cancer, as well as the company's
licensing program in gene activation technology.
Somatix Therapy Corporation is a leader in the field of gene therapy. The
company is focused on the research, development and commercialization of
proprietary processes for the genetic modification of cells and their use in the
treatment of human disease. Somatix's assets include their highly efficient
gene transfer technology, broad-based intellectual property and product
development programs focused on cancer and degenerative neurological diseases.
- --------------------------------------------------------------------------------
Statements made in this press release and in the accompanying Q & A about Cell
Genesys and Somatix, the proposed merger, events and operations post-merger,
product pipelines, corporate partnerships, licenses and intellectual property,
including statements other than statements of historical fact, are forward
looking statements and are subject to a number of uncertainties that would cause
actual results to differ materially from the statements made, including risks
associated with the success of research and product development programs, the
regulatory approval process and competitive products. Please see the Cell
Genesys Form 10-K dated March 28, 1996, and Somatix's Form 10-K dated June 30,
1996, including the portions of the Annual Report to Stockholders incorporated
therein by reference as well as the companies' reports on Form 10-Q and 8-K and
other periodic reports filed from time to time with the Securities and Exchange
Commission, for information about risks associated with clinical trials and
product development programs and other risks which may affect the companies
individually or jointly.
- --------------------------------------------------------------------------------
###
[1/13/97]
